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The Drug and Alcohol (D&A) Psychosocial Interventions 
Professional Practice Guidelines are the first generic 
professional guidelines for psychosocial interventions to 
be developed in NSW for drug and alcohol practice. The 
Guidelines take a stepped care approach to drug and 
alcohol treatment, which focuses on the adoption of 
best practice models for people with drug and alcohol 
issues, and reflects current best evidence and practice in 
the drug and alcohol counselling field. 
Responsibility for implementation of the Guidelines 
is shared across all levels of drug and alcohol clinical 
practice, and the Guidelines aim to increase the 
effectiveness of staff as psychosocial clinicians and 
systematise the use of psychosocial interventions for 
problematic drug and alcohol use across NSW. The 
Guidelines are intended to be applicable across the 
various allied health disciplines within drug and alcohol 
specialist services that are providing clinical psychosocial 
interventions. This includes Specialist and Generalist D&A 
professionals across public and private sectors. 
These Guidelines are not intended to provide detailed 
information relating to the implementation of all 
psychosocial therapies relevant to problematic drug and 
alcohol use. Rather, a range of psychosocial models are 
described with reference to the available evidence base 
for treating problematic drug and alcohol use, with 
readers referred to a range of additional resources, texts, 
and training courses that can provide advice and skills in 
the use of these psychosocial models.
A range of treatment processes are described in Section 
3 of these Guidelines, which are considered fundamental 
to any psychosocial intervention, regardless of the 
theoretical model on which the intervention is based. 
These elements include:
■  The importance of strategies for engaging and 
retaining drug and alcohol clients in treatment
■  Integration of psychosocial strategies with other 
treatment modalities (eg. pharmacological options, 
inpatient/outpatient settings, public/private and 
Non-Government sectors, face-to-face and internet-
based approaches, etc) 
■  The development and maintenance of clinical 
partnerships with professionals working in other 
treatment modalities and settings.
Once a client is engaged with a service and/or D&A 
professional, the following components will also form 
part of any psychosocial treatment strategy that is 
offered:
■  Intake and screening regarding acuity of 
presentation (intoxication, need for withdrawal 
management, etc), problematic drug and alcohol 
use, concurrent mental health problems (depression, 
anxiety, etc), social/other health problems, welfare 
issues and other risk management issues that need 
attention prior to engaging with a drug and alcohol 
treatment program
■  Informal and formal comprehensive assessment 
of the presenting drug and alcohol issues of the 
client, background and personal history, drug and 
alcohol history, readiness to change, and screening for 
psychological problems
■  Provision of feedback to the client about the 
outcomes of the assessment
■  Development of a treatment plan in collaboration 
with the client, including decisions about abstinence 
versus harm reduction goals, preventing relapse, 
strategies for achieving goals and methods for 
evaluation progress and outcomes
Executive Summary
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■  Implementation of interventions based on the 
treatment plan
■  Regular measurement and review of progress and 
outcomes in response to interventions provided
■  Consideration of the need for continuing care 
■  Discharge and onward referral when appropriate.
Specific psychosocial interventions for problematic drug 
and alcohol use will be offered, based on the agreed 
treatment plan developed by the D&A professional 
and the client. Regardless of the background, training 
and experience of D&A professionals, it is important 
that a range of therapeutic tools and approaches to 
assisting clients with problematic drug and alcohol use 
is made available. Such approaches will include brief and 
intensive psychosocial treatments, group therapies for 
couples/families, etc, self-help materials and so on.
In particular, all D&A professionals implementing 
psychosocial treatments should be able to provide 
Cognitive Behavioural Therapy, and be competent 
in the use of one additional intensive psychosocial 
treatment with a strong evidence base for use with 
problematic drug and alcohol use.
In Section 4, a range of specific psychosocial 
interventions is reviewed and evaluated in terms of the 
available evidence for treating problematic drug and 
alcohol use. These interventions are associated with 
a ‘★’ to ‘★★★’ recommendation system (increasing 
number of ‘★’ associated with increasing strength of 
recommendation and increasing strength of evidence of 
effectiveness in problematic drug and alcohol use). 
Psychosocial interventions with a ‘★★★’ rating and the 
strongest evidence and expert consensus for treating 
problematic drug and alcohol use are:
■  Assessment and Brief Intervention
■  Motivational Interviewing
■  Contingency Management
■  Cognitive Behaviour Therapy
■  Psychodynamic Therapy
■  Dialectical Behaviour Therapy
■  Self-Help Approaches (including web-based where 
available)
■  Continuing Care.
Psychosocial interventions with a ‘★★’ rating for treating 
problematic drug and alcohol use are:
■  Mindfulness-Based Stress Reduction
■  Acceptance and Commitment Therapy
■  Couple/Family Therapy
■  Self-Help Groups.
Psychosocial interventions with a ‘★’ rating and evidence 
based mainly on expert opinion suggesting effectiveness 
in treating problematic drug and alcohol use are:
■  Solution-Focussed Brief Therapy
■  Systemic Therapy
■  Narrative Therapy
■  Management of Crisis Situations. 
Strategies for improving sleep and dietary habits of drug 
and alcohol clients are also provided, along with tips 
for the D&A professional in managing specific types 
of problematic drug and alcohol use (tobacco, alcohol, 
cannabis, amphetamines/other stimulants, heroin/other 
opiates, ecstasy/other club drugs and polydrug use).
Given co-morbidity (concurrent physical, mental 
health and problematic drug and alcohol use issues) is 
increasingly common among drug and alcohol clients, a 
range of strategies and considerations are presented for 
drug and alcohol clients who also have co-morbid issues 
of depression, anxiety, psychosis, personality disorder, 
trauma, anger/aggression, pain and blood-borne viruses. 
In general, a thorough assessment of all presenting 
conditions should be conducted by D&A professionals, 
with most severe symptoms being prioritised for 
treatment. 
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From here, a focus on the impairment and distress 
experiences by the client, rather than on the 
establishment of a primary/secondary diagnosis of drug 
and alcohol disorder is recommended. D&A professionals 
should consider using a clinically-integrated treatment 
approach, incorporating psychosocial strategies relevant 
to both the problematic drug and alcohol use and the 
concurrent condition into the same intervention, while 
ensuring the development and maintenance of good 
rapport and strategies to actively engage clients in 
treatment. 
Since co-morbidity is often a complex treatment 
challenge, D&A professionals are advised to seek 
specific co-morbidity training to increase confidence in 
addressing these issues in drug and alcohol clients.
Care co-ordination and case management practices 
will also form part of the interventions offered by D&A 
professionals. In particular, the core activities of intensive 
case management should include:
■  Screening and assessment across all factors relating to 
the client’s presentation
■  Development of comprehensive, individual treatment 
or care plans
■  Co-ordination of treatment or care plan 
implementation
■  Facilitation of access to specialist treatment for drug 
and alcohol disorders
■  Facilitation of access to other health services including 
mental health, hepatology, emergency etc as required
■  Facilitation of access to a broad range of community 
services
■  Maintenance of contact with and support for the 
individual client 
■  Monitoring progress and outcome across the care plan
■  Review and revision of individual care plans.
A range of additional strategies is provided in Section 
7, which are important for use among special groups 
within the community who will also access treatment for 
problematic drug and alcohol use. These groups include:
■  Aboriginal people and communities
■  Sexual and gender diverse groups
■  Ageing population
■  Coerced clients (including those from criminal justice 
settings)
■  People from diverse cultural and linguistic backgrounds
■  Rural communities
■  Parents with drug and alcohol issues (including issues 
with pregnant clients)
■  Young people with emerging problems.
Also contained within Section 7 are tips for working 
with and accessing services for domestic violence, family 
violence and child protection.
In the final Section of these Guidelines, the important 
issue of clinical governance is addressed for individual 
clinicians, clinical teams and services, and at the 
managerial level. It is suggested that individual D&A 
professionals are responsible for their individual 
clients, and need to have sufficient skills, training and 
competence regarding the treatment of presenting 
complaints of clients accessing their service, be it in 
individual or group practice, in the public, private or 
Non-Government sector. However, D&A professionals 
are not expected to be an expert in the treatment of 
every issue or problem a client presents with, and thus 
should not work in isolation of other service teams, drug 
and alcohol agencies and services.
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At the service level, D&A professionals should have 
access to regular clinical supervision (not provided by the 
D&A professional’s clinical line manager), clinical review/
support practices (either with or without clinical line 
managers), and access to a senior person or clinical line 
manager who is familiar with and knowledgeable about 
the range of psychosocial treatments appropriate for 
drug and alcohol clients and the complex issues involved 
in delivering these treatments. 
Clients are also important partners in the clinical 
governance process, most often as active participants in 
their individual clinical reviews (eg. treatment planning 
and review) that form part of good clinical practice, with 
strategies for client collaboration, and the engagement 
of significant others, communities and other support 
people are outlined in Sections 3, 4 and 7.
A comprehensive reference list is provided in Section 9 
of these Guidelines, providing D&A professionals with a 
number of additional sources of information and detail 
about the above issues.
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These guidelines aim to provide services involved in the 
delivery of drug and alcohol (D&A) treatments with 
a benchmark for the delivery of quality psychosocial 
interventions. Each D&A professional needs to use these 
guidelines within the context of their role and scope of 
practice, and update their knowledge by accessing new 
research and clinical guidelines as they emerge. 
1.1 About these guidelines 
These guidelines were developed by the NSW Health 
Drug and Alcohol Allied Health Workers Advisory 
Committee, which is a sub-committee of NSW Health 
Drug and Alcohol Council. The Allied Health Workers 
Advisory Committee acted as the steering committee for 
the Guidelines. A consultant, Dr Frances Kay-Lambkin, 
was appointed by the then Centre for Drug and Alcohol, 
NSW Health, in 2006 to assist in the writing and 
editing of the guidelines. A list of key informants and 
committees consulted is included in Appendix A.
A number of key factors created the impetus for the 
NSW Health Drug and Alcohol Council to support 
the development of these Psychosocial Interventions 
Professional Practice Guidelines. These included a 
growing recognition of the value and importance of 
psychosocial interventions within the drug and alcohol 
field, a desire to provide support to its professional 
implementation, and the need for a greater level of 
understanding about the purpose and benefits of 
psychosocial interventions. Indeed, the 2004/5 Annual 
report on the NSW Minimum Data Set for drug and 
alcohol treatment services indicated that psychosocial 
interventions are the most common interventions offered 
in treatment (eg. 33.1% of closed episodes of treatment 
were for counselling interventions, 1). 
The Guidelines are aligned with the NSW Health Drug 
and Alcohol Plan 2006 - 2010, and aim to provide a 
professional framework to those workers who deliver 
specialist drug and alcohol psychosocial interventions. 
The Guidelines are not a policy directive and are not 
intended to replace or take precedence over local 
policies and procedures. Rather, they are intended to 
provide a broad overview of the main issues involved 
in delivering psychosocial interventions within drug and 
alcohol treatment settings, and direct the reader to more 
detailed information where it is available.
These Guidelines are based on a review of the existing 
evidence for the effectiveness of psychosocial assessments 
and interventions among people using drugs and alcohol. 
In cases where limited research literature exists on the 
approaches described herein, expert opinion has been 
used as the basis for recommendations. At the time of 
writing these Guidelines, an important Australian text 
on counselling for addictive disorders was published 
by Ali Marsh and Ali Dale (2). While this text covered 
many domains relevant to these Guidelines, there were 
important gaps in relation to providing psychosocial 
interventions for drug and alcohol clients, at least in 
NSW, which still needed to be addressed. As such, 
these Guidelines draw heavily on the Marsh and Dale 
text where appropriate (2), and attempt to fill these 
gaps with additional literature and expert opinion. Key 
references also include practice guidelines published by 
the American Psychiatric Association (http://www.psych.
org/psych_pract/treatg/pg/prac_guide.cfm), Managing 
Alcohol and Other Drug Problems (3), and the World 
Health Organisation’s Management of Mental Disorders 
(4). A number of NSW Health Clinical Practice Guidelines, 
Discussion Papers and circulars are also relevant, and are 
available at http://www.health.nsw.gov.au/pubs/a-z/a.html 
and the Centre for Drug and Alcohol website http://www.
health.nsw.gov.au/public-health/dpb/publications.htm. 
These include:
■  Clinical Guidelines for methadone and buprenorphine 
treatment (5)
■  Withdrawal Clinical Practice Guidelines (6)
■  Case Management in drug and alcohol treatment (7)
■  Stepped Care in drug and alcohol treatment (8)
Introduction
SECTION 1
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■  Framework for Suicide risk assessment and 
management (9)
■  Clinical Supervision Guidelines (10).
1.2 Drug and Alcohol services in NSW 
The NSW Health Drug Treatment Services Plan (11) 
describes the following activities as core within the drug 
and alcohol service setting:
■  Outpatient services (triage, assessment, case 
management, day programs, medical care)
■  Withdrawal (inpatient and community)
■  Pharmacotherapy
■  Residential Rehabilitation (intensive rehabilitation)
■  Infrastructure (essential components of service 
delivery such as training, early intervention, 
consultation and liaison).
Likewise, within the non-government sector, drug and 
alcohol services are provided around the same core 
activities, such as service delivery, policy development 
and advise through Peak Organisations and advocacy on 
behalf of clients with problematic drug and alcohol use. 
Psychosocial approaches are easily integrated into each 
of these core treatment activities across government and 
non-government sectors.
1.3  Who are these guidelines 
intended for? 
The Guidelines are intended to be applicable across 
the various allied health disciplines within drug and 
alcohol specialist services that provide direct clinical 
psychosocial interventions. This includes professionals 
working in ‘specialist’ drug and alcohol services, such 
as psychologists, social workers, health education 
officers, nurse Drug and Alcohol Workers as well as 
positions that are classified more generally as ‘Drug 
and Alcohol Worker’. They also include student Drug 
and Alcohol Workers who are undertaking placements 
at services and students completing TAFE-based 
traineeships in drug and alcohol issues. In addition, 
these guidelines will be relevant to professionals 
in ‘Generalist’ roles who provide drug and alcohol 
interventions, such as medical practitioners, school 
counsellors, etc They are also applicable for both the 
government and non-government sector in relation 
to community-based services. The recently released 
drug and alcohol treatment guidelines for residential 
settings (12) is the appropriate resource for residential 
settings and therapeutic communities. A significant 
number of professionals in the private sector will also 
assess and treat clients with problematic drug and 
alcohol use. Private sector drug and alcohol workers 
will include a range of drug and alcohol specialist and 
generalist professionals as outlined above, working 
either in collaboration with drug and alcohol services 
or in isolation of them. These Guidelines can also be 
used by private sector D&A professionals to guide the 
psychosocial interventions they provide to clients with 
problematic drug and alcohol use, and potentially offer 
some suggestions as to how the public and private 
sector can work together to deliver a comprehensive 
program of drug and alcohol treatment.
Access to comprehensive health care is every individual’s 
right. D&A professionals need to ensure that their own 
attitudes, value judgments and personal experiences do 
not interfere with a client’s right to quality care. Clients 
have the right to be engaged routinely in direct clinical 
care, with D&A professionals also providing links to 
referrals and case management services.
More specifically, the focus of drug and alcohol 
psychosocial services aims to give equal regard to the 
physical, psychosocial and cultural wellbeing of all 
people receiving care. All practice should therefore 
include a comprehensive substance use assessment, 
and offer suitable interventions and harm reduction 
strategies to all clients identified as being at risk of, 
or experiencing, problems associated with substance 
use. These problems may include intoxication, regular/
harmful use, withdrawal and/or dependence, and 
related health and social issues. D&A professionals have 
an important advocacy role to play for clients in terms 
of improving access to the range of these services in a 
timely and equitable manner.
1.4 The nature of the problem
Substance use disorders tend to be chronic in nature 
with genetic, psychosocial, and environmental factors 
influencing their development and manifestation (13). 
People with substance use disorders have a pattern of use 
that is characterised by continuous or periodic impaired 
control over their use of alcohol or drugs, preoccupation 
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with the substance, use despite adverse consequences, 
and distortions in thinking, most notably denial (14).
Problematic drug and alcohol use can give rise to 
many areas of concern. There are often social, cultural 
and economic consequences of problematic drug 
and alcohol use, in addition to a range of physical, 
psychological and other health consequences. As 
such, any treatment for these conditions must 
consider a range of physical, psychological and social/
environmental approaches. These Guidelines describe 
how such approaches may be combined to provide the 
best response to the client’s needs.
The primary goals of treatment for problematic drug and 
alcohol use should be concerned with reducing harms 
associated with the use of substances, if not actually 
reducing or ceasing the use of drugs and or alcohol 
altogether. These harms can be categorised according to 
the pattern of use of the substance in which the client 
engages. That is, the greater the quantity and frequency 
of problematic drug and alcohol use, the more severe 
the potential for substance dependence, and the more 
severe the medical and psychosocial consequence of use 
(15). Four core diagnoses are typically used to describe a 
client’s drug and alcohol use (15): 
■  Non-user/abstinent
■  Non-hazardous use
■  Hazardous or harmful use
■  Substance use disorders (including abuse and 
dependence).
Non-hazardous use would include low levels of drug and 
alcohol use, which may not necessarily warrant clinical 
intervention. Potential harms would be those associated 
with intoxication, and encompass overdose, risk taking 
activities, hangovers, poor work and study performance 
etc (2). Hazardous or harmful use characterises drug and 
alcohol use that is clinically significant and regular, but 
not sufficient to meet formal diagnostic criteria for abuse 
or dependence (16). Functional impairment and distress 
may be evident at this level of misuse across a number of 
social, occupational, physical, legal domains, and it may 
also act as an early warning sign for the development of 
a formal substance use disorder (2, 16). The American 
Psychiatric Association (16) suggests that brief interventions, 
for example, can be used to reduce this risk. 
Substance use disorders include abuse and dependence, 
intoxication, withdrawal, and various mental states 
(dementia, psychosis, anxiety, mood disorder, etc) that 
the substance induces when it is used. Understanding 
the patterns of alcohol and drug use and related harms 
will assist the D&A professional to work with the client 
to identify clear targets for treatment. 
Criteria for Substance Abuse (14)
A pattern of drug and alcohol use leading to one 
or more of the following within the same 12-month 
period:
■  Failure to fulfil major role obligations
■  Recurrent use in physically hazardous situations
■  Recurrent drug and alcohol-related legal problems
■  Continued use despite having persistent or 
recurrent problems.
Criteria for Substance Dependence (14)
A pattern of drug and alcohol use leading to 
three or more of the following within the same 
12-month period:
■  Tolerance 
■  Withdrawal
■  Substance taken in larger amounts or over longer 
period than intended
■  Persistent desire or unsuccessful efforts to 
modify use
■  Great deal of time spent in activities necessary to 
obtain the substance
■  Important social, occupational, recreational 
activities given up or reduced
■  Drug and alcohol use continues despite knowledge 
of problems.
In the literature and clinical practice, the terms 
‘addiction’ and ‘dependence’ tend to be used 
interchangeably to characterise problematic drug 
and alcohol use, and depending on the context of 
the discussion. The World Health Organisation and 
the American Psychiatric Association advocate the 
use of the term “substance dependence” rather than 
“drug addiction” in their formal publications (17). The 
term addiction, however, can draw attention to the 
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behavioural components of the problematic drug and 
alcohol use, highlighting that there are psychological as 
well as physiological components of dependence (17).
This is important, as treatment planning needs to 
address both the psychological as well as physiological 
aspects of a client’s problem in order to maximise 
outcomes.
Different parts of the brain are involved in the 
psychological and physiological dependence (13). 
For example, psychological dependence is primarily 
developed through the ‘reward pathway’ in the brain, 
involving different structures and pathways from 
those involved in the development of physiological 
dependence.
The important psychological aspect of dependence is 
the chronic, relapsing pattern of behaviour in which 
compulsive drug seeking and drug taking persists, 
despite serious negative consequences. Continued 
use of addictive substances induces adaptive changes 
in the central nervous system, which leads to 
tolerance, physical dependence, craving and relapse. 
Individuals vary in how long this process takes, with 
the psychological impact of the drug a likely major 
determining factor. The psychological component of 
addictive behaviour is determined to a large extent by 
the reasons why drugs are used and the beliefs and 
attitudes towards the drug. 
In contrast, the two main physiological features of 
substance dependence are tolerance and withdrawal. 
Tolerance develops when the central nervous system 
responds to reduce the effects of a drug, and develops 
at different rates to the different effects of a drug. For 
example, tolerance to the euphoric and analgesic effects 
of opiates develops rapidly but there is little tolerance to 
the effects on the bowel. The tolerance level a client has 
to a particular drug tends to fall when the drug has not 
been used for some time. For some, drugs tolerance can 
rise to a high level but small increases beyond this level 
can be fatal. That is, the margin between the ‘effective’ 
and lethal doses of a drug can become narrow in highly 
dependent users. In summary, comprehensive models 
of problematic drug and alcohol use involve multiple 
components, most notably biological, psychological 
and social factors (18). In addition, a client may have 
both genetically determined and acquired vulnerabilities 
that interact with their ongoing life experiences to 
influence the development of problematic drug and 
alcohol use, substance dependence/addiction. From a 
treatment perspective problematic drug and alcohol use 
is determined by biological, psychological and social 
factors all of which need to be addressed if treatments 
are to be effective.
1.5 Key definitions 
For the purposes of these guidelines, the term ‘drug 
and alcohol (D&A) professional’ refers to anyone 
with responsibility for the provision of direct clinical 
psychosocial interventions either individually or in a 
group setting. The term ‘client’ refers to the recipient 
of any of these services. The client may be an individual, 
couple, family, group, organisation or other social unit. 
‘Problematic drug and alcohol use’ will be used 
throughout these Guidelines as a way of describing 
patterns of drug and alcohol use that is considered 
problematic and warranting intervention by D&A 
professionals. This includes substance misuse and 
substance use disorders such as abuse and dependence. 
In 1992, Australia became the first country in the world 
to introduce harm reduction principles into drug policies 
(19), and a ‘harm reduction’ approach is recommended 
for all psychosocial interventions with drug and alcohol 
clients. Harm reduction approaches take a realistic and 
practical approach to the issues of problematic drug and 
alcohol use, and focus on reducing the harms (negative 
effects) associated with a client’s problematic drug and 
alcohol use, reinforcing any positive changes a client 
is able to make (20). It is important to note that harm 
reduction approaches to problematic drug and alcohol 
use recognise abstinence as the only safe goal for some 
severely substance dependent individuals. 
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However, for many drug and alcohol clients, abstinence 
is not always a realistic goal (19). Instead, clients and 
D&A professionals work together to build a hierarchy 
of goals for the client to work towards around their 
problematic drug and alcohol use, which may or may 
not culminate in total abstinence (19, 21). For a heroin 
user, this may include not sharing needles, participating 
in a needle/syringe program, engaging in safe sex, using 
methadone maintenance treatment, using other health 
services for relevant health issues, changing to oral or 
inhaled forms of heroin, etc (19). 
Harm reduction approaches are broadly grouped 
into three main categories: prevalence reduction 
(encouraging a reduction in problematic drug and 
alcohol use in society, eg through education about 
the harms of use;) quantity reduction (reducing the 
frequency and amount of drug and alcohol used); and 
harm reduction (managing the other negative effects of 
problematic drug and alcohol use, 22). More information 
on how to apply these strategies is available in MacCoun 
(22) and Marlatt (19).
1.5.1 A Note on Psychosocial Interventions
Clients with problematic drug and alcohol use will report 
multiple health and social problems (18). It is often 
difficult to establish whether these problems were the 
cause or effect of the client’s problematic drug and 
alcohol use (15). In addition, emotional and psychological 
difficulties will act as both predictors and outcomes 
of alcohol and drug use problems (2). Peers will exert 
considerable influence on problematic drug and alcohol 
use, with clients often limiting their social networks 
to those that reinforce their drug taking behaviours 
(2). As such, considering the ‘psychosocial’ factors of 
problematic drug and alcohol use in any treatment 
plan is important. The American Psychiatric Association 
(16), in the revised Practice guideline for the treatment 
of clients with substance use disorders, highlight 
psychosocial treatments as essential components to any 
comprehensive treatment program.
The term ‘psychosocial’ is used widely but is not well 
defined. In general, the National Institute on Alcohol 
Abuse and Alcoholism (National Institutes of Health, 
USA) and the American Psychiatric Association uses 
the term ‘psychosocial’ to describe the social and 
psychological behaviours involved in problematic drug 
and alcohol use (23, 24). Specifically, this may include:
■  The emotions, attitudes and behaviours that are 
characteristic of an individual (Psychological, internal 
context)
■  The social/external context (family, community, cultural 
factors) that is characteristic of the environment in 
which the individual lives 
■ The interaction between these two sets of factors.
The range of psychosocial issues affecting clients with 
problematic drug and alcohol use is described in Hulse, 
White and Cape (pg 25, 15).
Psychosocial interventions provide individuals an 
opportunity to explore, discover and clarify ways of 
living more resourcefully, with a greater sense of well-
being and encompass the physical, psychological, 
spiritual, environmental, family and cultural values. More 
specifically, clinicians whose main focus is psychosocial 
interventions need to have the skills and ability to 
integrate a number of differing theoretical models and 
approaches to help clients resolve specific problems, 
make decisions, cope with crises, work through conflict, 
improve relationships with others and improve their 
sense of self. These Guidelines aim to direct the D&A 
professional towards the key strategies, techniques and 
texts that will facilitate the delivery of an evidence-
based, effective psychosocial intervention.
Psychosocial interventions should focus both on content 
and process throughout treatment in order to maximise 
outcomes (2). Content refers to the skills, strategies and 
theoretical orientations of the treatment itself, such 
as those interventions described in Section 4. On the 
other hand, process refers to the interaction between 
the D&A professional and the client whilst engaged in 
therapy, the therapeutic relationship and interpersonal 
processes that occur during the therapy session (2). 
These strategies are discussed in Section 3. 
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1.6  Levels of evidence and strength 
of recommendation
In Sections 3, 4 and 5 of these Guidelines, the available 
literature on the process and content of psychosocial 
treatments has been reviewed, and rated according 
to the strength of evidence supporting its use among 
clients with problematic drug and alcohol use. As a 
guide, the following system of classifying the research 
has been used, which is based on the recommendations 
provided by the National Health and Medical Research 
Council (see Table 1) (25).
Randomised controlled trials remain the gold standard 
in determining the scientific quality of treatments. These 
studies will typically involve an active treatment group 
and a control group (who receive no treatment, reduced 
treatment, or placebo medication). Allocation to active 
treatment and control conditions occurs by chance, i.e. 
is randomly determined. Baseline measures will be taken 
prior to treatment allocation and provision, and these 
will be repeated at various stages following completion 
of the active treatment period, eg at six- and 12-months, 
by people who are unaware of the treatment allocation 
of the participant. Given that randomised controlled 
trials are not common for a number of the techniques 
described within these Guidelines, recommendations 
from Clinical Experts have been combined with the 
available evidence to assist the D&A professional to 
select the most appropriate psychosocial intervention 
for their client. To facilitate this, the National Health and 
Medical Research Council have provided the following 
outline for providing recommendations about treatments 
where randomised controlled trials are not available 
(see Table 2) (25).
Table 1 - Levels of evidence used to classify the range of psychosocial interventions described in these Guidelines.
Level of Evidence Study Design
1 A number of randomised controlled trials with similar findings indicating the efficacy of the intervention
2 At least one randomised controlled trial indicating the efficacy of the intervention
3-a Several well-designed controlled studies (non-randomised) indicating the efficacy of the intervention
3-b Several comparative studies, cohort studies, or case-control studies indicating the efficacy of the intervention
4 Single case studies, or expert editorials/commentaries indicating efficacy of the intervention
Table 2 - Strength of recommendations made for approaches described in these Guidelines, combining the available 
evidence and expert clinical opinions (25).
Strength of 
Recommendation
Description
★★★ The recommendation is supported by at least Level 2 research and expert clinical opinion
★★ The recommendation is supported by at least Level 3 research and expert clinical opinion
★ The recommendation is based on expert opinion
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This Section outlines the key elements involved in good 
professional practice for D&A professionals working with 
clients with problematic drug and alcohol use. Specialist 
D&A professionals should also refer to individual 
professional practice guidelines appropriate to their 
specialty area.
2.1 Physical settings 
The diversity of settings within which psychosocial services 
are delivered requires careful consideration. The D&A 
professional working alone, or in collaboration with another 
D&A professional and/or Health worker, may provide drug 
and alcohol treatment services. These services will take 
place in a range of physical settings, including:
■  Inpatient settings (ward, meeting rooms, hospital 
grounds, etc)
■  Outpatient settings (community centres, consultation 
rooms, primary care services, etc)
■  Client homes (eg. For community-based withdrawal, 
outreach work, etc).
Most work is undertaken face-to-face, but there are also a 
growing number of telephone and online services available. 
Some D&A professionals are moving between these 
different settings and modes of delivery during the course 
of their work and are therefore required to consider what 
constitutes good practice in different settings. 
2.2 Professional practice 
D&A professionals are responsible for setting and 
monitoring professional boundaries, and making this 
explicit to the client. These might include the times and 
frequency of counselling sessions, through to clarifying 
roles, expectations for therapy and the limits to the 
therapeutic relationship (26). Having more than one type 
of relationship may lead to enmeshment of relationship 
boundaries, misuse of power, and impaired professional 
judgement, increasing the potential for harm to the 
client. Examples of such relationships include, but are 
not limited to, familial, social, financial, business, or close 
personal relationships with clients.
Individual factors within the D&A professional will also 
impact on the psychosocial intervention provided (2). 
These factors include flexibility, warmth, respectfulness, 
confidence and interest in the client and the issues with 
which they present, as well as personal presentation, 
vocabulary, attachment and relating style of the D&A 
professional. All D&A professionals encounter the 
challenge of responding to the diversity of their clients 
and finding ways of working effectively with them.
Psychosocial activities are to be undertaken only 
with professional intent, and not casually and/or in 
extra-professional relationships. D&A professionals are 
responsible for:
■  Using agreements/contracts that clearly outline the 
expectations and parameters of psychosocial services
■  Communicating these parameters and expectations to 
the client
■  Disclosing any conflict of interest; and
■  Obtaining supervision.
2.3 Ethics and codes of conduct 
Ethical standards are important in promoting safe and 
professional psychosocial practices that cater to the best 
interests of clients and the public at large. Professional 
accountability is also critical in ensuring clients’ 
confidence in the psychosocial services provided.
D&A professionals need to be compliant with relevant 
codes of conduct, ethics and professional practice. The 
NSW Drug and Alcohol Clinical Supervision Guidelines 
(10) provide a summary of key ethical issues that are 
relevant in the drug and alcohol treatment context. All 
D&A professionals must also comply with the following:
SECTION 2
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■  Mandatory reporting requirements under the Children 
and Young Persons Care and Protection Act
■  The legal obligations outlined within the NSW Health 
Policy for Identifying and Responding to Domestic 
Violence 
■ The local Area Health Service Code of Conduct
■  Local service ethical codes and requirements under 
funding agreements for NGO’s. 
D&A professionals, regardless of the setting in which 
they are practising (eg. NSW Health, NGO, private 
sector) also need to be familiar with the above 
documents and have a sound understanding of 
compliance as it relates directly to the provision of 
psychosocial services for problematic drug and alcohol 
use. In addition, there are also specific professional and 
ethical codes that apply to some individual professions. 
In summary, these codes are:
■ The NSW Medical Board Code of Professional Conduct
■  Code of Ethics for Nurses in Australia 
■  Code of Professional Conduct for Nurses in Australia
■  Australian Association of Social Workers Code of Ethics
■  NSW Psychologists Registration Board Code of 
Professional Conduct
■ The Australian Psychological Society Code of Ethics
■  Australian Psychosocial Association Code of Conduct.
2.4  Confidentiality 
There is a need to ensure the confidentiality of 
individual psychosocial sessions in order to provide a 
safe and constructive environment for the client, and 
to encourage a sufficient level of disclosure from them. 
On the other hand, there is a need to ensure that any 
sufficiently serious issues related to clinical practice are 
dealt with appropriately and transparently. 
D&A professionals must refrain from disclosing 
information received in confidence, unless there is a 
sufficient and compelling reason to do so. Sufficient and 
compelling reasons include:
■  Having the written consent of the client to disclose 
confidential information eg about the client during 
the course of supervision, or when referred by 
other agencies for treatment. Some agencies (eg. 
Department of Community Services (DoCS), the 
Courts) may have legal authority to require reports; 
■  If the client threatens to harm her/ himself or 
someone else
■  If a child is currently ‘at risk’ of abuse or neglect; 
■  If the D&A professional or case notes are subpoenaed 
to court.
D&A professionals may also be required to disclose 
information about clients who are mandated to attend 
treatment or clients who are minors.
As Health Systems move towards integrating client/
client files, it needs to be recognised that all health 
professionals responsible for the care of the client may 
have access to information placed in files. In addition, 
the requirements of providing adequate clinical 
governance such as clinical reviews, as discussed in 
Section 8, will often result in relevant client details 
being discussed at team meetings, with clinical line 
management or in clinical supervision. Such sharing of 
information is allowed under the NSW Health Privacy 
Manual (Version 2, 27) or with the consent of the client.
Confidentiality and the limits of confidentiality need to 
be negotiated with the client where appropriate, and 
clearly articulated by the D&A professional in the case of 
mandatory reporting requirements (2). D&A professionals 
should follow the guidelines outlined in the NSW Health 
Privacy Manual (Version 2, 27) and if they are unclear 
at any stage about the appropriateness of disclosing 
information, they should seek advice or consultation 
with their line manager and/or their medico-legal 
department.
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This Section describes the basic components of 
psychosocial interventions that should be present 
regardless of the specific type of psychosocial treatment 
being delivered by the D&A professional. There is 
strong evidence to suggest that one of the most 
important ingredients of a successful intervention is the 
effectiveness of the D&A professional in building rapport 
and therapeutic alliance (28). These general counselling 
skills, such as supportive, non-judgmental discussions 
about the client’s problematic drug and alcohol use, 
have been associated with improvements in alcohol use 
in a few studies (Level 3-b evidence). However, they 
have not been researched as a stand-alone treatment 
for problematic drug and alcohol use in the research 
literature (29). 
A few studies do exist to suggest that good 
interpersonal skills, empathy and the ability to provide 
clients with a warm, supportive environment in which to 
discuss their problematic drug and alcohol use, while not 
sufficient on their own to produce long term change, 
are associated with increased treatment effects (Level 
2 evidence) and better outcomes for clients (Level 3-a 
evidence) when combined with specific psychosocial 
treatments (2, 28, 29, see Section 4). It is generally 
accepted that, regardless of the treatment applied, 
therapeutic alliance and environment are likely to have a 
significant impact on client outcomes (29). 
3.1  Stepped Care Framework and the 
Importance of Client-Centred Care
In the stepped care approach to treatment, a set of 
empirically-based guidelines determine what treatment 
to start with and when to progress to an additional 
or more intensive treatment (30-32). The principle of 
Stepped Care as outlined by Schippers (32) states that 
“a more intensive or different form of care or treatment 
is offered only when a less intensive form has been 
insufficient”. For drug and alcohol treatment, this would 
involve monitoring the results of interventions and 
changing the intervention in some way if the outcome in 
relation to treatment goals was poor (8). 
Stepped care models for psychosocial treatments can 
sidestep the often difficult task of predicting from 
the outset of treatment which strategies will be most 
appropriate for a particular client at a particular point 
in time (33). In addition, stepped care treatment models 
offer an alternative way to manage existing treatment 
resources more efficiently (eg. time), and are flexibly 
able to incorporate new evidence directly into practice 
as it becomes available (33). Stepped care approaches 
to treatment have been tested in several different 
settings, including: depression (34); anxiety (35); alcohol 
problems (30); smoking (36); heroin dependence (37); 
and recently for people experiencing mental health and 
substance use co-morbidity (38).
A proposed model of stepped care for psychosocial 
treatment of problematic drug and alcohol use is illustrated 
opposite (Figure 3.1). It should be noted that the stepped 
care model in Figure 3.1 is a simplified model, and is not 
intended to cover the range of individual variations in 
treatment plans and clients likely to be encountered by 
D&A professionals. Further, the model in Figure 3.1 applies 
only following an initial intake process, where issues related 
to risk management, withdrawal, and rehabilitation options 
have been ruled out and a psychosocial intervention 
is indicated. See the range of NSW Health clinical 
practice guidelines on withdrawal (6) and detoxification 
management (39) and residential rehabilitation options (12) 
for more information on these issues.
Within a stepped care model, D&A professionals and 
clients should discuss commencing treatment at any 
of the levels outlined in Figure 3.1, and following a 
comprehensive assessment phase. Usually, a first step 
in the management of these conditions is to gain an 
understanding of the range of issues impacting on 
the client with problematic drug and alcohol use, 
and set some immediate goals for change that are 
relevant to the client at that point in time (first tier of 
intervention). Client distress may need to be triaged 
within this first step, with immediate pressing concerns 
such as suicidality, emergency accommodation or other 
crisis issues given priority over others (30). For further 
SECTION 3
Treatment processes
PAGE 16 NSW HEALTH Drug and Alcohol Psychosocial Interventions Professional Practice Guidelines 
information about the management and assessment 
of suicide risk, refer to NSW Health Department Policy 
PD2005_121 ‘Management of clients with possible 
suicidal behaviour.’ Alternatively, D&A professionals 
working outside the public sector should refer to 
their own body’s professional practice guidelines for 
information relating to this issue.
Following assessment, a minimal intervention could be 
offered that addresses the client’s immediate goals for 
change (second level intervention). This may take the 
form of education about symptom management, and 
information about non-hazardous drug and alcohol use 
or other self-help booklets as appropriate. Brief advice or 
suggestions about other lifestyle factors that might be 
enhanced or reduced may also be included at this time.  
Following the brief (minimal) intervention, response to 
treatment should be assessed to determine the need for 
continued monitoring, referral, crisis support or more 
intensive intervention (third level intervention). At this 
time, issues that need crisis intervention and immediate 
action may be identified, such as suicide risk, risk to 
others, urgent medical care, withdrawal etc At this 
monitoring point, the plan may be to continue with 
regular monthly monitoring, as negotiated between D&A 
professional and client, with the option to re-enter a more 
active treatment or be discharged from the service at a 
later stage. Clients who have not responded to the brief 
intervention could be offered the next step of treatment.
If there has been no response to the brief intervention, 
and/or the client has some residual symptoms or issues 
to address, a more intensive intervention is suggested. 
At this step, psychosocial intervention (eg. Cognitive 
Behaviour Therapy) is recommended, given its potential 
to prevent relapse and continue to produce improvement 
outside the active treatment phase (34).
Figure 3.1: A simplified stepped care model for delivering psychosocial interventions to clients accessing drug and 
alcohol (D&A) treatment.
Comprehensive assessment, triage and inital goal setting
D&A use, functioning, readiness to change, mental health issues, etc
Level 1: Brief, minimal intervention
Feedback from assessment, brief advice, psychoeducation
Monitor response to Level 1
D&A use, functioning, readiness to change, mental health issues, etc
Level 2: Psychosocial intervention
Cognitive behaviour therapy, motivational interviewing.
? Other psychosocial approaches  ? Case management, self-help, etc.
Monitor response to Level 2
D&A use, functioning, readiness to change, mental health issues, etc
Level 3: Targeted intervention
Focus on residual problems, 
more intensive psychological/pharmacological approaches
Monitor response to Level 3
D&A use, functioning, readiness to change, mental health issues, etc
Crisis
Maintenance
Crisis
Maintenance
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Following completion of the second tier of treatment 
and a monitoring period, residual symptoms and other 
problems may still require attention. For example, if 
alcohol issues persist at this stage, a focus on this issue 
could occur. Extended treatment programs may be 
an essential next step among clients with problematic 
drug and alcohol use who have not made significant 
improvements in outcome following the completion of a 
brief program of treatment (40).
Several options exist for extended, targeted interventions 
at this stage of treatment, including pharmacotherapy, 
extended psychotherapy, and inpatient treatment. 
These will vary in length and frequency of contact (40). 
Consequently, longer programs of psychological treatment, 
if available, could also be considered. Other interventions 
might focus on relapse prevention, community intervention, 
relationship counselling, trauma intervention etc as 
suggested by the ongoing monitoring process (38, 41). 
These approaches are described in more detail in Section 4. 
The next and any subsequent steps in treatment would 
be determined by the results of ongoing monitoring and 
assessment, following completion of a previous step in 
treatment.
3.2 Treatment process issues 
3.2.1 Engagement and Retention in Treatment 
Central to the provision of any psychosocial intervention 
is a strong bond and working alliance between the client 
and the D&A professional (28). Indeed, the focus of early 
interactions with the client should be on maximizing 
their engagement with the Service/D&A professional and 
fostering a sense of collaboration in working through 
the set of issues and distress that the client brings 
to treatment (42). An empathic, non-confrontational 
approach from the D&A professional is often associated 
with better client outcomes (Level 3-a evidence, 29).
D&A professionals must respond to clients in a different 
way from the other people in the client’s life who 
contribute to their ongoing problems (2). By doing so, 
the client can learn new ways of responding to and 
thinking about old, recurrent situations. 
Clients will bring a range of reactions and behaviours 
into the counselling relationship that mirror the problems 
they experienced in their early development with parents 
who were under- or over-involved (15). In these cases, 
the challenge for the D&A professional is to respond 
to these behaviours in a way that does not exacerbate 
or perpetuate them. To best address these issues, D&A 
professionals need to gather as much information 
as possible about the client’s early developmental 
experiences, (eg. how loved and accepted they felt, 
how secure they felt and the extent to which they were 
encouraged to establish their independence etc), while 
working hard at establishing a safe and warm therapeutic 
bond with the client. Marsh and Dale (2) describe these 
issues in more detail, and provide a detailed discussion on 
working with clients with unmet developmental needs.
D&A professionals can use a variety of tools to 
encourage these processes. For example, testing out the 
relationship between the client and D&A professional 
within sessions can be useful in clarifying the reactions 
and behaviours of clients (2). In addition, a range of 
‘self-involving’ statements can be made by the D&A 
professional to enhance collaboration and bond, and to 
process any negative reactions (2, pgs 221-225):
“I’m feeling kind of stuck right now...like we are going 
around in circles...I wonder if you are feeling the same...?”
“You seem to be finding it really hard to look at me 
today, and I wonder if you are feeling unsafe...”
“As I listen to you talk about what happened, I find 
myself feeling sad too...”
“How were you feeling about coming to see me today...?”
What do you think I expect you to do...?
“I noticed that you went really quiet just then...I wonder 
what you think I meant when I said...?”
Clients will need different types and durations of 
process work relative to content work. These issues are 
explored in more detail by Marsh and Dale (2), who 
also recommend that these specific process tools only 
be used when the D&A professional has observed a 
particular reaction or behaviour several times and is 
reasonably confident about their observations.
The challenge for the D&A professional is to monitor client 
reactions to them, work with these issues, and balance 
these process issues with the content of the psychosocial 
intervention. Supervision for the D&A professional is central 
to identifying and working through these issues (2).
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3.2.2  Integration within other treatment 
modalities 
A range of options should be presented to clients 
with substance use problems (29). This will include 
pharmacological and/or psychosocial options, inpatient 
programs, outpatient programs, public, private and 
Non-Government sectors, etc. In addition, a range of 
modalities is available for the delivery of psychosocial 
interventions, including face-to-face approaches, 
internet-based treatments, and other forms of self-
administered interventions. D&A professionals can 
help clients to weigh up the positives and negatives 
associated with each treatment option, and decide on a 
course of action that best suits their needs (42, 43). The 
American Psychiatric Association (16) suggests that this 
integrated approach is associated with improved rates of 
treatment retention and better treatment outcomes. 
There is a wide range of modalities and settings in which 
psychosocial interventions can be delivered to clients 
with problematic drug and alcohol use. Accordingly, 
D&A professionals need to be aware of, and able to 
discuss the range of available treatment options with 
clients, provide advice around these issues and integrate 
the most appropriate options into the drug and alcohol 
treatment plan developed for each client.
3.2.3 Clinical partnerships 
To facilitate an integrated treatment program for the 
client, D&A professionals need to develop and maintain 
strong clinical partnerships with professionals working 
with other treatment modalities, and in other treatment 
settings. Formalising these partnerships, particularly 
between government and non-government sectors, can 
enhance treatment provision, and ensure a co-ordinated, 
consistent approach to the client’s care is maintained. If 
the service within which the D&A professional is operating 
does not have links with particular relevant services, the 
D&A professional can create and foster these partnerships 
with individual workers within other clinical settings. This 
way, arrangements can be formalised for the responsibility 
of service provision to the client, and the release/sharing 
of client information (with client consent).
3.3  Common treatment processes in 
psychosocial interventions 
The basic components of any psychosocial intervention, 
regardless of the theoretical underpinnings, include: 
measurement (screening and assessment), treatment 
planning and goal setting, implementation of the specific 
intervention, evaluation of outcomes, and follow-up (44). 
These core components are described in detail below.
3.3.1 Intake and screening 
The evidence for the benefits of routine screening for 
problematic drug and alcohol use across a range of 
health settings is strong (28). Routine screening upon 
intake should occur for acute presentations, such as 
intoxication and withdrawal (15), along with sufficient 
information about problematic drug and alcohol use 
such that an appropriate service can be mobilised to 
assist with the management of the client (15). Given 
the high co-morbidity of mental health problems 
among clients with problematic drug and alcohol use, 
screening for common mental health problems (such as 
depression, anxiety, etc) should be considered as part 
of the routine intake and screening procedures across 
drug and alcohol settings (private sector, public sector, 
inpatient, outpatient, etc (45)).
Upon intake, a range of information needs to be 
gathered to assist in directing the client to the most 
appropriate treatment service. This information is 
summarised below (4). 
Example of Information to be Collected 
upon Intake (4)
■  Does the client’s problematic drug and alcohol use 
warrant treatment?
■  What is the most suitable treatment for this client?
■  Can this treatment be provided by the available staff 
members? If not, what referral options are there?
■  Is there a past history of withdrawal management 
or substitution maintenance that is important in 
deciding on an appropriate treatment plan?
■  Are there any concurrent mental health, social, or 
other health problems that need urgent attention 
before drug and alcohol treatment is commenced?
■  Are there any immediate welfare issues that need to 
be addressed? (eg. homelessness)
■  Are there any other risk management issues that 
require urgent attention? (eg. children living at 
home with the client).
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A comprehensive list of screening instruments for use with 
problematic drug and alcohol use is available (see 46). For 
further information, refer to the NSW Drug and Alcohol 
Program, Centralised Intake Guidelines, June 2004 (47).
3.3.2 Comprehensive assessment 
Both informal and formal assessment needs to occur prior 
to the development and implementation of a treatment 
plan (2). This will include assessments of the presenting 
issues of the client, their background and personal history, 
alcohol and drug use history (including current use), 
readiness to change current issues, and screening for 
psychological problems. Informal discussions around these 
issues can be supplemented by the use of standardised 
assessment instruments (2, 28). The specifics of a 
comprehensive pre-treatment assessment are described in 
Section 4.
During the assessment, the need to raise sensitive 
issues will arise for the D&A professional (2). This is 
particularly the case when discussing problematic drug 
and alcohol use with a client who is not yet ready to 
engage in treatment for these issues. Focusing too soon 
on substance use in these situations will most likely elicit 
resistance from the client and interfere with rapport 
building. In these cases, the critical conditions for 
promoting change and reducing resistance are: accurate 
empathy, non-possessive warmth and genuineness (48). 
Tips for Raising Sensitive Issues (48)
■  A good general approach is to ask open-ended 
questions, to listen reflectively, affirm the client 
and summarise throughout 
■  Begin by asking generally about the client’s lifestyle, 
using any preceding discussion as a guide: “The 
information we have talked about in this session has 
given me a bit of an idea about what is going on in 
your life at the moment. But, I really don’t know a 
lot about you and the kind of life you lead. Perhaps 
we can spend a few minutes with you telling 
me about a typical day in your life, so that I can 
understand in more detail what happens? Tell me a 
bit more about the things you struggled with and 
how you felt at the time. Can you think of a typical 
recent day from beginning to end...You got up...” 
3.3.3 Feedback to client 
Providing feedback to the client on the outcomes and 
impressions gained from the pre-treatment assessment 
is an important tool in the psychosocial intervention. 
Feedback about the client’s disorder (if relevant), the nature 
and effects of problematic drug and alcohol use, medical 
and behavioural harms associated with specific substances, 
and the importance of treatment should also be provided 
(16). To maximise the potential benefits of this process, 
an emphasis on the client’s strengths as well as their 
weaknesses, communicated in an honest and encouraging 
manner, is recommended (2). Feedback from the 
assessment phase should be linked explicitly to clear goals 
for treatment (2). In addition, clients should also receive 
education about their substance use problems, information 
about different treatment options, and guidance as to how 
family members and friends may be engaged to promote 
recovery and reduce risk of relapse (16, 29).
Tips for Providing Feedback (2, pages 53-54)
■  Focus first on the client’s strengths
■  Gently and tactfully outline the client’s difficulties
■  Focus on the pattern of results, rather than an 
overall score
■  Pull the assessment results together and create 
a ‘story’ of how the client came to be in their 
current situation, and how they explain their current 
difficulties with alcohol/drugs, work, relationships, 
the law, and other life areas
■  Explore the client’s reactions to the feedback provided.
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3.3.4 The treatment plan 
A useful place to start the treatment planning process 
is by asking the client what brings them to treatment. 
This will assist the D&A professional to develop a 
broad idea of the client’s goals for therapy and then 
tailor a treatment plan accordingly. Clients will likely 
describe their presenting concerns in very general terms 
(eg. ‘I’m worried about my use of ...’), and the D&A 
professional will need to work with the client to refine 
these into concrete, measurable goals for change. In 
addition, the client and the D&A professional must have 
a shared understanding of the course of psychosocial 
treatment, in terms of its duration, regularity, review and 
termination procedures (2). 
Feeding back the results and impressions gained from 
assessment leads into a discussion around setting 
goals for treatment. Treatment that is planned and 
implemented according to a shared set of goals between 
client and D&A professional is associated with improved 
clinical outcomes (49). In addition, setting clear, concrete 
goals will also provide the D&A professional with a firm 
idea as to whether he/she has the skills necessary to 
assist the client to work towards and achieve these goals 
(2, 44). In general, psychosocial interventions will have 
five main goals (16, 44): 
1. Engage the client in treatment
2.  Reduce problematic drug and alcohol use to non-
harmful levels (may mean abstinence)
3.  Prevent relapse to pre-treatment levels of problematic 
drug and alcohol use
4.  Address lifestyle issues to encourage adherence to 
drug and alcohol goals
5. Improve the psychosocial status of the client.
Clients unwilling to discuss immediate and long-term 
abstinence might be more responsive to a short-term 
(trial) abstinence period (“a holiday from alcohol”) or 
tapering off their substance use toward abstinence. 
Miller & Rollnick (49) describe the following alternatives 
to immediate abstinence:
1. Negotiate a period of trial abstinence
2.  Commence a process of gradual tapering down 
toward abstinence, or
3.  Commence a period of trial moderation. Moderation 
may be an appropriate goal to start with, even though 
abstinence may be the longer-term outcome.
It is important to provide education about the potential 
risks of eliminating problematic drug and alcohol use 
completely after a period of heavy use. In cases of severe 
alcohol dependence, any client wanting to abstain totally 
from alcohol should be advised to do so only under 
medical supervision. In cases where medical staff are 
unavailable, then the NSW Drug and Alcohol Specialist 
Advisory Service is available for consultation. 
Tip for Commending Goals of Abstinence 
If the client has identified abstinence as a goal, then 
offer the following: 
“Successful abstinence is a safe choice. That is, you 
can be sure that you won’t have problems because 
of D&A use. There are good reasons to at least try a 
period of abstinence (eg to find out what it’s like to 
live without alcohol/other drugs, and how you feel, 
to learn how you have become dependent on it, to 
break habits, to experience a change and build some 
confidence, etc). 
Some people experience withdrawal symptoms 
when they cut back or stop alcohol, which can be 
uncomfortable as well as physically harmful. So, if 
you have a GP, and you decide to try a period of 
abstinence, please let him/her know, so that they can 
monitor your health during that period.”
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NSW Drug and Alcohol Specialist 
Advisory Service (DASAS):
Sydney Metropolitan Areas: 02 9361 8006
Other Areas: 1800 023 687
A goal of abstinence may need to be suggested if the 
client has co-existing medical conditions, psychological 
problems that are likely to be exacerbated, uses 
medications that are hazardous in combination with 
drugs and alcohol, is pregnant, or has a history of severe 
abuse and dependence. 
Tip for Recommending Abstinence When Indicated
Consider whether it is appropriate to advise abstinence 
as a goal, and if so, use the following approach:
“It’s your choice of course. I want to tell you, 
however, that I’m worried about the choice you’re 
considering, and if you’re willing to listen, I’d like to 
tell you why I’m concerned.”
The client needs to choose his or her own goal(s) 
within the treatment plan, rather than having the D&A 
professional ‘impose’ standards on their change process. 
While abstinence may be the desired goal for the D&A 
professional, this prospect may be overwhelming for 
a client to contemplate. It is far more important to 
maintain rapport and a good working alliance, and to 
start with goals that he or she is motivated to achieve. 
Accordingly, clients may prefer a non-abstinence or 
controlled-use goal for their drug and alcohol use, and 
will need similar assistance in planning for this and in 
harm reduction strategies to assist in achieving this goal. 
Controlled-use goals also need to be concrete, specific 
and realistically achievable. For example, the goal of 
“quitting alcohol” is not as specific or concrete as “I will 
stop drinking completely by XXX date.”
Central to the goal setting and treatment planning 
process is negotiation (2). Clients should feel that goals 
and treatment plans target their wants and needs, even 
in cases where these options conflict with the D&A 
professional’s ideas about what is in the client’s best 
interests. The exception to this is in cases of mandatory 
reporting, such as when the client is a danger themselves 
or others, or is breaking the law, etc the use of back-up 
or alternative plans is also important in case the client’s 
first option does not work out in the way they intend 
(2, 50). In addition, the client needs to decide whether 
their major goal needs to be broken down into smaller, 
short-term goals, as this approach will allow for positive 
reinforcement of any changes made in the direction of the 
ultimate goal, and maximise chances for success (44).
It is probable that over the next few years, the number 
of clients entering services through Court Diversion 
Programs and/or directed to attend by other agencies 
(eg. DoCS) will increase. This requires the counsellor to 
manage a range of possible conflicting agendas - see 
Section 7.6. Coerced Clients.
Taking a strengths-based approach to treatment planning 
and implementation will help counter the messages 
clients receive and internalise about their problematic 
drug and alcohol use, and encourage self-efficacy for 
change (2, 44). The D&A professional can help the client 
to focus on the things they already do well, and provide 
some practical skill development. In this way, confidence 
and motivation to change and make improvements to the 
situation are likely to be enhanced (2, 51). 
The treatment plan should be developed in collaboration 
with the client (and, where appropriate, external agencies) 
and recorded formally for both the client and D&A 
professional. This will serve as a summary of the intended 
psychosocial intervention that lies ahead (2, 52).
Tips for Creating a Treatment Plan (2, pgs 87-89)
■ A review of the client’s situation, including strengths
■ A statement of client goals
■ A statement of current support needs
■  Strategies for achieving goals
■  Methods of recording progress and evaluating 
outcomes.
3.3.5 Implementation of interventions 
The decision about which specific psychosocial 
intervention is to be used with the drug and Alcohol 
client should be made by both the client and D&A 
professional, and be related to the list of problems 
and goals generated in the above phases (52). Where 
possible, the choice of intervention should be based 
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on supporting evidence suggesting its effectiveness for 
the client’s issues, along with the skill and expertise of 
the D&A professional in delivering the intervention (52). 
Adjunctive therapies should also be considered (eg. 
pharmacotherapy, etc) and appropriate referrals made 
at this time. Both the client’s and D&A professional’s 
expectations for treatment should be clarified, including 
a discussion about each client’s role/boundaries for 
treatment. These issues should be documented in the 
clinical notes.
In addition, decisions need to be made about the 
modality of treatment (eg. Individual, group-based, 
telephone-based, etc) and the frequency with which 
psychosocial treatment sessions will occur (eg. Once 
weekly, fortnightly, etc). Ideally, the timing and physical 
location of the intervention sessions should be as 
consistent as possible to maximise treatment attendance, 
optimise the establishment of a working rapport with 
the D&A professional and assist the client in becoming 
comfortable with the therapeutic arrangements. All of 
these decisions should be made in conjunction with the 
client, discussed openly with them, and documented in 
the clinical file.
The client and D&A professional should discuss 
and agree on a way to prevent and manage missed 
appointments, which are a relatively common occurrence 
among clients with problematic drug and alcohol 
use, especially those with co-morbid mental health 
and other issues (15, 53). Pre-appointment reminder 
phone calls, letters or mobile phone text messages may 
be considered by the D&A professional as a way of 
encouraging treatment attendance. Assertive follow-
up of missed appointments by the D&A professional is 
recommended within two working days of the missed 
appointment to maximise the likelihood of the client’s 
return (50). If a reasonable explanation for the missed 
appointment is not offered, this should be explored with 
the client to determine whether the missed appointment 
is reflective of any of the following: uncertainty about 
whether or not treatment is necessary; ambivalence 
about making a change; frustration/anger for 
participating in treatment. These issues can be handled 
by the D&A professional in a manner consistent with a 
motivational interviewing approach (see Section 4, 50).
Finally, the client and D&A professional should agree 
on the duration of the treatment program. This may 
be governed by service policies, the service setting, 
etc or freely negotiated between the client and D&A 
professional. If the duration of treatment is based on 
the achievement of the client’s goals, then regular 
monitoring and review sessions should be planned to 
assess progress in relation to these goals. Again, these 
issues should be documented in the clinical file for the 
client as a record of this discussion.
Tips for Follow-up of Missed Appointments (50, 54)
■  Negotiate a pre-appointment reminder (eg phone 
call, text message) with the client.
■  The follow-up of missed appointments can be via 
telephone or letter.
■  If by telephone: speak with the client and clarify the 
reasons for the missed appointment; affirm the client 
- reinforce him/her for having previously attended; 
express eagerness to see the client again; briefly 
mention any serious concerns that emerged and an 
appreciation (as appropriate) that the client is exploring 
these; express optimism about the prospects for 
change and reschedule the appointment.
■  If by letter: provide contact details to enable the 
client to re-establish contact if another appointment 
is required, affirm the client - reinforce him/her for 
having previously attended; express your eagerness 
to see the client again; provide a timeframe for the 
client to re-establish contact and reschedule the 
appointment.
■  Regardless of the mode of contact, Drug and 
Alcohol professionals should take steps to maintain 
the confidentiality of the client. This includes 
refraining from identifying themselves as being 
from a Drug and Alcohol Service when speaking to 
people other than the client and/or leaving phone 
messages, and using plain envelopes (without 
service logos, etc) when mailing clients.
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3.3.6 Outcome measurement 
An important part of the psychosocial treatment 
program is regular review and assessment of the client’s 
progress in relation to their treatment goals (4). Some 
of these factors can be carried out informally during 
each treatment session (eg. assessing withdrawal 
symptoms, implementation of strategies discussed 
during session, medication side effects, etc), with 
treatment tailored accordingly (16). 
However, it will also involve the formal measurement/
review of relevant outcomes, such as quantity/frequency 
of problematic drug and alcohol use, psychiatric 
symptomatology, biological measurements (blood, 
urine, etc) as guided by the initial assessment, and/or 
the service policy within which the D&A professional 
is operating. Formal, objective outcome measurements 
are essential to this process, as they minimise the risk 
of both clients and D&A professionals overestimating 
the effect of a treatment program, and of focusing too 
much on one domain of the client’s presentation, when 
another area may be deteriorating (4).
Within a stepped care framework, the results of these 
measurements can be used to inform decisions to 
‘step-up’ or ‘step-down’ the intensity, duration and 
content of the psychosocial intervention (8). The D&A 
professional should use their clinical judgement to 
decide on an appropriate course of action, taking into 
account the need for crisis intervention, the severity 
of conditions, client stage of change and engagement 
with the treatment program (33). Importantly, however, 
if the results of these outcome measurements indicate 
that the client can be discharged from the service, 
then arrangements should be made for either a further 
review/follow-up session, or to re-engage with the 
service/D&A professional in the case of an exacerbation 
in problematic drug and alcohol use (53). 
There are no firm rules guiding the frequency with which 
outcome measurement and monitoring should occur, 
and often it is left to the D&A professional to use their 
judgement about the most appropriate measurement 
timeframe (4). Several authors have suggested for 
any intervention, if a client is going to respond to the 
intervention, they will have usually done so within one-
month of delivering the treatment, depending on the 
frequency of contact with the D&A professional (34, 38, 
55). However, in some service settings, three-monthly 
assessment/review sessions are recommended. 
3.3.7 Continuing Care 
Continuing care following discharge from an inpatient 
facility is associated with improved substance use 
outcomes (16). Indeed, the lowest rates of relapse to 
alcohol use have been shown when a formal program of 
continuing care has been provided, following discharge 
from a detoxification unit (2).
A standard program of continuing care has been 
described as regular contact (usually monthly) with 
a psychiatrist/medical professional for medication 
monitoring, along with access to a case manager for 
service co-ordination, outreach, etc (53). Within a 
stepped care framework, these contact points could 
again be used as a trigger to ‘step-up’ or ‘step-down’ 
treatment for the client.
3.3.8 Discharge and onward referral 
Termination of treatment needs to be a carefully 
negotiated process with the client and the D&A 
professional, as it can be a difficult time for both 
(2). Termination can be ‘natural’, whereby the client 
has achieved all the goals set down in the treatment 
plan, or ‘artificial’, as often happens when treatment 
is time-limited because of policy, or D&A professional 
preference (2). Regardless of nature of the termination, 
it is important that the time limits for treatment have 
been clearly articulated in the treatment planning 
phase (i.e. work will continue until all goals are met, 
or six sessions of psychosocial intervention is available, 
etc), and by formally processing the termination of 
psychosocial treatment towards the end of therapy (4). 
For example, any areas that are yet to be addressed 
should be acknowledged, as should the gains clients 
have made throughout treatment. D&A professionals 
should give the client the opportunity to discuss their 
feelings about the termination of treatment and, where 
appropriate, leave the door open for re-engagement 
with the service at a future date (2). In addition, offers 
of referral should be made to the client, to assist them 
in tackling their remaining goals. Marsh and Dale (2) 
discuss the issues around successful termination of 
treatment in more detail.
There are no rules governing the process of referral. 
Rather, referral should be considered throughout 
the assessment and treatment processes as D&A 
professionals consider their ability to assist the client to 
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work through his/her presenting issues and treatment 
plan. This includes any limits within the service that may 
impact on the type of, and extent to which, psychosocial 
and other interventions may be offered (2). This process 
means that the D&A professional must have a clear idea 
of the types of issues he/she is able to help with, both 
from an individual and service perspective. 
Tips for Effective Referrals 
■  Occurs with the agreement of the client
■  Knowledge of available facilities (specific, current 
information)
■  Skill in selection
■  Provide rationale for referral and allow client to 
raise concerns
■  Objectivity (across disciplines and sectors)
■  Timing (early, to maximise engagement)
■  Includes follow-up.
In addition, a range of strategies will assist the D&A 
professional and client maximise the success of a referral 
process. It is suggested that good practice in referral 
includes a written letter to the referral service in which 
the following issues are clearly articulated:
■ The reasons for referral
■  Issues already covered by the D&A professional 
with the client
■  The clients understanding of the reason for 
the referral; 
■  Any arrangements made with the D&A professional 
and client to continue contact
■  A suggested avenue for communicating the outcomes 
of the referral with the D&A professional.
A copy of this letter should be provided to and discussed 
with the client.
To assist the client in attending a referral appointment, 
the following issues should also be discussed by the D&A 
professional, prior to the appointment:
■  Name, phone number, address and directions of the 
referral service
■  Discussion around transport to and from the referral 
service appointment
■  What the client can expect upon arrival at the referral 
service, along with the nature, purpose and value of 
the referral
■  Written material about the referral service (if available);
■ A method of contacting the D&A professional.
In cases where the referral is related to a risk 
management issue (eg. suicidality), it may by appropriate 
for the D&A professional to discuss being alerted by the 
referral service about whether the client attended the 
appointment.
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Psychosocial treatments are considered to be the 
foundation of drug and alcohol treatment, especially 
for substances where pharmacological treatments have 
not been sufficiently evaluated (16). Pharmacotherapy is 
most successful when clients are motivated to change 
and willing to comply with their prescribed medication 
regime, and is commonly indicated for clients who 
are using drugs and alcohol at the severe end of 
the spectrum (16, 28). A review of psychosocial and 
pharmacological treatments for problematic drug and 
alcohol use suggested that outcomes are enhanced by 
combining pharmacological and psychosocial treatment 
approaches (44, 56, 57). Furthermore, pharmacotherapy 
may often be useful within the context of psychological 
support and intensive psychosocial treatment programs 
to promote improvements in lifestyle, thinking and 
coping strategies, leading to longer-term change and the 
prevention of relapse (44, 57, 58).
Psychosocial treatment may be offered in an individual- 
or group-based format, according to client need. It is 
important to note that group-based treatments are not 
suitable for everyone with problematic drug and alcohol 
use (eg. when given the choice, some clients will not elect 
group-based therapies, or will have too many immediate 
issues of concern to participate in a group program, 59). 
It is good practice to provide clients with information 
sheets containing basic information about the type 
of psychosocial intervention being provided to them. 
This basic information can include the rights and 
responsibilities of both the client and D&A professional, 
a brief description of the treatment, a summary of what 
the client can expect during treatment and tips for 
troubleshooting potential barriers to treatment.
4.1 Specific interventions 
It is important to note from the outset that the majority 
of drug and alcohol research has been carried out for the 
psychosocial intervention, Cognitive Behaviour Therapy 
(CBT), which includes relapse prevention, problem-
solving etc being a highly structured therapy, CBT lends 
itself well to the traditional methods of research and 
evaluation (eg. randomised controlled trials). Several 
other psychosocial treatments are described in this 
section, in addition to CBT, as many D&A professionals 
find these approaches very useful with a number of 
clients. Based on the levels of evidence set out for use 
in these guidelines (see Section 1), recommendations 
provided for the use of these additional therapies is 
not as strong as for CBT. This is not to imply that these 
therapies should not be used for clients with problematic 
drug and alcohol use, nor that they are ineffective in 
treating problematic drug and alcohol use. Rather, this 
is an effect of the lack of a research agenda for these 
approaches for clients with these problems. Indeed, 
many of these treatments have a strong evidence base in 
mental health and other settings. There is clearly a need 
for more comprehensive research to be conducted across 
the full range of treatment modalities for psychosocial 
interventions in problematic drug and alcohol use. It 
is especially important that D&A professionals have 
available a range of therapeutic tools and approaches 
to assisting clients in managing problematic drug and 
alcohol use, as different clients will be better suited to 
different therapeutic models or approaches.
Recommendation (★★★)
All drug and alcohol professionals providing 
psychosocial treatments should be able to provide 
cognitive behavioural therapy and be competent in the 
use of one additional intensive psychosocial treatment 
with a strong evidence base for use with problematic 
drug and alcohol use.
4.1.1 Assessment 
Drug and Alcohol services will likely have a core list of 
assessments to be administered to clients, and these 
should be used by the D&A professional in assessing a 
client’s presenting condition. Usually, a comprehensive 
drug and alcohol assessment will include the following 
components (pg 478, 4): 
Psychosocial interventions
SECTION 4
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■  Severity of dependence (using standardised scales such 
as the severity of dependence scale, 60)
■  Signs and symptoms of withdrawal (as indicated by 
each drug type)
■  Physical health consequences of problematic drug 
and alcohol use (such as liver disease, heart problems, 
hypertension, nutritional problems, ulcers, hiv, 
hepatitis, etc)
■  Risk taking behaviours associated with problematic 
drug and alcohol use
■  Stages of change of drug and alcohol use (using scales 
such as the readiness to change scale, 61)
■  Pattern and context of problematic drug and alcohol 
use (including reasons for use, and quantity and 
frequency of use, using scales such as the BTOM or 
the Opiate Treatment Index, 62, or the Alcohol Use 
Disorders Identification test, 63)
■  Previous attempts to stop problematic drug and 
alcohol use (including treatment history, high-risk 
situations, causes of relapse, etc).
Suicide ideation and behaviour is significantly higher among 
people using substances than in the general population 
(16). At all assessment and monitoring points throughout 
the psychosocial intervention, suicidal ideation should 
be assessed and reviewed. This enables effective and 
appropriate crisis intervention if necessary (4). In addition, 
given the high co-occurrence of mental health issues with 
problematic drug and alcohol use (see Section 5), screening 
for mental health conditions, such as depression and 
anxiety, should also be included in the assessment (4).
A comprehensive list of diagnostic and screening 
instruments for problematic drug and alcohol use is also 
available (see 46).
Clients will differ in both the extent to which they are 
motivated to discuss and address their use of substances, 
and in their insight into their problems. As a result, the 
content of assessment will need to be altered to reflect 
this (eg. extending the assessment over a longer period 
of time, providing education about key issues, focusing 
on building rapport and engagement, etc, 16). As trust 
and rapport develops between the client and the D&A 
professional, the client will likely feel more comfortable 
discussing the extent and impact of their problematic 
drug and alcohol use (64). For this reason, the initial 
assessment should continue to be re-visited as the 
therapeutic relationship develops, with initial assessment 
results modified as more comprehensive and accurate 
information becomes available (4). 
Consulting multiple sources of information will assist in 
gaining an accurate picture of the client’s presenting 
condition. These additional sources could include 
other treatment professionals (primary care providers, 
mental health professionals, other medical or allied 
health professionals), clinical records for the client (if 
available) and family members, friends or relatives who 
can provide corroborative information about the client’s 
problematic drug and alcohol use (current and previous, 
64). This will be particularly important if the client 
is intoxicated, has difficulty remembering details of 
problematic drug and alcohol use, and/or is experiencing 
some impairment of memory or functioning (4). An 
essential part of collecting this information, however, 
is to discuss these activities with the client prior to 
consulting additional sources, and gaining their explicit 
consent for you to do so (64).
A caveat about assessment (pg 33, 28)
If the client feels that little progress is being made, 
motivation to engage with treatment may decrease. 
As such, it is important to balance the need for a 
complete assessment with the overriding goal of 
engaging a client in drug and alcohol treatment.
4.1.2 Brief interventions 
Brief interventions are generally between 5-30 minutes 
in duration, and can be delivered across a range of 
health settings (eg. general practice, hospital wards, 
emergency departments, community, etc, 50, 65). 
Because of the brief nature of these interventions, they 
can be delivered opportunistically in both inpatient and 
outpatient settings by a range of specialist and generalist 
professionals who have been trained the use of these 
approaches (28). Brief interventions can be an effective 
first level of treatment offered to drug and alcohol 
clients within a stepped care framework (38, 65).
Typically, brief interventions involve the provision of 
formal feedback from the assessment phase, and 
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brief advice regarding how best to reduce the harms 
associated with the client’s problematic drug and alcohol 
use. This advice needs to be delivered in a sensitive, 
non-confrontational manner, as clients may not have 
previously considered that their drug and alcohol use 
is problematic. As such, the positive interpersonal 
style associated with motivational interviewing will be 
important to adopt in these brief interventions (42). The 
most effective brief interventions will combine good 
general counselling skills with motivational interviewing 
techniques, using the FRAMES approach (28, 66).  
Elements of a brief intervention (29, 66)
Feedback (risks, indicators, health status)
Responsibility (communicate choice to change)
Advice (importance of change, with permission)
Menu (variety of change options - harm reduction)
Empathy (warm, non-judgmental, non-confronting)
Self-efficacy (optimism to attain chosen goals)
More detailed information on the provision of brief 
interventions for drug and alcohol clients can be found 
in Shand (28), Bien, Miller and Tonigan (66, 67), and 
Hulse (68).
The effectiveness of brief opportunistic interventions 
has been established primarily for alcohol use problems, 
although they have been applied to clients using a 
range of other substances. Currently, there is Level 1 
evidence supporting the benefits of brief interventions 
for reducing alcohol use among people drinking in 
excess of recommended guidelines (28, 65). In addition, 
brief interventions for alcohol use problems produce 
greater reductions in alcohol consumption relative to no 
treatment at all (Level 1 evidence, 28). 
This is the case when both generalist health professionals 
or those with specific drug and alcohol training deliver 
the intervention, in both generalist and specialist settings 
(65). The same is likely true for other drugs in addition 
to alcohol, however the evidence has only begun to 
emerge to support this for cannabis (Level 3-b evidence, 
69) and amphetamine use (Level 2 evidence, 70), with 
effectiveness for other illicit drugs yet to be tested. In 
light of this, and the clinical utility of this approach, brief, 
opportunistic interventions should be used routinely in 
clinical practice.
Recommendation (★★★)
Brief, opportunistic interventions, using the frames 
approach, should be used routinely in all clients with 
problematic drug and alcohol use across a range of 
settings by specialist and generalist drug and alcohol 
professionals
4.1.3 Motivational interviewing 
Motivational interviewing strategies are detailed in 
Marsh and Dale (2), and Miller and Rollnick (49). While 
these techniques are useful stand-alone therapeutic 
tools, a motivational approach should be adopted 
throughout the psychosocial intervention (2).
Brief motivational interventions have been applied in 
inpatient and outpatient contexts, and by practitioners 
with little formal clinical (psychological) training. 
Typically, brief motivational interventions are of between 
one and four-sessions in duration, in addition to 
assessment (71, 72). Within a stepped care framework, 
motivational interviewing can be used for drug and 
alcohol clients who have been non-responsive to an 
initial brief intervention, or it can be combined with brief 
interventions as a first-line treatment option (38).
Motivational interviewing is based on the stages of 
change model, developed by Prochaska and Diclemente 
(73). This model suggests that people will progress 
through a series of five stages in deciding and acting 
upon a plan to change a particular behaviour. These 
stages include: (i) precontemplation, (ii) contemplation, 
(iii) preparation, (iv) action, and (v) maintenance, each 
characterised by the balance between the benefits/losses 
of maintaining current behaviour versus the benefits/
losses of changing that behaviour.
For people in the earlier stages of change, the balance 
tends to favour no change to current behaviour. As the 
benefits/losses of staying the same are outweighed by 
the benefits/losses of changing, the client progresses 
through to the later stages of action and maintenance. 
Movement through these stages is not always linear, and 
people may shift backwards and forwards through each 
stage before eventually reaching the point where they 
can maintain the change in behaviour. 
Motivational interviewing can be used to help tip the 
balance of benefits and losses in favour of reducing/
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quitting problematic drug and alcohol use (74). Each 
stage of change has a range of motivational strategies 
for the D&A professional to implement, that are matched 
to the wants, needs and attitudes of clients within 
that stage (43). In this way, motivational interviewing 
seeks to promote engagement, minimise resistance and 
defensiveness, and encourage behaviour change. It should 
be noted, however, that while the client’s stage of change 
is a useful tool in assessing how they currently regard their 
problematic drug and alcohol use, care should be taken 
not to overemphasise the importance of stage of change 
in deciding on an appropriate treatment strategy. 
For example, recent evidence has emerged suggesting 
that movement toward the action stage of change 
is not necessarily associated with actual behaviour 
change (75). Also, clients will often be at different 
stages of change for different drugs, and this also 
needs to be accounted for in providing treatment.
The main features of motivational 
interviewing (2, 49): 
■  Discussion about the good and less good things 
about problematic drug and alcohol use and the 
importance of these factors in their decision to 
change use
■  Assessing client concerns about current levels of use
■  Assessing confidence in making changes to current 
levels of use.
If the client’s balance of issues raised during the 
discussion outlined above is in favour of the good things 
about their problematic drug and alcohol use, the 
following strategies are employed to tip the balance in 
favour of change (2, 48):
■  Summarising with an emphasis on the less good things 
of greatest concern to the client
■  Highlighting and creating discrepancies in the client’s 
assessment of their use (eg. looking to the future, 
exploring past goals and expectations, contrasting the 
self with the drug and alcohol user).
In addition, the aim is to elicit self-motivational 
statements from the client about the arguments for 
change (49). Self-motivational statements fall into the 
following categories (48): 
■  Problem recognition: “I guess there is more of a problem 
than I thought”, “I never realised it was as serious as this”
■  Expression of concern: “I’m worried about this”, or 
nonverbal cues such as tears, gestures etc 
■  Intention to change: “this isn’t how I want to be”, 
“maybe it’s time to think about changing” 
■  Optimism about change: “I think I can do it”. 
The evidence suggests that motivational interviewing on 
its own is particularly effective in increasing treatment 
engagement and adherence for people with problematic 
drug and alcohol use (Level 1 evidence, 76). This 
approach is strongly recommended in all phases of 
assessment and treatment for drug and alcohol clients.
A sub-type of motivational interviewing, compliance 
therapy, has been specifically developed to increase 
compliance with prescribed pharmacotherapy regimes and 
behavioural treatment plans. Specifically, compliance therapy 
uses motivational techniques to target those factors within 
a client that may impact on their ability to be compliant 
with their treatment (eg. ambivalence about medication, 
insight into illness, misinformation about the effectiveness 
of medication, etc, 77). Typically, compliance therapy has 
been evaluated in mental health settings (eg. among clients 
with psychotic disorders, 78). However, one Australian study 
has used compliance therapy among clients with alcohol 
dependence to improve compliance with acamprosate 
(Level 2 evidence, 77). Results indicated that those clients 
who completed three or more sessions of compliance 
therapy reported significantly greater levels of adherence 
to medication and improved treatment outcomes relative 
to a control group who received usual medical care (77). 
This result awaits further replication and expansion to other 
types of problematic drug and alcohol use. 
Recommendation (★★★)
Motivational interviewing can be used in all phases 
of assessing and treating drug and alcohol clients to 
increase treatment engagement and adherence.
A review of the alcohol treatment literature revealed 
that brief motivational interventions, were among 
the best approaches in reducing alcohol use (Level 1 
evidence, 74). Evidence is also emerging to support its 
use among clients with cannabis use problems (Level 
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2 evidence, 79, 80) and problematic amphetamine 
use problems (Level 2 evidence, 70). However, the 
application of motivational interviewing to people 
with other drug use problems has not yet been fully 
tested (79). Although it can be used as a stand-alone 
treatment, in general, motivational interviewing is 
combined with other psychosocial techniques as a 
means of encouraging a reduction in problematic drug 
and alcohol use (79).
Recommendation (★★★)
Motivational interviewing should be combined with 
other psychosocial approaches by suitably trained 
drug and alcohol professionals to reduce problematic 
drug and alcohol use.
4.1.4 Contingency Management
Contingency Management is a common component 
of many psychosocial treatments offered by D&A 
professionals in clinical practice (81). This approach 
to treatment is based on the behavioural principles 
of reinforcing behaviours that are ‘desirable’ or that 
the client wishes to continue into the future (82). For 
example, clients receive positive attention, vouchers or 
other incentives to encourage/reinforce the maintenance 
of abstinence, medication compliance, attendance at 
treatment sessions and other treatment-related goals 
(83). Equally, negative reinforcement (withholding of 
incentives, reports to other professionals, etc) can occur 
in response to less-desirable behaviours (83).
Several studies exist to support the effectiveness of 
contingency management in encouraging clients to 
comply with medications designed to reduce/eliminate 
drinking (Level 2 evidence), to maintain abstinence from 
alcohol (Level 3 evidence), cocaine (Level 2 evidence), 
adherence to opiate substitution programs (Level 2 
evidence), and to encourage treatment attendance at a 
drug and alcohol service (Level 2 evidence, 83).
Level 2 evidence exists for the use of contingency 
management strategies to encourage and maintain 
abstinence and to encourage treatment compliance and 
attendance among clients with problematic drug and 
alcohol use.
An important caveat exists for the use of contingency 
approaches in treating problematic drug and alcohol 
use, namely that the implementation of this treatment 
is considered in line with the client’s treatment goals 
and that it is used in the context of other psychosocial 
approaches (82-84). That is, contingency management 
has generally been successful with clients working 
towards a goal of abstinence, however only recently 
is being modified and tested as it applies to other 
treatment-related goals, such as engaging in positive 
non-drug and alcohol related activities (84). Further, 
these strategies need to be embedded within a range 
of other treatment approaches, to encourage clients to 
take ownership of their goals and the treatment process, 
following withdrawal of the reinforcement strategy.
Recommendation (★★★)
Contingency Management can be combined with 
other psychosocial approaches by suitably trained 
drug and alcohol professionals to reduce problematic 
drug and alcohol use.
4.1.5 Intensive psychosocial therapies
Evidence is emerging that for some drug and alcohol 
clients, more intensive and longer interventions are 
required to produce improvements in their psychosocial 
outcomes and levels of problematic drug and alcohol 
use (85). A range of intensive interventions can be 
offered to clients with problematic drug and alcohol 
use, according to their level of dependence, history of 
withdrawal symptoms and current lifestyle issues. These 
interventions can be offered in a range of settings, with 
the following psychosocial interventions forming part 
of the intervention provided. Residential rehabilitation 
and therapeutic community settings can be regarded 
as intensive drug and alcohol treatments, however 
these interventions are not specifically discussed in this 
section (or in these guidelines). Refer to (12) for more 
information about these treatments.
Typically, intensive psychosocial interventions are 
regarded as being of eight or more sessions in duration 
(72), and should only be used by specially trained and 
experienced D&A professionals. Within a stepped care 
framework, intensive interventions can be combined 
with a motivational approach and general counselling 
skills as a first-line treatment for people with severe 
levels of drug and alcohol use (38). For those with 
mild-moderate levels of use, intensive psychosocial 
interventions can be offered as a second tier of 
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treatment, following provision of a brief intervention 
or motivational interview to which the client has not 
responded (38). A number of intensive psychosocial 
interventions appropriate for use with problematic drug 
and alcohol use are described below. 
4.1.5.1 Cognitive Behavioural Therapies (CBT)
CBT was developed by Aaron Beck in the 1960’s as 
a time-limited, structured treatment that combines 
behavioural approaches (such as self-monitoring, 
pleasant events scheduling) with cognitive strategies to 
address the client’s perception and beliefs about their 
world (51, 86). It is based on the premise that events 
or situations are not the cause of feelings or behaviour; 
rather interpretations (or thoughts/cognitions) about 
those events will lead to actions and emotions. 
When clients are using drug and alcohol in a problematic 
way, it is common for them to have narrowed their 
behaviours to those associated with using. As such, they 
tend to over-emphasise the importance of using in their 
day. This distorted view of the world will influence the 
way they interpret daily situations and events, keeping 
them in a cycle of distress and problematic drug and 
alcohol use. The overall objective of CBT is to identify 
and challenge these dysfunctional beliefs that maintain 
problematic patterns of thought and behaviour, and 
replace them with more adaptive beliefs and behaviours 
(51, 86). The key CBT techniques designed to encourage 
these changes are listed in the previous box.
There are a number of detailed textbooks and 
intervention manuals describing how the above skills 
may be applied within a CBT treatment program. These 
include, but are not limited to, Marsh and Dale (2), 
Beck (51), and Persons (52). In general, behavioural 
strategies should be introduced first, with the cognitive 
strategies commenced later in the treatment program, 
when thinking may be clearer, problematic drug and 
alcohol use may have reduced and negative mood 
states lifted (51, 86).
Tips for Planning a CBT Program (51, 86)
■  Prioritise problematic drug and alcohol use in the 
early stages by using behavioural strategies
■  Move into using cognitive strategies when the 
client feels able to address these internal process
■  Structure each session using the following: 
Phase 1 (approximately 20 minutes): review of 
previous week and set agenda for current session, 
review homework activities, 
Phase 2 (approximately 20 minutes): introduce 
new CBT strategy, in-session practice), 
Phase 3 (approximately 20 minutes): review session, 
set homework for upcoming week, review progress, 
address any outstanding issues from agenda.
CBT has the best-documented efficacy of the 
psychosocial approaches for the treatment of clients 
with problematic drug and alcohol use (29, 51). 
This is because it is the most thoroughly research 
psychosocial intervention. There is Level 1 evidence 
for the use of CBT as a means of effectively reducing 
problematic alcohol use (28), cannabis use (79, 80), 
amphetamine use (70, 87), cocaine use (88), heroin 
use (16, 87), and injecting drug use more generally 
(89, 90). In addition, there is specific Level 1 evidence 
for the addition of cue exposure techniques to a CBT 
intervention to assist clients in working towards a goal 
of abstinence among heroin-dependent clients (91) 
A summary of common CBT techniques
Typical cognitive strategies (16):
■  Identifying and challenging dysfunctional 
thoughts about substances 
■  Recognising seemingly irrelevant decisions that 
lead to a relapse
Typical behavioural strategies (16):
■  Coping with cravings for substances
■  Cue exposure 
■  Promotion of non-drug related activities
■  Contingency management
■  Relaxation training
■  Preparing for emergencies
■  Coping with relapses
Other elements of CBT (29, 87):
■  Social skills training (effective communication, 
refusal skills)
■  Problem solving skills
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and clients with problematic alcohol use (92), and for 
moderation of drinking among clients with alcohol use 
problems (93-95).
Level 1 evidence for the use of CBT exists for:
■  Alcohol
■  Cannabis
■  Amphetamines
■  Cocaine
■  Heroin
■  Injecting drug use.
CBT is often rated as the most effective approach to 
treatment with a drug and alcohol population (96, 97), 
has been shown to have equivalent effectiveness to 
pharmacotherapy (16), and is accepted well by clients 
(98-100). Furthermore, the benefits of CBT may extend 
beyond the treatment period, with research revealing 
that CBT can “protect” clients against relapse or 
recurrence after treatment termination (101).
Recommendation (★★★)
CBT should be used with all drug and alcohol 
clients to improve psychosocial outcomes, reduce 
problematic drug and alcohol use, and reduce risk of 
relapse
4.1.5.2  Psychodynamic and Interpersonal 
Approaches
Psychodynamic Therapy grew out of the psychoanalytic 
school of Psychology, as a less intensive and less 
expensive form of psychoanalysis (102). In contrast to 
CBT, which focuses on the effect of external stimuli on 
the client, Psychodynamic Therapy encourages the client 
to look at the unconscious meaning and motivation 
behind behaviours and symptoms (102). Typically, 
sessions of psychodynamic therapy are of 45-50 minutes 
duration, and occur from one to three times per week 
(103). A program of treatment will be of at least 16 
sessions, but can continue for several years.
Typically, Psychodynamic Therapy assumes that clients 
have an unconscious mind, and that defences are built 
up over time to avoid experiencing the pain of feelings 
held in the unconscious (104). When a client accesses 
treatment, it is usually because these defences are not 
working and are causing harm (102). One example of a 
defence is denial (104). 
Together, the Psychodynamic Therapist and client work 
through these feelings in an ‘expressive’ or ‘supportive’ 
manner (104). An ‘expressive’ approach encourages the 
client to develop insights into the cause of the painful 
feelings in their unconscious, by bringing their awareness 
of these feelings into conscious thought (104). In contrast, 
a ‘supportive’ approach focuses on addressing the 
immediate distress experienced by the client, providing 
a safe environment for the client to explore these issues 
(104). During a program of psychodynamic therapy, a 
strong focus on the development of therapeutic alliance is 
taken, and attempts to use the therapeutic relationship to 
demonstrate to the client how they are feeling (105).
Psychodynamic Therapy has been subject to several 
randomised controlled trials for conditions such as 
depression, anxiety and personality disorders (106). In 
addition, four trials exist which examine psychodynamic 
therapy among opioid users, cocaine users and alcohol 
users (Level 2 evidence, 106, 107). These studies 
generally indicate that psychodynamic therapy of 
between 12-36 sessions, combined with general drug 
counselling, was associated with improvements in the 
problematic drug and alcohol use targeted in treatment, 
and a range of psychosocial outcomes (106). 
In addition, several case studies suggest that with 
experienced clinicians, Psychodynamic Therapy is 
associated with improvements in problematic drug 
and alcohol use (Level 4 evidence, 103). Importantly, 
across the range of research trials in this area, different 
models of Psychodynamic Therapy have been applied in 
different studies. In a major review of evidence for CBT 
and Psychodynamic Therapy (108), the reviewers could 
not identify one psychiatric disorder for which the same 
model of Psychodynamic Therapy had been applied 
across different studies and different research groups. 
Thus, more research is required to determine if the 
results reported in one study of Psychodynamic Therapy 
can be generalised to other studies and/or disorders 
or drug types, etc (108). Level 2 evidence exists for 
the use of Psychodynamic Therapy in the treatment of 
problematic drug and alcohol use.
A variation of Psychodynamic Therapy is Interpersonal 
Therapy (IPT), and has been used and tested in the 
treatment for depression (Level 2 evidence, 109). 
However, there is no evidence for the use of IPT in the 
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treatment of problematic drug and alcohol use. IPT is 
divided into three phases (109):
■  Phase 1 (1-3 sessions): diagnostic evaluation and 
assessment of current situation, social functioning, role 
obligations, etc, and the D&A professional determines 
which of four interpersonal problems are most relevant 
to the client (grief, interpersonal role disputes, role 
transitions, interpersonal deficits)
■  Phase 2 (7-14 sessions): the D&A professional assists 
the client in exploring the relevant interpersonal 
problem, using an active but supportive relating style
■  Phase 3 (1-2 sessions): enhances confidence in new 
insights and reinforces therapeutic gains.
Although the principles of Psychodynamic Therapy and 
IPT may seem clear, extensive training in these techniques 
is essential, prior to engaging in this therapy (109). In 
addition to training, ongoing supervision is important 
to ensuring the D&A professional is coping well with 
the demands of this psychosocial treatment. Experts 
suggest that, given the nature of these approaches, 
psychodynamic and interpersonal therapies generally 
require clients to be well-motivated and prepared to 
undertake longer-term therapy involving periods of non-
specific treatment and introspection (107).
Recommendation (★★★)
Psychodynamic therapy can be used to treat 
problematic drug and alcohol use, but should only 
be used by suitably qualified, trained and well 
supervised clinicians (109). This treatment is most 
suitable for well-motivated clients who are willing to 
address a range of internal issues in addition to their 
presenting problematic drug and alcohol use (107).
4.1.5.3 Emotion regulation 
Therapeutic approaches to managing emotion regulation 
among drug and alcohol clients have increased in 
popularity in the last decade, given the clear association 
between mood states and problematic drug and alcohol 
use (110, 111). Typical emotion regulation approaches 
include Dialectical Behaviour Therapy (DBT), Mindfulness-
Based Stress Reduction (MBSR) and more recently, 
Acceptance and Commitment Therapy (ACT).
4.1.5.3.1 Mindfulness Based Stress Reduction
The application of MBSR to clients with problematic drug 
and alcohol use has occurred with increasing frequency 
(112). MBSR is a meditative practice originating in Buddhism 
(113), and involves intentionally bringing one’s attention to a 
range of physical, emotional and cognitive experiences in the 
present moment (49). MBSR has been used as a stand-alone 
treatment for urge management and relapse prevention in 
drug and alcohol treatments. It has also been added to other 
therapies such as CBT and DBT to augment the strategies 
taught to people with eating disorders and borderline 
personality disorder (114). Very little research exists to test 
the effectiveness of MBSR among drug and alcohol clients. 
However, one study examined a program of MBSR among a 
sample of prison inmates and among the general community 
(114). Over the six-month follow-up, participants in both 
groups reported reductions in problematic drug and alcohol 
use, improved psychiatric symptomatology and improved 
readiness and motivation to change problematic drug and 
alcohol use (Level 3-b evidence, 115). 
Level 3-b evidence exists for the use of MBSR in the 
treatment of problematic drug and alcohol use.
Detailed information about the use of MBSR is also 
available (49, 114).
Recommendation (★★)
MBSR can be used to treat problematic drug 
and alcohol use problems by suitably trained and 
experienced drug and alcohol professionals.
4.1.5.3.2 Dialectical Behaviour Therapy
DBT was developed by Marsha Linehan (113) for the 
treatment of clients with borderline personality disorder. 
Given the high co-morbidity of problematic drug and 
alcohol use and the increased impulsivity associated 
with borderline personality disorder, DBT seems suitable 
for use in treating problematic drug and alcohol use 
(116). Typically, DBT draws on CBT and MBSR to provide 
treatment components such as group skills training, 
telephone counselling, behavioural and cognitive 
modification of problem behaviours, reflection, empathy 
and acceptance (116). Individual sessions are combined 
with group-based skills training sessions over a 12-
month period, with participants also permitted access to 
a 24-hour telephone line for crisis situations (eg. threat 
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of self-harm, 113). Several large-scale randomised trials 
exists indicating the effectiveness of DBT in reducing 
self-harm behaviours among people with borderline 
personality disorder (Level 1 evidence, 117). However, 
in these trials, DBT had no demonstrable effect on 
reducing problematic drug and alcohol use among the 
sample (116, 117).
In recognition of the high rates of co-morbid 
problematic drug and alcohol use among people with 
borderline personality disorder, DBT was modified 
to directly target problematic drug and alcohol use, 
develop coping skills for managing withdrawal and 
cravings, increased use of case management, and 
options for pharmacotherapy (117, 118). 
Modifications to traditional DBT to better address 
problematic drug and alcohol use (117-119)
■  Direct discussion of problematic drug and 
alcohol use
■  Skills for coping with cravings and withdrawal
■  Increased use of case management
■  Options for pharmacotherapy
■  Development of a set of attachment strategies to 
encourage treatment engagement and retention 
and reduce missed appointments
To date, two randomised controlled trials have been 
conducted using this modified version of DBT, with 
participants reporting improved drug and alcohol use 
outcomes relative to a no-treatment control group (Level 
2 evidence, 117, 119)
Level 2 evidence exists for the use of modified DBT for 
problematic drug and alcohol use in the treatment of 
drug and alcohol problems.
Detailed information about the implementation of DBT is 
available elsewhere (113, 119).
Recommendation (★★★)
Modified DBT (for drug and alcohol use) can be used 
in the treatment of problematic drug and alcohol 
use by suitably trained and experienced drug and 
alcohol professionals.
4.1.5.3.3 Acceptance and Commitment Therapy
ACT grew out of Cognitive Behaviour Therapy and 
mindfulness-based approaches to managing a range of 
conditions, such as pain, chronic illness and stress (120). 
Generally, ACT aims to retrain clients who have typically 
been avoiding painful events such as thoughts, memories, 
feelings and bodily sensations, to feel more comfortable 
experiencing these events (121). This ‘approach’ to 
problems, rather than avoidance of them and situations 
that stimulate experience of these problems, is thought 
to increase the client’s capacity for change (121). Given 
clients are asked to explore a range of deep emotional 
issues, a strong therapeutic relationship, built solidly on 
trust, is fundamental to the use of ACT (120).
Research on the effectiveness of ACT is in its 
development phase, with few large scale studies 
currently available (120). However, evidence is starting to 
emerge to indicate that ACT is effective in the treatment 
of stress management, depression, pain, and chronic 
illness (Level 2 evidence, 120, 121). One small study 
involved clients using methadone maintenance for opiate 
dependence, who were randomised to receive solely this 
treatment, or 16-weeks of adjunctive 12-step therapy or 
ACT (Level 2 evidence, 122). 
Results indicated that ACT, in combination with 
methadone maintenance, was associated with reduced 
opiate use and total drug use relative to clients receiving 
solely methadone maintenance. No differences were 
noted between the 12-step and ACT conditions (122). 
An additional study randomised 76 clients with nicotine 
dependence to receive either nicotine replacement 
therapy or ACT for smoking cessation (Level 2 evidence, 
123). No differences in smoking outcomes were reported 
between the groups at post-treatment, however ACT 
participants reported improved smoking outcomes at 12-
month follow-up (123).
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Level 2 evidence exists for the use of ACT for drug and 
alcohol use in the treatment of problematic drug and 
alcohol use.
Detailed information about the implementation of ACT is 
available elsewhere (121, 124).
Recommendation (★★)
ACT (for drug and alcohol use) can be used in the 
treatment of problematic drug and alcohol use by 
suitably trained and experienced drug and alcohol 
professionals.
4.1.5.4 Family Approaches
A range of psychosocial approaches stem from the 
family therapy school of treatment, whereby treatment 
is focussed on the interactions of the family and its 
individual family members (125). 
4.1.5.4.1 Couple/Family Therapy 
Given the toll that problematic drug and alcohol use 
can take on the family and partners of clients, the 
importance of couple and family-based strategies cannot 
be over-emphasised (16). Partners and other family 
members can also act as useful supports in assisting 
clients with goals and strategies for change. 
Within the drug and alcohol context, couples and 
family therapies should focus on the drug and alcohol 
issues relevant for the client, how these issues impact 
on the relationships within the family/couple setting, 
and increasing effective communication between family 
members and the client (28). Although a range of 
other issues may warrant clinical attention (eg. long-
standing marital problems, parenting skills, aggression 
and violence within the family, etc), it is strongly 
recommended that these be addressed by a clinician 
with specific training and expertise in how to manage 
these issues, rather than by the D&A professional (28). 
The first priority for the D&A professional is to ensure 
the needs of the client are being met in terms of 
his/her problematic drug and alcohol use and related 
issues. A partner/family member could be engaged in 
the treatment process, particularly in the context of 
offering assistance and support or where the additional 
problems are of a low-moderate nature. It is important 
that a dual relationship with the client and family 
members should not be entered into (28), and referral 
for any significant additional issues is important when 
they exist. 
Very little evidence exists that examines the effectiveness 
of couples/families therapy among drug and alcohol 
clients (28). Despite this, clinical experts agree that 
it forms an important part of any drug and alcohol 
intervention. However, behavioural marital therapy, 
which focuses on increasing caring behaviours, 
increasing joint recreational, non-drug and alcohol 
related activities and enhancing communication on the 
part of the drug and alcohol client has also shown to be 
an effective intervention among people with alcohol use 
problems (Level 3-a evidence, 29). 
Level 3-a evidence exists for the use of behavioural 
marital/family therapy in the treatment of problematic 
drug and alcohol use.
Drug and alcohol clients may like to invite a support 
person to their treatment sessions, but this should 
only occur with the full consent of both parties. An 
appropriate support person will be someone who cares 
about the client, and often will be affected by any 
changes the client makes. The support person’s input will 
be valuable in setting goals and developing strategies, 
and he/she may be of practical help in working towards 
whatever goal the client chooses. Although change is the 
client’s responsibility, the support person may facilitate the 
process of change, and help to maintain these changes 
over the longer term (28).
There are a range of strategies for including input from 
support people within a drug and alcohol treatment 
session, all of which take a motivational interviewing 
approach. For example, the session could commence by 
inviting the support person to explore their reasons for 
attending the session using the following prompts:
“What has it been like for you?”
“What have you noticed about [client’s] drinking/using?”
“What has discouraged you from trying to help in the past?”
“What do you see that is encouraging?”
Emphasise the client’s positive attempts to deal with 
the problem. Reframe the negative experiences as 
normative, or common within families with problematic 
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drug and alcohol use issues. Elaborate on risks and costs 
of the problem behaviour with the support person in the 
following way:
“How has the drinking/using affected you?”
“What is different now that makes you more concerned 
about the drinking/using?”
“What do you think will happen if the drinking/using 
continues as it has been?”
It is important to avoid overwhelming the client by 
eliciting statements from the support person, especially 
if feedback from the support person is particularly 
negative towards the client. The support person can 
be asked questions to elicit supportive and affirming 
comments. Examples include:
“What are the things you like most about [client] when 
s/he is not drinking/using?”
“What positive signs of change have you noticed that 
indicate [client] really wants to make a change?”
“What are the things that give you hope that things can 
change for the better?”
Supportive and affirming statements outlined above help 
to enhance commitment to change. It is also important 
to elicit the client’s response to the support person’s 
comments:
“Of these things your sister has mentioned, which 
concern you the most?”
“How important do you think it is for you to deal with 
these concerns that your wife has raised?”
Recommendation (★★)
Couples/families therapy can be useful for drug and 
alcohol clients in improving communication skills, 
addressing drug and alcohol-related issues, and 
managing drug and alcohol relapse. Couples/family 
therapy within the drug and alcohol setting should 
not address entrenched relationship difficulties, 
aggression/violence, or non- drug and alcohol-
related issues, as these should only be addressed by 
trained and experienced family therapists.
4.1.5.4.2 Solution-Focused Approaches
Solution-Focused Brief Therapy (SFBT) arose from the 
family therapy approach in the early 1980s (126). In 
contrast to other approaches, SFBT assumes that the 
client is motivated and willing to make changes, and 
treatment concentrates on helping the client to imagine 
they would like things to be different and what needs 
to happen to bring this about (126). The focus is on 
solutions, rather than problems, and as such little time is 
spent taking histories, etc (126, 127).
SFBT assumes that the client is the expert in the 
experience of their problem (128). As such, they have 
the skills, insights and solutions they need to attain the 
goals they see as relevant to them (126-128). The task 
of the clinician is to ask questions that encourage the 
client to think about actions and solutions they can take 
in managing problem behaviours, while focusing on the 
client’s strengths, competencies and successes (129). For 
example, clinicians can ask (pg 137, 128):
“When you do this, how will things be better?”
“Tell me about a time when you were not using... 
How did you manage to stay straight for so long?”
When clients relapse, again the focus is on solutions (pg 
137, 128):
“How did you manage to stop?”
As the name suggests, SFBT is brief, usually lasting 
around six sessions (126).
The Solution-Focused Approach (pgs 343-344, 129)
■  all people have strengths, resources and competencies
■  change is happening all the time
■  engage in solution talk rather than problem talk
■  clients are the experts
■  emphasise the present and future
■  only small change is all that is necessary for 
larger changes to occur.
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SFBT has been used in the context of case management 
activities (see Section 6), and has been evaluated among 
clients with mental health problems (Level 3-b evidence, 
126, 129). However, very little evidence exists to test the 
effectiveness of SFBT among drug and alcohol clients. 
One study reported the results of a single case of the use 
of SFBT with a client with alcohol use issues preventing 
him from attending to his work commitments (126). 
Results indicated an implied improvement in problem 
drinking, as measured by an increase in the client’s work 
attendance (Level 4 evidence, 126). Drug and alcohol use 
outcome were not directly measured in this study.
Recommendation (★)
SFBT can be used in the treatment of problematic drug 
and alcohol use by suitably trained and experienced 
drug and alcohol professionals. There is evidence for 
the use of SFBT as a generic therapeutic technique, 
although specific evidence in treating problematic drug 
and alcohol use is lacking at this time.
4.1.5.4.3 Systemic Approaches
Systemic approaches examine a client’s presenting 
problem in terms of the ‘system’ of relationships, activities 
and parts that make up the client’s problem (125). Joining 
together the individual parts of the ‘system’ will lead to 
a greater understanding of the whole problem, which is 
more than just the sum of the parts (125).
Typically, clients are viewed in terms of their relationships 
with key others in their lives, with family members and 
extended families all taking active roles in the treatment 
(130). The systemic therapist works with each of the 
family members willing to take part in treating an 
identified ‘problem’ (125). Treatment is typically between 
5-20 sessions (125).
 During treatment discussions, the clinician focuses 
on how the people within the system communicate 
with each other, what they communicate and how 
these translate into the various roles and expectations 
the system has for its individual members (130). D&A 
professionals take an active questioning approach in 
therapy, and attempt to enable individuals within the 
system to decide where and how change might be 
needed (130). Importantly, what happens in between 
therapy sessions is regarded as at least as vital to treat-
ment as what happens during the treatment session (130).
The main targets for treatment using a systemic 
approach are suggested to be the serious psychiatric 
disorders, including addictions (125). These approaches 
may be particularly useful for the treatment of 
adolescents clients, and could be used in isolation or as 
an adjunctive approach to other psychosocial treatments 
(125, 130). However, currently there are no treatment 
trials or case studies describing how systemic approaches 
relate to drug and alcohol use outcomes.
Recommendation (★)
Systemic approaches to treatment may be of use 
in the treatment of problematic drug and alcohol 
use, and should only be used by suitably trained 
and experienced drug and alcohol clinicians. There 
is evidence for the use of systemic approaches as 
a generic therapeutic technique, although specific 
evidence in treating problematic drug and alcohol 
use is lacking at this time.
4.1.5.4.4 Narrative Approaches
Narrative Therapy is based on the assumption that 
people use stories to make sense of their lives and 
relationships (131, 132). As people mature, these stories 
govern how they see themselves, and their behaviour 
will be either consistent or incongruent with these 
stories (132). It is of little relevance whether these stories 
are accurate, rather the emphasis is on the impact these 
stories have on the client’s life (132).
Narrative Therapists encourage clients to talk about their 
problems in terms of these ‘stories’ and asks the client 
to consider how these stories might act as a barrier to 
overcoming their presenting problems (131). The Narrative 
Therapist then assists the client to re-author their story 
in a way that might assist this process (133). In addition, 
narrative approaches see problems as very separate from 
the people experiencing the problem, which can often 
make the problems seem more manageable (131). The 
Summary of Narrative Therapy Techniques 
(CAREE, 132)
■  Curious stance
■  Alternative stories
■  Reframe the problem
■  Expert knowledge from the client about own situation
■  Envisioning a preferred future.
NSW HEALTH Drug and Alcohol Psychosocial Interventions Professional Practice Guidelines PAGE 37
key strategies used by narrative therapists are summarised 
using the CAREE acronym (132). 
Narrative Therapy has not been evaluated formally in terms 
of its impact on treatment outcomes, such as mental 
health, quality of life, functioning, etc. No study currently 
exists that examines the use of narrative therapy among 
drug and alcohol clients. However, proponents of the 
therapy suggest that it is very useful in working with clients 
presenting with a wide range of problems.
Recommendation (★)
Narrative approaches to treatment may be of use in the 
treatment of problematic drug and alcohol use, and 
should only be used by suitably trained and experienced 
drug and alcohol clinicians. There is evidence for the 
use of narrative approaches as a generic therapeutic 
technique, although specific evidence in treating 
problematic drug and alcohol use is lacking at this time.
4.1.6 Self-help groups 
A self-help group is any group that has the aim of 
providing support, practical help and care for group 
members who share a common problem (134).
12-Step groups are the most common form of self-help 
groups available for clients with substance use problems 
(eg. Alcoholics Anonymous, Narcotics Anonymous) 
and are often broadly available within the community 
(16). Very few treatment studies exist to support the 
effectiveness of 12-step programs as stand-alone 
interventions. However, for some clients they can provide 
an adjunctive support and benefit in maintaining changes 
brought about by other drug and alcohol treatments (28, 
135). One major randomised trial (project match, Level 
2 evidence, 136) indicated that a 12-step program for 
alcohol use problems resulted in equivalent improvements 
in alcohol use to CBT and motivational interventions. 
However, several limitations exist with this study and, 
while encouraging, this result awaits further replication. 
This is particularly the case when other research exists to 
suggest that the benefits of 12-step programs only come 
into effect when clients attend more frequently than once 
weekly, and usually only in conjunction with concurrent 
formal drug treatment programs (135). Importantly, if a 
client has previously benefited from 12-step approaches to 
their problematic drug and alcohol use, then it is essential 
that goal setting within the current treatment plan is 
coherent with this philosophy (eg. abstinence-oriented 
approach rather than modified use).
Recommendation (★★)
D&A professionals should be aware of local 
12-Step groups and provide this information to 
interested clients. 
More recently, SMART (Self Management And Recovery 
Training) groups have commenced in Australia, targeted 
specifically at recovery from problematic drug and 
alcohol use. Groups are available face-to-face or on-line 
(see http://www.smartrecoveryaustralia.com.au/).
There are very few clinical trials looking at the effectiveness 
of self-help groups (16). However, they are considered an 
important tool in assisting people to achieve and maintain 
their goals in relation to substance use. 
4.1.7 Self-help material 
Self-help material (books, information pamphlets, computer 
programs, etc) have been used as an adjunct to ongoing 
face-to-face treatment and as a stand-alone intervention 
since the 1970s (28). Self-help materials are thought to 
have some advantages over other modes of treatment, as 
they can be made widely accessible and are flexible enough 
to be used as necessary by the individual client (137).
In the drug and alcohol treatment arena, a 
correspondence-based CBT program for problematic 
drinking produced a 50% reduction in alcohol use over a 
12-month period (controlled drinking by correspondence, 
Level 2 evidence, 138, 139). In addition, research has 
suggested that approaches such as bibliotherapy may 
be preferred for people with alcohol use problems, who 
may be reluctant to seek treatment given stigma or 
other adverse consequences associated with admitting 
to problematic drug and alcohol use (140). For example, 
self-help booklets aimed at reducing drinking behaviours 
and the negative consequences of problematic drinking 
resulted in increased treatment seeking for alcohol 
problems relative to a control group. This is particularly 
the case when ‘drinking diaries’ are included as a means 
of encouraging the client to monitor their problematic 
drinking patterns (65). A further review of the 
effectiveness of self-help material for alcohol problems 
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discussed several studies that indicated it was associated 
with a decrease in alcohol consumption (141). Very 
little evidence exists to examine the impact of self-help 
material on other problematic drug and alcohol use.
CBT has been adapted for delivery via computer 
programs and/or the internet for the following 
conditions: anxiety (142); panic (143); agoraphobia (144); 
smoking cessation (145); and eating disorders (146). 
However, very few computerised or internet-based 
interventions exist for substances other than alcohol or 
nicotine (147). For example, one small-scale study has 
been conducted using computer-based therapy among 
people with problematic alcohol use in the US (148). An 
eight-session windows-based computer intervention was 
developed and trialled among 40 problem drinkers. 
Although the study lacked an alternative treatment 
control condition, the intervention resulted in clinically 
significant reductions in alcohol consumption that were 
maintained at 12-month follow-up (148).
Level 1 evidence exists for the use of self-help material in 
the treatment of problematic alcohol use.
Although self-help materials are an important clinical 
tool in managing problematic drug and alcohol use, 
it is important to remember that they are not always 
associated with a change in behaviour (28).
Recommendation (★★★)
D&A professionals should encourage the use of 
self-help materials, particularly for alcohol use 
problems among clients with problematic drug and 
alcohol use.
A range of on-line self-help resources and useful websites 
are available to clients and D&A professionals. These 
include (but are not limited to) the following: 
■  Centre for Drug and Alcohol, NSW Health, fact sheets 
and guidelines: http://www.health.nsw.gov.au/public-
health/dpb/publications.htm 
■  Australian Drug Foundation: www.adf.org.au
■  Australian Drug Information Network: www.adin.com.au
■  Family Drug Support at: www.fds.org.au
■  Make a Noise: www.makeanoise.ysp.org.au
■  Community Builders: 
www.communitybuilders.nsw.gov.au
■  NSW Health: www.health.nsw.gov.au
■  Counselling On-line: www.counsellingonline.org.au
■  Australian National Council on Drugs: www.ancd.org.au
■  National Drugs Campaign: www.drugs.health.gov.au
■  Turning Point Alcohol and Drug Centre: 
http://www.turningpoint.org.au 
■  Alcoholics Anonymous: http://www.aa.org.au
■  Narcotics Anonymous: http://www.na.org.au
■  Beyond Blue (national depression initiative): 
http://www.beyondblue.org.au 
■  Black Dog Institute: http://www.blackdoginstitute.org.au
■  Moodgym (on-line counselling for depression): 
http://www.moodgym.anu.edu.au 
■  Bluepages: http://www.bluepages.anu.edu.au 
■  Reach Out (advice for young people): 
http://www.reachout.com.au/home.asp 
■  Beyond Blue (young people): 
http://www.beyondblue.org.au/ybblue/
4.1.8 Sleep and dietary issues
Problematic drug and alcohol use will harm the body in 
several ways, including the direct affect of the substance 
on the client, and the associated negative lifestyle 
changes that often accompany problematic drug and 
alcohol use. In particular, sleep problems, poor diet/
exercise and hydration issues will emerge, and require 
intervention from the D&A professional.
Encouraging clients to eat regularly and healthily 
will help them to resume an active and healthy 
lifestyle commensurate with a reduction/cessation in 
problematic drug and alcohol use. Often, hunger can 
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be mistaken for cravings for drug and alcohol and so it 
is important to educate clients about the importance 
of eating regularly to achieve their drug and alcohol 
use goals. In addition, this will also assist the client 
to better cope with the demands that withdrawal 
from problematic drug and alcohol use places on 
their bodies. Developing a meal plan with clients 
that focuses on low-fat, increased protein, complex 
carbohydrates and fibre is recommended (149). Specific 
advice regarding dietary recommendations according 
to drug type is provided at http://www.umm.edu/
ency/article/002149.htm. Finally, during withdrawal 
and recovery from problematic drug and alcohol use, 
dehydration is common. Therefore, it is important for 
clients to also ensure they are drinking plenty of fluids 
during and in between meals (149).
Sleep disturbances are also common among clients 
with problematic drug and alcohol use, and can also 
be associated with withdrawal from some substances. 
Although sleep problems can be among the most 
difficult to address, there are various strategies to help 
clients increase their chances of a reasonable sleep. 
Such strategies involve developing a routine or ritual 
around going to sleep at night, and include the 
following tips (150): 
■  Avoid sleeping unless tired
■  If client is not asleep after 20 minutes, get out of 
the bed
■  Begin rituals that help the client relax each night 
before bed
■  Encourage the client to set an alarm clock and to get 
up at the same time every morning
■  Encourage the client to get a full night’s sleep on a 
regular basis 
■  Avoid taking naps if the client can manage this
■  Ask the client to keep a regular schedule 
(mealtimes, sleep times, activity times)
■  Avoid reading, writing, eating, watching tv, talking on 
the phone, or playing cards in bed
■  Avoid caffeine after lunch 
■  Avoid alcohol within six hours of bedtime 
■  Avoid cigarettes or any other source of nicotine before 
bedtime 
■  Do not go to bed hungry, but avoid eating a big meal 
near bedtime
■  Avoid any strenuous exercise within six hours 
of bedtime
■  Avoid sleeping pills, or use them cautiously
■  Try to get rid of or deal with things that the client is 
worried about 
■  Encourage the client to make their bedroom quiet, 
dark, and a little bit cool.
These strategies are described in more detail at http://
www.sleepeducation.com/hygiene.aspx 
4.1.9 Continuing care 
Generally, continuing care is regarded as the system of 
continuing contact between a client and D&A professional 
once the initial (or acute) treatment phase is completed 
(28). Continuing care programs can take many forms, and 
often includes the following components (151, 152):
■  ‘Pinch hitting’ (a service provider steps outside their 
regular role to undertake another task)
■  Trouble shooting (anticipating and planning for 
problems likely to be encountered by clients)
■  Smoothing transitions (such as between services, and 
moving back into the community)
■  Speeding up the system (such as repeated phone calls to 
update other professionals on aspects of the client’s care)
■  Contextualising (communicating the history of a client 
to other health care providers).
In addition to these activities, continuing care can also 
include assisting the client to establish a social system to 
enhance and support their long-term recovery, including 
ways in which they can engage in employment, meet 
educational needs, and undertake recreational activities 
that are non-drug related (153). Providing information 
to general practitioners and other service providers is 
integral to this process, as is the engagement of families, 
peers and other social supports. Continuing care can 
also extend to providing the client with assistance in 
relapse prevention (154), using the ‘4As’ framework:
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■  Awareness: of problematic drug and alcohol use and 
other issues and factors affecting health and wellbeing
■  Anticipation: self-management approaches, continuity 
of care and crisis planning
■  Alternatives: availability of a range of services to 
address risk and protective factors for problematic 
drug and alcohol use
■  Access: early, easy and equitable access to services 
that meet these needs.
Several well controlled trials exist supporting the use of 
structured continuing care programs, particularly among 
clients with alcohol use problems (Level 2 evidence, 155) 
and opioid addiction (Level 2 evidence, 156, 157). The 
key features of these programs were that the content 
and format was highly structured, and negotiated with 
the client and D&A professional. The evidence from 
these studies indicate that pre-planned continuing care 
appointments, which the client attends regardless of drug 
and alcohol status, are associated with significantly lower 
rates of relapse, crime and unemployment relative to 
having this assistance provided only upon request (28).
Continuing care can be provided in person or via 
telephone contact initiated by the D&A professional 
(28), and should be regarded as part of the overall 
psychosocial intervention.
Recommendation (★★★)
A structured program of continuing care should 
be organised for drug and alcohol clients, which 
includes trouble shooting, smoothing transitions, 
relapse prevention, and assistance with other 
lifestyle concerns.
4.1.10 Management of crisis situations 
A range of crisis situations can confront a client whilst 
engaged in treatment for problematic drug and alcohol 
use. These include those associated with the problematic 
drug and alcohol use itself (intoxication states, overdose/
heavy use, withdrawal, risky drug use behaviours) and 
those associated with other areas of the client’s life 
(children, welfare issues, homelessness, pregnancy, cultural 
background, mental health co-morbidities, suicide risk, 
etc).  Each D&A professional should regularly assess 
and monitor the risk factors affecting each client and 
adapt the treatment plan accordingly. This will include 
referral to relevant and available services designed to 
address particular risk factors (eg. mental health services, 
family services, etc) when these issues become more 
pressing for a client than the agreed upon treatment 
plan. Risk management is an important component of a 
psychosocial intervention, and can be used to enhance 
the therapeutic alliance and treatment program (158).
The management of intoxication of a client should 
be guided by the local service policy of the D&A 
professional. Broadly, however, intoxicated clients need 
to have access to a safe, well-monitored environment, 
with low levels of external stimulation, and access to 
reassurance, reorientation and reality testing (16). Acute 
intoxication may require medical intervention, to remove 
the substance/s from the client’s body. Clients using 
multiple substances simultaneously will need to have the 
effect of each substance considered when deciding on a 
management plan (16). Psychosocial interventions should 
not be attempted with an acutely intoxicated client.
Overdose among drug and alcohol clients can be 
accidental or deliberate (see suicide risk management 
below). Typically, the D&A professional needs to 
maintain a supportive stance for the drug and alcohol 
client who has overdosed and mobilise emergency 
medical treatment as soon as possible (44). Local service 
policies should also guide the management of clients 
who have overdosed in the drug and alcohol setting.
Risk factors associated with increased risk of 
suicidal behaviour (suicidal, pg 25, 4)
■  S (sex: women attempt more than men, but men 
complete more than women; lack of significant 
others, stressful life events)
■  U (unsuccessful previous attempts, unemployment, 
unexplained improvement in symptoms)
■ I (identification with others who have suicided)
■  CI (chronic illness or severe illness of recent onset)
■  D (depression, decision that suicide remains a 
possibility)
■  A (age: older at increased risk, alcohol/other drug 
intake, availability of means to suicide)
■  L (lethality of previous attempts and of method 
selected for future attempts).
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In general, D&A professionals perform one of two roles 
in managing the suicide risk of clients (4). In the first 
instance, D&A professionals may need to address an 
actual suicide attempt, and should refer to their service-
based guidelines for this event. 
Secondly, the D&A professional will need to recognise 
and assess suicidal thinking among their clients. This 
involves having a good basic understanding of the risk 
factors associated with suicidal behaviour (as indicated 
on the previous page).
If a client is exhibiting several of these risk factors, 
the D&A professional has sufficient cause for concern 
about the wellbeing of the client. Typically, the use of a 
suicide contract has been used by health professionals 
to safeguard against suicidal behaviours in clients (158). 
However, the evidence suggests that the presence of 
a contract (i.e. A formal agreement between client 
and D&A professional that the client will not harm 
themselves within a given time period) is not associated 
with a reduction in subsequent suicidal behaviours (158). 
A suicide contract should not be seen as replacing a 
thorough suicide risk assessment, regular monitoring and 
supportive/engaging practices. 
The management of suicidal clients is usually governed 
by agency policies and procedures. D&A professionals 
should also be familiar with the requirements of the 
mental health act, and the NSW health framework for 
suicide risk assessment and management (9). 
4.1.11  Summary of evidence and 
recommendations
The table below summarises the above evidence 
regarding the use of psychosocial interventions among 
clients of drug and alcohol services. Clinician judgment 
is central to planning the use of particular interventions 
with particular clients, especially in the absence of 
research data to support these decisions. However, D&A 
professionals should also use the results from studies 
on the effectiveness of treatments, where available, to 
supplement this process (159).
Table 4.1 Summary of evidence and recommendations regarding psychosocial interventions for drug and alcohol clients
Psychosocial 
Treatment
Level of Evidence for Use with 
Problematic Drug and Alcohol use
Strength of Recommendation for 
Use with Drug and Alcohol Clients
Brief Interventions Level 1 ★★★
Motivational Interviewing Level 1 ★★★
Contingency Management Level 2 ★★★
CBT Level 1 ★★★
Psychodynamic Approaches Level 2 ★★★
Emotional Regulation
MBSR
DBT
ACT
Level 3b 
Level 2 
Level 2
★★ 
★★★
★★
Family Approaches
Couple/Family Therapy
SFBT
Systemic Approaches
Narrative Approaches
Level 3a 
Level 4 
Nil
Nil
★★ 
★
★
★
Self-Help Groups Level 2 ★★
Self-Help Level 1 ★★★
Continuing Care Level 2 ★★★
Management of Crisis Situations Level 4 ★
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´4.2  Considerations for specific 
drug types 
Marsh and Dale (2) provide a detailed description of the 
range of substances and related difficulties that clients 
will present with to the D&A professional. Additional 
information on these issues is provided at the Australian 
drug foundation website (www.druginfo.adf.org.au) and 
from a number of additional texts and reports (see 4, 
68, 135).
4.2.1 Tobacco
Tobacco contains nicotine, which is a highly addictive 
stimulant that temporarily increases alertness, 
concentration, memory and mood, but quickly forms a 
strong physical and psychological chemical dependence 
in regular users (160). Evidence suggests that smoking 
tobacco increases the levels of dopamine in the brain, 
resulting in abnormally high levels of this ‘feel-good’ 
chemical similar to that experienced by clients using 
heroin and/or cocaine (160).
Smoking is one of the most preventable causes of 
premature death and morbidity worldwide (161, 162). It 
is responsible for 20% of all deaths in the US and 45% 
of smokers will eventually die of a tobacco-induced 
disorder (163). Cigarette smoking is also linked to lung 
cancer; other lung problems such as emphysema; 
other cancers such as lip, mouth, oesophageal and 
breast cancers; and complications in pregnancy such as 
miscarriage, and birth defects (160).
Cigarette smoking causes neurochemical changes in 
the brain (164) and as such, researchers have examined 
the use of pharmacological treatments, such as nicotine 
replacement therapy (NRT) with a view to improving 
outcomes for people with nicotine dependence. of the 
four available forms of NRT (gum, patches, inhalers and 
sprays), nicotine gum has been the most extensively 
examined (Level 1 evidence, 165, 166). However, the 
other forms of NRT are also consistently associated 
with high rates of abstinence among heavy smokers. 
Generally, the use of NRT is associated with double 
the rates of abstinence from smoking compared with 
placebo or no-medication conditions (167). 
Other non-nicotine based pharmacotherapies have 
also been used to address smoking cessation. 
These include antidepressant medications (such as 
nortriptyline and bupropion), anxiolytics and some 
anti-psychotic medications (167). Importantly, the 
addition of psychosocial treatments (eg. CBT) to these 
pharmacological approaches, increases the quit rates 
reported by smokers by 50-100% (167). 
A range of support services are available to assist 
smokers effectively and affordably make a quit attempt 
(168). In NSW, a telephone-based counselling service 
is available to all smokers who would like support for 
a quit attempt. The Quitline also provides assistance to 
the family and friends of smokers and others requesting 
information about smoking. 
Callers to the Quitline receive a free quit kit, along with 
24 hour access to advice about quitting smoking, nicotine 
dependence, strategies on preparing to quit, preventing 
relapse and staying a non-smoker, as well as information 
on products and services to help with a quit attempt. Up 
to six follow-up phone calls can be scheduled throughout 
the most difficult period of quitting.
Quitline: 13 QUIT (13 7848) is a confidential telephone 
based service designed to help smokers quit smoking.
4.2.2 Alcohol 
Alcohol is a central nervous system depressant (169), 
with effects that vary according to the concentration 
of alcohol in the blood, prior use of alcohol, genetic 
susceptibility, and the situation (170). It also presents the 
client with the most diverse range of additional problems 
of all the drugs of abuse (15). 
Low-risk drinking guidelines (171)
■  Males: two to four standard drinks* per day with 
two alcohol-free days per week, avoid binges.
■  Females: One to four standard drinks* per day with 
two alcohol free days per week, avoid binges.
Binge drinking guidelines: (171)
■  Males: no more than six standard drinks* on any 
one drinking occasion.
■  Females: more than four standard drinks* on any 
one drinking occasion.
*Standard drink = 10g of alcohol 
(Eg one middy of full strength beer, one schooner of 
light beer, one nip of spirits, 100ml wine)
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Aside from developing alcohol abuse and/or dependence 
disorders, many clients will engage in unsafe drinking 
practices, consuming alcohol outside the recommended 
guidelines for non-hazardous use. 
Drinking outside these guidelines (see above) can be 
associated with both short- and long-term problems. 
Short-term risks include the risks of harm such as falls, 
assaults and car accidents, increased likelihood of 
engaging in risky behaviours while intoxicated (driving, 
unsafe or unwanted sex), exposure to verbal or physical 
abuse, etc continuing to drink in excess of these levels can 
also increase risk of medical or health-related problems. 
There are also the risks of developing emotional 
problems, such as depression, and problems at school, 
work and with relationships. Even if clients do not have 
a strict alcohol use disorder (abuse or dependence), 
risky or unsafe drinking should be assessed by the D&A 
professional. Steps need to be taken to control drinking 
within these guidelines and manage any of these 
additional problems associated with unsafe alcohol use. 
The American Psychiatric Association (16) indicates that 
the majority of alcohol abuse/dependence problems can 
be treated in the outpatient setting, with the exception 
of clients showing signs of alcohol withdrawal. In these 
cases, detoxification is recommended. However, once 
the physical symptoms of withdrawal are managed, it is 
important to follow up with some form of psychosocial 
treatment (28). Indeed, one of the key ingredients in 
successful alcohol treatment is engaging the client 
in a longer-term program of psychosocial treatment, 
emphasising relapse prevention and management 
strategies (Level 1 evidence, 16). This is particularly 
important in managing the more enduring symptoms of 
alcohol withdrawal such as cravings for use (170).
Withdrawal syndrome can occur in clients who are 
dependent on alcohol within 6-24 hours of their last 
drink, and is potentially fatal if not recognised and 
managed appropriately (4). Symptoms usually include 
tremors, hypertension, increased pulse and respiration 
rates, sweating, nausea/diarrhoea, sleeping problems, 
anxiety and decreased appetite (28, 170). The syndrome 
tends to peak approximately two to three days 
following abstinence, and symptoms subside within 
one week following abstinence (170). In severe cases 
of dependence, seizures can be experienced, usually 
one to three days following abstinence (170). In these 
clients, major withdrawal syndrome (which could include 
delirium tremens) may be present, emerging around 
three to ten days following the client’s last drink (170). 
Symptoms include disorientation, high fevers, paranoia, 
tactile, auditory or visual hallucinations and extreme 
agitation (28, 170). 
Approximately 5% of clients will experience major 
withdrawal syndrome, and it is rare in people under 
30 years of age (170). Withdrawal symptoms should 
be monitored, using formal withdrawal scales to 
supplement clinical judgment (see 28), and medical 
advice should be sought for moderate-high level 
drinkers prior to commencing a period of abstinence. 
D&A professionals should obtain a thorough history 
of past withdrawal symptoms in clients, as this profile 
of symptoms is most closely associated with future 
withdrawal symptoms, more so than the current number 
of drinks consumed by the client.
In cases where abstinence is not a realistic or desired 
goal for the client, a goal of controlled drinking may 
be more feasible. A controlled drinking goal is a 
legitimate harm reduction strategy, and needs to be 
clearly articulated for the client (eg. specific number of 
drinks, specific number of days per week when they will 
drink). One option may be to recommend a reduction of 
drinking to within the low-risk levels. Evidence suggests 
that controlled drinking goals are most effective among 
clients with low-level alcohol use through to hazardous 
or harmful use (172). There is less evidence that clients 
with severe alcohol dependence are able to maintain 
a reduced level of drinking (as opposed to abstinence) 
without relapsing to pre-treatment levels. However, 
chances are increased significantly when the client 
believes that a controlled drinking goal will be able to be 
achieved and maintained (172).
CBT, Motivational Enhancement Therapy and Brief 
Interventions have a strong evidence base for their 
effectiveness in treating alcohol use problems (Level 1 
evidence, 16). Psychodynamic, Interpersonal Therapies 
and 12-step treatments have received less research 
attention, but may well be effective for some clients 
with alcohol use disorders (eg. suicidality, acute 
psychosis, etc, 16). 
A number of pharmacotherapies are available to assist a 
client in working toward abstinence, manage withdrawal 
symptoms and to prevent cravings. In particular, 
naltrexone, acamprosate (Campral) and disulfiram 
(Antabuse) have shown benefits in treating alcohol 
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use problems over the short-term, if combined with a 
psychological intervention (173). Naltrexone in particular, 
if combined with coping skills training, is useful in 
preventing relapse to alcohol use (16).
Naltrexone is an anti-craving drug that acts on the 
brain’s opiate receptors and reduces the likelihood of 
relapse to alcohol dependence (28). Acamprosate is 
thought to reduce drinking by moderating the brain’s 
response to withdrawal from alcohol, and may be most 
suitable for people who are moderately to severely 
alcohol dependent and medically stable, provided they 
are also willing to comply fully with the medication 
regimen and engage in regular counselling (28). There 
is less evidence for the use of disulfiram among people 
with alcohol dependence. It is most commonly indicated 
for clients who are highly motivated to abstain from 
alcohol, and good outcomes can be achieved with close 
supervision. Disulfiram works by interacting with alcohol 
to create an intensely aversive reaction when alcohol is 
consumed (28), however is not currently subsidised by 
the pharmaceutical benefits scheme.
4.2.3 Cannabis 
Cannabis is the most commonly used illicit drug in 
Australia (174), with sedative, euphoric and (in high 
concentrations) hallucinogenic actions (169). There are 
several major health risks associated with cannabis 
use, including psychosis, memory and attentional 
problems, respiratory disease, etc (15). The risk of these 
complications increases with increasing quantity and 
frequency of use. There is no ‘safe’ level of cannabis use, 
and abstinence should be recommended in order to avoid 
complications and longer-term health consequences. 
However, research suggests that these harms are 
minimised if use is limited to once a week or less (175).
Generally, withdrawal from cannabis is considered 
straightforward and mild (135), and is suggested to occur 
in clients who smoke two or more units of cannabis per 
day for three weeks or more (176). Upon cessation of 
cannabis use, these clients will experience a range of 
withdrawal symptoms, such as anxiety, disturbed sleep, 
irritability, nausea, increased body temperature, tremor, 
stomach pain, etc (176). These symptoms will usually 
subside without complication. Tobacco is also often 
used among clients smoking cannabis, and withdrawal 
from tobacco will need to be managed appropriately by 
the D&A professional in assisting clients to reduce their 
cannabis use.
Evidence suggests that the symptoms of cannabis use 
disorder are best managed on an outpatient basis, 
unless hospitalisation is indicated for another condition 
(16). Whilst very few studies exist suggesting an optimal 
psychosocial approach with clients using cannabis, 
treatment that combines motivational enhancement, 
and elements of CBT such as relapse prevention and the 
development of coping skills, is likely to be successful 
(Level 2 evidence, 16, 135). The effect of CBT on 
cannabis use problems is also more enduring than other 
psychosocial therapies (Level 2 evidence, 135). No specific 
pharmacotherapies can be recommended with any clinical 
confidence for cannabis withdrawal or dependence (16). 
4.2.4 Amphetamines and other stimulants 
Amphetamines are central nervous system stimulants, 
often producing feelings of well-being, euphoria, 
increased energy and confidence and decreased 
appetite (177). Other stimulants will include cocaine 
and ephedrine/pseudoephedrine. Acute and chronic 
stimulant use (including amphetamines) is associated 
with increased risk of psychosis, hyperactivity, delirium, 
and cardiac problems (15). Heavy stimulant users may 
become violent for no apparent reason, and experience 
constant sleep problems, anxiety and tension, high 
blood pressure and rapid, irregular heartbeat (135). 
Another common side effect is depression (70). The 
greater the stimulation effects reported by clients using 
stimulants, the greater the negative effects and rebound 
will be when they stop using (169). There is no ‘safe’ 
level of amphetamine use, and abstinence should be 
recommended in order to avoid complications and 
longer-term health consequences. However, research 
suggests that these harms are minimised if use is limited 
to once a week or less (175).
Upon abstinence, acute withdrawal symptoms include 
lethargy and fatigue, cravings, increased appetite, 
insomnia (or excessive sleep), and bizarre dreams (4). 
Depression is also common, placing these clients at an 
increased risk of suicide (177). Withdrawal symptoms can 
last for hours in the case of cocaine use, up to around 
three weeks for amphetamine use (177).
As with cannabis, stimulant dependence, particularly 
cocaine, is also best managed in outpatient clinical 
settings, using a treatment approach that encompasses 
a variety of modalities (16). A combination of 
motivational interviewing and CBT has been shown to 
be effective in reducing amphetamine use and other 
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side effects of use (eg. depression, Level 2 evidence, 
70). However, an important factor in the success of 
these psychosocial approaches with this population has 
been efforts to engage amphetamine users in therapy 
(70). As such, the D&A professional should spend time 
properly engaging the amphetamine use client with the 
treatment plan/service. 
There are currently no evidence-based medication 
regimens for reducing or managing amphetamine 
use (178). However, the use of dexamphetamine as a 
substitution therapy has recently increased as a clinical 
tool in many drug and alcohol treatment programs 
(179). Very few studies of the use of dexamphetamine 
in the treatment of problematic amphetamine use 
have occurred to date. However, one small-scale study 
reported that the use of dexamphetamine prescriptions 
among oral- and injecting amphetamine users was 
reasonably safe, and associated with some reductions in 
amphetamine use (179). 
Clearly, more research into this treatment needs to occur. 
In response to this, NSW Health have established two 
specialist amphetamine clinics across the state to explore 
the potential of a range of amphetamine treatments, 
including substitution therapies. The clinical outcomes 
of these centres will contribute to the evidence base 
for treatment among this important group of drug and 
alcohol clients. In lieu of these results, any medications 
(eg. antidepressants, dexamphetamine) should be 
integrated within a psychosocial treatment program, 
which emphasises CBT, 12-step and other self-help 
approaches (16). 
4.2.5 Heroin and other opioid drugs
Opioid drugs, including heroin, stimulate the opioid 
receptors in the central nervous system, and produce 
drowsiness, reduced pain perception and euphoria (180). 
Overdose among heroin/other opioid users is more 
common than for any other illicit drug (15). Opioid overdose 
is associated with neuropsychological damage. However, 
the primary complications of opioid use will often arise 
from the psychosocial problems associated with use (eg. 
poor nutrition, menstrual irregularities, poor hygiene, etc) in 
addition to the risks associated with injecting drug use (15). 
Withdrawal from heroin and other opioids includes 
cravings, sneezing, muscle aches or cramps, nausea or 
vomiting, diarrhoea, recurrent chills, heart problems, 
yawning and restless sleep (4). These symptoms are not 
fatal, except in newborn children (180). Rather, it is the 
client’s perception of the severity of these symptoms that 
presents the most concern (180).
Abstinence is an ideal goal for clients with heroin use 
problems. However, from a harm reduction perspective, 
focusing on safe injecting and sexual practices can be an 
early and important treatment focus (4).
Two main pharmacotherapies are recommended for use 
among people with opiate dependence: Methadone 
Maintenance Treatment (MMT) and buprenorphine 
(181). Other forms of pharmacological treatment for 
opiate dependence include naltrexone (182). Of these, 
MMT is the most thoroughly studied and widely used 
treatment (183). Relevant NSW Health policy documents 
and guidelines include: Clinical Guidelines for methadone 
and buprenorphine treatment (5), and Drug and Alcohol 
Withdrawal Clinical Practice Guidelines (in print) (8). 
CBT has been shown to reduce illicit drug use among 
people on a methadone maintenance program, as well as 
other risk-taking behaviours (184, 185), and in decreasing 
the psychosocial problems associated with heroin use (eg. 
depression, risk taking, criminality, etc, Level 1 evidence, 
16). In addition, CBT and motivational interviewing 
increases the effectiveness and adherence to MMT (Level 
1 evidence, 135). Intensive inpatient programs have been 
shown to be no more effective than weekly psychosocial 
treatment as an adjunct to mmt (Level 2 evidence, 135).
4.2.6  Ecstasy (MDMA, 3, 4-methylenedioxy-N-
methylamphetamine) and other club drugs 
Hallucinogens (such as Ecstasy) produce thought 
distortions, and alter perception and mood (186). They 
differ from the other classes of drugs in that they are not 
usually associated with a clear dependence syndrome, 
and hence few withdrawal symptoms are present upon 
cessation of use (186). Ecstasy is chemically similar to 
amphetamines and mescaline, resulting in both stimulant 
and hallucinatory properties, such as euphoria, pleasant 
emotional effects, and increased energy (186).
The primary effects of Ecstasy and other hallucinogen use 
is psychiatric, including anxiety, hallucinations (psychosis-
type state), and poor decision making (15). Although 
Ecstasy is often regarded as a ‘safe’ drug by clients, use 
has been associated with renal failure, hyperthermia 
(overheating) and cardiovascular collapse (186). These side 
effects are unpredictable and can result in death (186).
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As with stimulant use, there are currently no approved 
medication regimens for reducing or managing 
hallucinogens (178). An evidence base for the use of 
motivational interviewing and CBT is beginning to 
emerge and is thought to be associated with a decrease 
in associated harms, although final results on these trials 
are not yet available (see National Drug and Alcohol 
Research Centre, University of NSW, http://ndarc.med.
unsw.edu.au/ndarcweb.nsf/page/current).
4.2.7 Poly-drug use
It is common for drug and alcohol clients to be using 
more than one drug at the one time. This ‘poly-drug 
use’, or hazardous use of more than one drug, is 
associated with increased risks and harms compared 
with single-drug use (187).
Clients may use multiple drugs in a variety of ways (187):
■  To increase their intoxication by using different drugs 
with similar effects at the same time (eg. alcohol + 
benzodiazepines + cannabis)
■  To offset the ‘undesirable’ effects of one drug (eg. 
sedation) by using an additional drug at the same time 
that diminishes this effect (eg. stimulant)
■  To manage withdrawal by using drugs in a sequence 
(rather than all at once) to regulate their withdrawal 
symptoms, improve mood, sleep, etc
Poly-drug use is associated with higher rates of psychiatric 
co-morbidity, increased risk of overdose, and risks 
associated with the interaction effects of different 
classes of drugs (187). For example, combining alcohol 
and heroin can fatally depress heart rate and breathing; 
combining amphetamines and ecstasy can result in 
severe dehydration, dangerously high body temperature, 
heart seizures and even death; and combining alcohol 
and amphetamines can result in dangerous amounts of 
the drugs being used without the client realising. (188). 
Additionally, withdrawal is likely to be more complicated if 
the client is ceasing use of several drugs simultaneously. 
A comprehensive assessment of poly-drug use is 
essential for every drug and alcohol client presenting 
for treatment. This will help to highlight for the D&A 
professional which drugs are being used problematically, 
which drugs the client is abusing and which drugs are 
being used at the level of dependence.
D&A professionals should take extra time engaging 
clients with poly-drug use issues, and should assess 
the individual and combined effects of poly-drug use 
on the client. Clients with poly-drug use issues will 
consider each drug differently in terms of its impact on 
their lifestyle and potential to cause harm in their lives 
(187). Treatment plans need to consider this, and tailor 
interventions to the relative concern expressed by clients 
about the different drugs they are taking.
More information on the management of poly-drug use 
in drug and alcohol clients is available at http://www.
turningpoint.org.au/library/lib_ctgs.html#7 (prescribing 
for drug withdrawal, and working with polydrug users).
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‘Co-morbidity’ may refer to multiple, co-existing physical, 
mental health and problematic drug and alcohol use 
issues, which may meet formal diagnostic criteria for a 
defined disorder such as in the diagnostic and statistical 
manual of mental disorders (38). However, mental 
health/problematic drug and alcohol use/other symptoms 
do not need to meet this formal criteria in order for 
co-morbidity to be present, and for these conditions to 
impact significantly on client functioning and thereby be 
worthy of treatment (189).
Co-morbidity is an important issue when considering 
treatment for substance use problems. Indeed, co-
morbidity is more common than would be expected by 
chance, with the presence of one disorder significantly 
increasing the risk of developing additional disorders 
(184, 190-192). For example, epidemiological surveys 
indicate that adults with lifetime mental disorders are 
twice as likely to experience alcohol use disorders than 
are their counterparts without mental disorders (14).
It is imperative that a co-morbidity-specific treatment 
plan is developed for clients presenting with co-morbid 
problematic drug and alcohol use and other conditions, 
as failure to effectively treat one condition will impact on 
the other present conditions (189, 193). In addition, co-
morbidity is associated with an increased burden of illness 
and disability. If left untreated, it will also result in an 
increased use of emergency and other high-cost services 
more often than would otherwise be necessary (59, 194). 
The risk of HIV infection, medical complications and early 
mortality are also significantly increased among clients 
with co-morbid mental health and problematic drug and 
alcohol use (53). Clients with co-morbid issues are also the 
most likely to consistently miss appointments with health 
professionals (53). It is important that D&A professionals 
realise that compliance with treatment and management 
plans among clients with co-morbidity is often low (191). 
Therefore, additional efforts to engage and retain clients 
in treatment will often be required. 
On the other hand, outcomes are improved when 
these clients are engaged within an integrated system 
of mental health and drug and alcohol treatment 
(195). This is particularly the case when psychosocial 
treatments are part of this treatment plan, given that 
a multitude of psychosocial problems will likely be 
present in a client with co-morbidity (53). The onus 
is on the D&A professional to develop local links 
with mental health services to improve collaboration 
between the two systems of care, as clients with 
co-morbid issues will experience a range of barriers 
negotiating through health services on their own (38, 
53). In addition, D&A professionals can encourage the 
development of supportive activities and relationships 
outside of the helping-related context, by supporting 
and maintaining client involvement in regular activities 
such as sport, music, art, social clubs etc engaging 
and activating a range of supports outside the helping 
relationship (eg. with families, schools, friends, carers, 
teachers, other role models) can also help provide 
the client with co-morbid issues with stability and 
‘normalcy’ in other areas of their lives. This will have a 
flow-on effect to their wellbeing. 
5.1 Models of co-morbidity 
Given the frequency with which problematic drug and 
alcohol use co-occurs with other conditions, population-
based surveys have been used to more closely examine the 
various environmental, genetic and neurobiological factors 
that may explain this co-morbidity (196, 197). As a result, 
several different models have been proposed to explain 
the co-occurrence of any disorder with a substance use 
disorder, and these can be applied with a view towards 
planning treatment approaches for these co-morbid 
conditions. The main models of co-morbidity are (198):
1.  Primary substance use disorder with psychiatric 
consequences (assumes that treatment of the 
problematic drug and alcohol use will resolve the 
mental health symptoms)
2.  Primary psychiatric disorder with secondary substance 
misuse (assumes that treatment of the mental health 
symptoms will resolve the drug and alcohol problem)
Co-morbidity
SECTION 5
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3.  Dual primary disorders (assumes that problematic 
drug and alcohol use acts as a trigger and maintaining 
factor for the other co-occurring disorder, and 
vice versa)
4.  Common aetiology (assumes that one or more 
factors, such as genetic predisposition, antisocial 
personality disorder, social difficulties, stressful events 
etc contribute to an increased risk of both problematic 
drug and alcohol use and mental health problems).
Little firm evidence exists to support the adoption of 
one co-morbidity model over another (199), and experts 
have suggested that the primary/secondary distinction 
between co-morbid disorders is immaterial once the 
two disorders have surfaced (15, 200). Moreover, 
clinical practice suggests that the relationship between 
substance use and mental health disorders in particular 
will change over time. For example, depression may 
trigger alcohol use at some times and the reverse may 
occur at other times (201).
Schuckit and colleagues (201) also suggest that the 
pattern of mental health symptoms in primary and 
secondary substance use problems is so similar that it 
is difficult for D&A professionals to use the presence 
of certain key symptoms as a guide when planning 
treatment programs for co-morbidity. Thus, D&A 
professionals may not be able to identify from the 
outset which clients are more likely to have a mental 
health problem that persists beyond abstinence from 
problematic drug and alcohol use (15, 202). Instead, 
experts recommend that treatments for co-morbidity 
should focus on the impairment and distress experienced 
by the client, rather than primary/secondary diagnoses 
(Level 3-a evidence, 203, 204). Such an approach 
means that treatment can proceed in absence of formal 
diagnosis and even when substance use is active, 
thereby facilitating earlier engagement in treatment, and 
encouraging multi-disciplinary input from a range of 
health professionals. 
In line with this recommendation, the concept of 
integrated treatment was developed for co-morbid 
problematic drug and alcohol use and mental health 
disorders (205). Integration of treatment for co-morbidity 
can occur at the level of the service or organisation that 
does not necessarily specify a particular defined clinical 
approach to treatment, or can refer to treatment that 
is offered by the one D&A professional, simultaneously 
targeting co-occurring substance use and mental health 
conditions, using techniques drawn from evidence-
based treatment approaches across mental health and 
substance use domains (16). This “clinical” integration 
of treatment for co-morbidity may provide superior 
outcomes, as treatment can additionally target the 
mutual relationship between conditions in a meaningful, 
consistent way, potentially encouraging the client to 
develop better management skills for both conditions 
(38). Indeed, in its revised practice guidelines for 
treatment of substance use disorders, the american 
psychiatric association (16) suggests there is sufficient 
evidence currently available to support the efficacy of 
integrated treatments for co-morbid substance use and 
mental health disorders, particularly when psychosocial 
approaches to treating substance use problems are 
combined with psychosocial treatments for mental 
health problems.
Integrated treatments can be tailored more easily to 
the particular needs of the client with co-morbidity, 
targeting areas of high distress and priority as they 
identify, addressing both acute and non-acute symptoms 
(205). In addition, clinically-integrated treatments provide 
clients with a coherent treatment plan that can arguably 
be delivered in a manner that is cost- and time-effective 
for service providers and clients themselves (16, 202).
Recommendation (★★)
Principles of practice for co-morbidity (38)
1.  Focus treatment on the impairment and distress 
experienced by the client, rather than trying 
to establish a diagnosis of primary/secondary 
substance use disorder
2.  Use a ‘clinically-integrated’ treatment approach, 
incorporating psychosocial strategies for both 
substance use and mental health problems into 
the same intervention
3.  Conduct a thorough assessment of all presenting 
conditions, and manage those symptoms that are 
the most severe first
4.  Ensure the development of good rapport and the use 
of strategies to actively engage clients in treatment
5.  Professionals working with co-morbid clients 
should seek training to ensure they possess skills to 
incorporate psychosocial strategies for both drug 
and alcohol and mental health problems into a 
treatment plan.
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5.2 Specific co-morbidities 
A general approach to managing co-morbidity should 
be to conduct a thorough assessment of the substance 
use and additional conditions, and to organise treatment 
according to the most distressing issues for the client at 
that point in time. In line with a stepped care approach 
to treatment, further intervention can be tailored to client 
need, and can focus on issues that remain problematic for 
the client following the initial intervention. Specialist input 
will be necessary for specific mental health issues, and this 
should be co-ordinated by the D&A professional, who can 
continue to offer drug and alcohol treatment.
At a minimum, D&A professionals could offer five key 
interventions to clients with co-morbid mental health 
problems (198): 
1.  Screening for mental health and other co-morbid 
conditions
2.  Engagement of the client in the process of treatment 
(see Section 3)
3.  Enhancing motivation and working towards change 
(see motivational interviewing, section 4)
4.  Active treatment, including goal setting, education 
and awareness about interaction between drug 
and alcohol use and mental health symptoms and, 
if suitably trained, a more intensive psychosocial 
intervention (see Section 4)
5.  Relapse prevention and management, including 
triggers for both drug and alcohol use and mental 
health symptoms. 
5.2.1 Depression 
Of the 6% of Australians with an alcohol problem, 40% 
also experience at least one other co-morbid disorder 
such as depression (184). Equally, among people with 
depressive disorders, 34% of men and 15% of women 
also experience concurrent alcohol use problems (16).
Given the overlap in the symptoms of depression and 
substance use/withdrawal profiles, it is recommended 
that antidepressant treatment not commence as a first-
line treatment option, unless indicated by the presence 
of severe depressive symptoms, high levels of suicidal 
ideation, and evidence of prior mood disorder (16). A 
delay of one to four weeks is recommended, during 
which a program of psychosocial treatment can be 
commenced to encourage a reduction in substance use 
and depressive symptomatology without pharmacological 
intervention (16). In particular, CBT and IPT have been 
associated with improvements in depression, along with 
other psychosocial strategies discussed in Section 4. 
Sleep and anxiety problems are also common among 
people with co-morbid depression and substance 
use problems, and these issues can be targeted using 
behavioural psychosocial techniques (see Section 
4.1.8, 207). In addition, given that situations involving 
negative mood are among the most commonly cited 
reasons for relapse across a range of substances (16), 
the relationship between the two co-morbid conditions 
should also be examined. 
The APA Practice Guideline for the treatment of clients 
with depression provides more detailed information on 
evidence-based treatments for this condition (208).
5.2.2 Anxiety 
Epidemiological research indicates that anxiety disorders 
will occur in around 50% of clients who are misusing 
substances (16). Clients with co-morbid anxiety and 
substance use disorders will benefit from an integrated 
approach to treatment that uses both pharmacological 
and psychosocial strategies. In particular, CBT has been 
successfully evaluated among a range of specific anxiety 
disorders, such as obsessive-compulsive disorder, social 
anxiety disorder and panic disorder (see section 4.1.5.1, 
16). Post-traumatic stress disorder will also commonly 
co-occur with substance use problems, and clients 
will benefit from a range of psychosocial treatment 
approaches, particularly when the relationship between 
the two conditions is examined (16).
The APA Practice Guideline for the treatment of clients 
with panic disorder (209) provide more information on 
the evidence-based treatments for this specific condition.
5.2.3 Psychosis 
Approximately 40-60% of people with schizophrenia 
will have a co-occurring substance use problem at 
some stage in their lifetime (16). This rate is even higher 
when conditions such as bipolar affective disorder 
are considered. Given the typically limited training of 
D&A professionals in treating schizophrenia and other 
PAGE 50 NSW HEALTH Drug and Alcohol Psychosocial Interventions Professional Practice Guidelines 
psychotic disorders, treatment usually occurs within the 
mental health system (16). However, D&A professionals 
can often supplement this care, by offering psychosocial 
support that emphasises optimism, empathy, assertive 
outreach and case management, as described in Sections 
3 and 6. The evidence suggests that these approaches 
are effective for between 50-60% of clients with co-
morbid psychotic and drug and alcohol use disorders (16).
Information about evidence-based treatment approaches 
for the psychotic disorders can be found in the APA 
Practice Guideline for the treatment of clients with 
schizophrenia (210) and the APA Practice Guideline for 
the treatment of clients with bipolar disorder (211).
5.2.4 Personality disorders 
Problematic drug and alcohol use and personality 
disorders frequently co-occur (16). The combination of a 
substance use problem and a personality disorder (such 
as borderline personality disorder, antisocial personality 
disorder, etc) places a client at extremely high risk for 
suicide, engaging in other high-risk behaviours and a 
poorer prognosis (16). An approach that emphasises 
engagement and rapport building, structure and firm 
boundaries between the D&A professional and the 
client will enhance treatment outcomes (16). DBT (see 
Section 4.1.5.3.2) Is also a helpful approach for clients 
with personality disorders, and can have an effect on 
problematic drug and alcohol use.
The APA Practice Guideline for the treatment of clients 
with borderline personality disorder (212) provides more 
detailed information on evidence-based treatments for 
this condition.
5.2.5 Trauma 
Traumatic events can take many forms, including 
community disasters, road accidents, through to sexual 
abuse, exposure to violent situations, etc experience of 
these events is often associated with increased rates of 
problematic drug and alcohol use (213). For example, 
hospital statistics indicate that between 20-40% of 
injured clients admitted to trauma units have current 
or lifetime alcohol abuse/dependence (214). Further, 
among clients with heroin dependence in Australia, 
trauma exposure and post-traumatic stress disorder are 
highly prevalent, occurring at rates of 92% and 41% 
respectively across drug and alcohol settings (215). 
Other research suggests that, among women seeking 
treatment for problematic drug and alcohol use, up to 
80% report a lifetime history of sexual assault, physical 
abuse, childhood abuse or a combination (216).
In a similar way to other co-morbidities, problematic 
drug and alcohol use within the context of trauma is 
viewed as either being a coping strategy (self-medicating 
the distress associated with the trauma), or as increasing 
the likelihood that a client is exposed to a traumatic 
situation (eg. Intoxication can increase risk of injury, 
exposure to violence, etc 214). 
Some research exists to suggest that, particularly in 
the early stages of treatment, specific drug and alcohol 
treatment should occur concurrently with treatment 
for the trauma issues (with or without post-traumatic 
stress disorder, 217) in an integrated treatment program 
(216, 218). Such treatment could focus on engagement 
and rapport building, motivational interviewing, CBT 
strategies and relapse prevention (217).
The APA Practice Guideline for the treatment of 
clients with acute stress disorder and posttraumatic 
stress disorder (219) provide more information on the 
evidence-based treatments for these conditions.
5.2.6 Anger/aggression 
The occurrence of angry and aggressive behaviours is 
significantly increased among clients with problematic 
drug and alcohol use (16). Such behaviours include 
verbal abuse and intimidation, physical and sexual 
aggression, domestic violence (including child abuse) and 
in some cases homicidal behaviour (2). The likelihood of 
these behaviours increases with increased intoxication.
A range of factors will increase the potential for 
‘reactive’ violence in drug and alcohol clients, that is, 
violence that arises from fear or frustration (4). These 
factors may include a noisy waiting room, a long wait 
to see a D&A professional, fear of unknown people or 
environments etc. In these cases, an empathic approach 
that attempts to build rapport and decrease the threat or 
unpleasantness in the environment will usually help de-
escalate the situation (4). If the client feels they have been 
‘wronged’, it may be possible for the D&A professional 
to calm them down enough to explore the situation and 
determine how to rectify these thoughts/feelings. 
In some cases, however, clients will not be calmed, and 
it may be necessary to ask them to leave the service, or 
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for the D&A professional to leave the session and seek 
support from peers/supervisors within the service (4). 
Personal safety of the D&A professional, other staff and 
clients is of key importance in these situations and a 
range of strategies can be used to minimise aggressive 
and violent outbursts.
5.2.7 Pain 
Pain is the most common reason medical treatment 
is sought, and is often under-treated (220). It is 
estimated that, among clients engaged in a Methadone 
Maintenance Program, up to 60% may also have a 
concurrent chronic pain condition (221). Pain also alters 
the presentation of problematic drug and alcohol use, 
with an increased risk of using non-prescribed analgesic 
medications or cannabis use often evident (221). 
Suicidality is also likely to be elevated among drug and 
alcohol clients with co-morbid pain issues (221).
Co-morbid pain and problematic drug and alcohol use 
complicate treatment for both conditions, especially 
given opioids are commonly used to treat pain (221). It 
is often difficult to tell whether the client is only using 
opioids in response to pain (therefore not necessarily 
requiring drug and alcohol treatment) or whether a drug 
and alcohol use problem is evident. Some research has 
presented tips for distinguishing between these clients 
in practice (see below). However, the use of drug and 
alcohol to manage pain does not necessarily mean that 
clients do not need or will not benefit from treatment 
for drug and alcohol use. 
Treatment of drug and alcohol clients with pain, 
particularly those engaged in Methadone Maintenance 
programs, requires skills that complement best practices 
in opioid prescribing (see NSW Health Guidelines, 5, 
222). However, the presence of pain will often result 
in increased drug and alcohol seeking and heightened 
cravings for drug and alcohol (221). Also, because pain 
reduces well-being and quality of life experiences, 
drug and alcohol may be sought as a way of increasing 
euphoria, if only for a limited time (221). These issues 
should also become targets for drug and alcohol 
treatment.
Instead of deferring treatment for pain, particularly if 
drug and alcohol abstinence is not a realistic goal for 
clients with co-morbid pain, treatment programs need 
to be flexible and assist the client to work toward a 
goal of moderated drug and alcohol use while working 
with other health professionals to better manage the 
client’s chronic pain. It may be appropriate, for example, 
to treat the client’s problematic drug and alcohol use 
within the drug and alcohol setting, and seek agreement 
to have the client’s prescription medications dosed 
by providers in that setting (223). Taken together, it is 
suggested that clients with concurrent chronic pain and 
Tips for Enhancing Personal Safety and 
Minimising Aggression with Potentially Violent 
Clients (pgs 640-641, 4)
Prior to the therapy session:
1.  Structure the environment (communicate with 
other team members, protocol for alerting 
others to violent behaviours, staff passing by the 
appointment room, lockable doors, etc)
2.  Inform clients about anticipated delays
3.  Avoid excess stimulation (noisy waiting rooms, 
bright lights, etc).
During the therapy session:
4.  Use warm, empathic, therapeutic skills
5.  Provide supportive feedback (“you seem to be a 
bit agitated...Perhaps you can tell me why you’re 
feeling agitated, then I may be able to help you in 
some way...”)
6.  Never turn your back on an agitated or 
aggressive client
7.  Let an aggressive or agitated client talk without 
interruption
8.  Ensure a safe escape route (both drug and alcohol 
professional and client have equal access to the 
door, or if not possible, then drug and alcohol 
professional sits closest to the door)
9.  Look for anger (rising voice, tensing muscles, 
red face, etc)
10.  Do not try to handle a violent client on your own
11. Never try to disarm a client who has a weapon
12.  Remove ‘dangerous’ items/clothing you may be 
wearing (scissors, knives, items that could be 
thrown, glasses, earrings, necklaces, neckties, 
cigarette lighters, etc).
PAGE 52 NSW HEALTH Drug and Alcohol Psychosocial Interventions Professional Practice Guidelines 
problematic drug and alcohol use need to be engaged in 
an integrated treatment model of pain management and 
drug and alcohol treatment (221, 224).
5.2.8 Blood-borne viruses
Human Immunodeficiency Virus (HIV), Hepatitis B and 
Hepatitis C are common blood-borne viruses associated 
with problematic drug and alcohol use. Injecting drug 
use remains the largest risk factor for Hepatitis C 
infection (225), and unsafe injecting practices, increased 
risky sexual behaviours, etc places clients at high risk for 
developing these conditions.
Testing for blood-borne viruses such as Hepatitis and 
HIV is important among clients with problematic use 
of illicit substances, and involves a blood test. Prior 
to recommending this test, D&A professionals should 
discuss the implications of a positive and negative 
test result with drug and alcohol clients, and provide 
feedback on the outcomes of testing in person rather 
than via non-face-to-face modes (225). Testing should 
only be carried out with the full informed consent of 
the client, and should occur when they are relatively 
stable (ie. not during a phase of withdrawal or acute 
use/intoxication). Further information about pre- and 
post-test counseling strategies for D&A professionals is 
outlined in: NSW Health Policy Directive PD2005_048: 
Counselling Associated With HIV Antibody Testing 
- Guidelines. Vaccinations are available and should be 
recommended for clients with non-positive blood tests.
No drug and alcohol use issues (pg 28, 220) Drug and alcohol use issues (pg 28, 220) 
■  Not out of control with medication (ie. Only uses in 
response to pain)
■  Medication improves quality of life
■  Aware of side effects
■  Concerned about medical problems
■  Follows agreed treatment plan
■  Has medications left over from previous prescriptions
■  Out of control with medication
■  Medication decreases quality of life
■  Medication use continues/increases despite 
side effects
■  Minimises medical problems
■  Difficultly following treatment plan
■  Does not have medication left over (always a ‘story’)
Drug and alcohol professionals can assess the 
risk of Hepatitis and HIV by asking clients about 
the following (64): 
■  Frequency of injecting drug use
■  Frequency of sharing needles
■  Needle cleaning/sterilising practices if re-used
■  Number of sexual partners in past month
■  Frequency of unsafe sexual practices (eg non-use 
of condoms).
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Marsh and Dale (2) highlight the importance of focusing 
psychosocial treatments for problematic drug and 
alcohol use on issues that are important to the client. In 
the short term, this may involve addressing very practical 
concerns for the client such as housing, economic, legal 
or social problems, and adopting a ‘case management’ 
or care co-ordination approach to treatment (226). 
Addressing these pressing issues for the client presents 
the D&A professional with an ideal opportunity to build 
strong rapport and engagement, potentially setting the 
scene for psychosocial and other treatment strategies. 
This section draws heavily on the position paper on case 
management developed by the NSW Health Drug and 
Alcohol Council Case Management Sub-Committee (227).
Case management grew out of community service 
models in the 1960s, in response to rapid service 
growth and the need to facilitate client care through 
uncoordinated and fragmented service systems. The 
development of case management approaches in 
conjunction with treatment for problematic drug and 
alcohol use is associated with the need to overcome 
fragmented treatment systems, inadequate service 
funding, service waiting lists, barriers between services 
(eg. drug and alcohol and mental health services), 
and admission criteria that exclude some clients. Case 
management is employed with substantial variety across 
treatment settings, with descriptions in the literature 
including:
■  A process to access ancillary services for clients to 
enable specialist clinicians to focus on clinical activities
■  Delivery of service linkages and co-ordination across a 
variety of service systems
■  Establishment of co-ordinated care partnerships 
through the establishment of close working 
relationships across the health system
■  The employment of designated case managers to 
ensure assessment, case planning, integration of 
responses to treatment needs, facilitation of access to 
substance abuse treatment places and engagement 
with clients throughout the treatment process. 
6.1 Definition of case management 
For the purposes of these guidelines, case management 
can be defined as the following: 
■  A direct client service in which case managers and 
clients collaborate in comprehensive assessment, 
individual care planning, service facilitation, outcome 
monitoring and advocacy. 
■  Case management is not a profession or discipline, 
but an area of practice employed across the range 
of professions in drug and alcohol programs. Case 
management is distinct from, however may overlap 
with, evidence-based clinical interventions employed 
in the management of problematic drug and alcohol 
use. The key distinction is that the case management 
provides a central process of co-ordination of 
individual client care and works to overcome obstacles 
in service access. The delivery of case management 
services within drug and alcohol programs should 
be established to maximise communication between 
professionals and agencies involved in the care of 
the individual and to minimise duplication of services 
where overlap occurs.
■  The case management approach is particularly useful 
for clients with complex needs and for those involved 
in ongoing care management. The case management 
approach assumes that clients with complex and 
multiple needs will access services from a range of 
service providers. The goal of case management is 
to provide seamless delivery across organisational 
boundaries.
Care co-ordination and case management 
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6.2 Evidence for case management
Case management is thought to encourage positive 
changes in the drug and alcohol client by enabling them 
to form a trusting, strong, and enduring relationship 
with a D&A professional (159). Over the longer term, by 
co-ordinating care for the client and organising ongoing 
support services, case management is thought to reduce 
the intensity with which drug and alcohol treatment will 
be required (159). 
The importance of case management in the treatment 
of clients with problematic drug and alcohol use has 
been agreed upon by many experts in the field, however 
very little actual research exists to suggest what the role 
of case management is in determining client outcomes 
(128, 228). Rather, studies of case management have 
largely focused on describing aspects of the treatment 
approach (159). 
No controlled trials exist to test the effectiveness of case 
management approaches among clients with substance 
use problems (2). A few cohort studies do exist to suggest 
that case management is associated with increased 
retention in treatment (Level 3-b evidence, 229), but 
this has not been directly related to improved drug and 
alcohol use outcomes. Rather than the number of hours 
spent with the client, the active ingredient in these cohort 
studies is suggested to be the implementation of a case 
management model that is based on a theoretically 
sound, structured standard of care (229).
Shortcomings in evidence reflect that:
■  Investment in clinical drug and alcohol research 
has primarily focused on clinical interventions 
including medical interventions (opioid treatment 
services, detoxification etc), cognitive-behavioural 
and behavioural interventions, psychotherapy 
and counselling, mapping, family and relationship 
interventions, and welfare and employment 
interventions. 
■  No controlled trials have been conducted on the 
effectiveness of case management in conjunction with 
opioid treatment services.
■  Research is difficult to conduct because case 
management is poorly defined, is applied inconsistently 
and it is therefore difficult to establish clear methods 
and goals.
■  Published studies suffer from inadequate research 
design and fail to control for non-experimental 
variables. 
■  International studies examine case management 
practices that differ substantially from the Australian 
experience as they relate principally to the case 
manager’s role in the direct purchase of substance 
abuse treatment.
Five models of case management have generally been 
used for drug and alcohol clients (7, 230): 
1.  Brokerage Model (brief approach whereby case 
workers ‘broker’ support services within one-two 
sessions; no evidence for effectiveness on retention 
in treatment or drug and alcohol outcomes, but 
associated with increased access to drug and alcohol 
services)
2.  Generalist/Intensive Model (Level 3-b evidence for 
effectiveness on retention in treatment, preliminary 
evidence for improved drug and alcohol outcomes)
3.  Assertive Community Treatment Model (Level 2 
evidence for effectiveness on mental health outcomes, 
but no drug and alcohol studies to date)
4.  Clinical Case Management (Level 2 evidence for 
effectiveness on mental health outcomes, but no drug 
and alcohol studies to date)
5.  Strengths-Based Case Management (Level 2 
evidence for effectiveness on mental health outcomes, 
but no drug and alcohol studies to date).
The three latter models (Assertive Community Treatment, 
Clinical Case Management, Strengths-Based Case 
Management) also involve significant clinical/therapeutic 
input as described in section 4. The Generalist/Intensive 
model uses the seven strategies most commonly 
suggested by experts in the case management area as 
the most effective case management approach (Level 3-
b evidence, 53, 128, 229, 230).
Several groups have carried out studies examining the 
benefits of Brokerage Case Management approaches 
to clients with a range of difference problematic drug 
and alcohol use issues. For example, case management 
providing assistance in accessing required services, 
including drug and alcohol treatment, was compared 
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to receiving information about referral services, 
among a group of 360 injecting drug users who were 
randomly allocated to each condition (Level 2 evidence, 
231). Results indicated that the case management 
group were significantly more likely to be admitted to 
treatment for drug dependence, had significantly lower 
periods between initial contact and admission, were 
retained in treatment for significantly longer than the 
comparison group and demonstrated better treatment 
outcomes. These results should be considered within 
the context that case management was provided 
externally to treatment services, and treatment places 
were purchased for clients in the experimental group 
where necessary. 
In a descriptive study (Level 3-b evidence), case 
management (Brokerage) services were provided to 
310 drug and alcohol clients presenting to a public 
health clinic for homeless, mentally ill and HIV positive 
issues (232). Results demonstrated that referrals to 
primary health care services reduced, drug and alcohol 
treatment services remained stable, and referrals to 
mental health services increased substantially over the 
three-year pilot study.
In another descriptive study (Level 3-b evidence), an 
enhanced model of case management was provided to 
51 postpartum drug and alcohol clients over a 12-month 
period (233). The Generalist/Intensive program, described 
as an advocacy model, included the establishment of a 
therapeutic relationship, identification of client goals, 
establishment of linkages with service providers, written 
agreements, skills training and evaluation. The authors 
reported improvements across the clinical population 
including reductions in drug and alcohol use, increased 
involvement in treatment for drug and alcohol problems, 
increased use of birth control and increased involvement 
in parenting classes. It should be noted that the study 
design did not establish a control group.
Considerable research has been undertaken in the 
delivery of case management in mental health 
services, highlighting controversy over the value of the 
intervention. In a Cochrane collaboration review of 
seven published randomised controlled trials on case 
management services for people with severe mental 
health disorders, over the preceding 20 years (234), 
case management was associated with increased 
client contact with psychiatric services and a two-
fold increase in admission/readmission to a psychiatric 
institution compared to those not case managed. Case 
management was not associated with improvements 
in clinical or social outcomes and cost data was 
inconclusive. 
The authors’ conclusions express concern that “case 
management is an intervention of questionable value, 
to the extent that it is doubtful whether it should be 
offered by community psychiatric services”. However, this 
review has since been criticised (235) for not including 
randomised controlled trials on Assertive Community 
Treatment (ACT) in the review of case management, 
and for focussing exclusively on passive Brokerage Case 
Management Models. 
It should be noted that Assertive Community Treatment, 
as a form of case management, is defined by a number 
of service conditions that, in general, NSW drug and 
alcohol services could not meet (227) including:
■  Longitudinal care
■  Provision of services on a 24 hour per day, seven day 
per week basis in a fully mobile, fluid system
■  High intensity service provision, generally provided in 
the client’s own setting
■  ACT teams are generally highly resourced and become 
self sufficient across the spectrum of care (including 
prescription and administration of medication) and 
are generally not required to refer clients to external 
services
■  Client to staff ratios should generally be established in 
a range from eight-to-one to ten-to-one.
For drug and alcohol clients, the core principles of case 
management are that client outcomes are improved 
where individual treatment or care plans are developed 
based on comprehensive assessment of the broad 
spectrum of biological, social, familial and behavioural 
factors. Although many models of case management 
currently in use are based on an accepted theoretical 
paradigm, in practice, these models have usually been 
adapted to suit the local conditions of the service and 
the individual needs of the client (128). 
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This client-centered approach is indeed a strength of case 
management, however this also means that the strategies 
used within a case management approach will vary a 
great deal between individual professionals and between 
services, geographic locations, etc (228). Consequently, 
within the drug and alcohol setting, case management is 
not well defined or operationalised (228, 229).
Recommendation (★★)
Core activities in Generalist/Intensive Case 
Management should include (53, 128, 227, 229, 230):
■  Screening and assessment of individual clients 
including assessment across all factors relating to 
the client’s presentation
■  Development of comprehensive, individual 
treatment or care plans
■  Co-ordination of treatment or care plan 
implementation
■  Facilitation of access to specialist treatment for 
substance use disorders
■  Facilitation of access to other health services 
including mental health, hepatology, emergency 
etc as required
■  Facilitation of access to a broad range of 
community services
■  Maintenance of contact with and support for the 
individual client 
■  Monitoring progress and outcome across the 
care plan
■  Review and revision of individual care plans.
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This section describes some additional considerations 
for important groups within the community to whom 
psychosocial interventions could be delivered. In general, 
many of these principles could be applied to any drug 
and alcohol client, however some additional practice tips 
provided here may assist the D&A professional to better 
engage with the target group.
7.1 Aboriginal people and communities 
A range of additional psychosocial issues are associated 
with high levels of problematic drug and alcohol use 
among Aboriginal and Torres Strait Islander people 
in Australia. These include increased risk of exposure 
to violence, risk of depression, anxiety, high rates of 
suicidality, increased risks of poor nutrition and other 
medical complications (236). In treating a client of 
Aboriginal or Torres Islander descent, these additional 
issues should be considered. 
D&A professionals need to take a proactive role in 
engaging additional services in the care of a client, 
acting as an advocate for them particularly if they are 
experiencing system-level barriers to treatment (eg. if 
co-morbidity issues are present). The onus is on the D&A 
professional to find out which local Aboriginal/Torres 
Strait Islander services are available, and actively seek out 
relationships and clinical partnerships with these services. 
This will include services within the drug and alcohol 
setting and those external to it.
In treating a client of Aboriginal or Torres Strait Islander 
descent, it is important to understand that the D&A 
professional is not just engaged with the individual 
client. Rather, the D&A professional is treating a client 
in the context of a close-knit Community. With client 
consent, consultation should occur with the individual 
client, other health providers (including indigenous 
support services), with family and Community members 
to determine the most appropriate course of action 
for the client (237). Realistic treatment plans should 
be developed, which can be incorporated into the 
wider social and cultural context of the client (238). In 
addition, the D&A professional must be sensitive to the 
possibility that the level of respect, rapport, trust and 
skill with which they treat any client will be evaluated 
by the larger Community, highlighting the need to 
manage these encounters appropriately.
Given that the experience of many Aboriginal and Torres 
Strait Islander people with the health and welfare system 
is unsatisfactory, it is unrealistic for the D&A professional 
to expect members of the Community to access their 
service in the same way that other groups may do. 
D&A professionals must be aware of and confront 
any stereotypes they may hold, and be aware of how 
they are perceived by the Community by virtue of their 
association with the health system (238). As such, the 
D&A professional needs to take time to engage with 
the Community, building a respectful and trusting 
relationship with them over time, which may then make 
the service more ‘accessible’ to members within the 
Community. 
Clear, effective and culturally appropriate 
communication is an essential component in providing 
care to people of Aboriginal and Torres Strait Islander 
descent (238). For example, just as different drugs 
have different ‘street’ names, Aboriginal and Torres 
Strait Islander languages have their own words for 
alcohol, and other drugs (239). It is important for 
the D&A professional working with these groups to 
be mindful of this, and to attempt to understand 
how alcohol/other drugs are referred to within the 
Community. Conversely, the D&A professional should 
avoid the use of technical and/or medical jargon when 
interacting with Aboriginal and Torres Strait Islander 
people as this may affect their understanding of 
discussions, treatment plans, etc, which in turn will 
impact negatively on engagement. D&A professionals 
should speak slowly, clearly and non-judgementally, 
and use culturally-specific labels for words only when 
appropriate and without condescension (238). Again, 
taking the time to develop a relationship with the 
Community, learning social cues, body language cues, 
etc, is the key (238).
Intervention for special groups
SECTION 7
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Finally, in the context of a therapeutic interaction with 
a client, the D&A professional should allow additional 
time for key messages to be communicated and 
discussed, and source culturally appropriate and sensitive 
documents that reinforce any advice or treatment plans 
involving the client (see 239 as a good example of this).
Tips for working with Aboriginal and 
Torres Strait Islander people:
■  Be proactive in establishing relationships with 
Aboriginal/Torres Strait Islander services and take 
responsibility for maintaining these relationships
■  Be proactive in engaging with the local 
Community, rather than waiting for them to 
access the drug and alcohol service
■  Understand that a client needs to be treated in 
the context of their Community
■  Community views of health professionals will 
likely be judged according to the Community’s 
experience with an individual drug and alcohol 
professional
■  Work with the local language for alcohol/other drugs
■  Avoid using technical or medical jargon
■  Reinforce key treatment messages with suitable 
documentation
■  Understand that relationships (including 
therapeutic relationships) will take time to develop 
and that this is often a necessary precursor to 
engaging in treatment and learning culturally 
appropriate ways of interacting with clients.
7.2  Services for domestic violence/ 
family violence 
The Policy and Procedures for Identifying and Responding 
to Domestic Violence (http://www.health.nsw.gov.
au/policies/pd/2006/pdf/pd2006_084.pdf) provides a 
framework for informing domestic violence responses for 
staff in hospitals and community health services in NSW. 
All D&A professionals should be aware of and follow the 
guidelines presented in this policy directive.
Domestic violence refers to abusive or violent behaviour 
that occurs between adults who are partners or former 
partners (see NSW Policy Directive PD2006_084, and 
240), and often occurs in the context of problematic 
drug and alcohol use. Drug and alcohol use does not 
cause or provide an explanation for domestic violence. 
However, it may exacerbate underlying problems and 
add an additional layer of management and intervention 
when responding to domestic violence situations. It is 
important to remember that episodes of domestic/family 
violence are one of the key notifiable issues for D&A 
professionals, particularly if children are involved.
The D&A professional should be aware of local services 
currently available to assist perpetrators and victims of 
domestic/family violence, and make appropriate referrals 
to these specialised services rather than attempting 
to treat them in the drug and alcohol context. If it is 
identified that issues of anger management are related 
to problematic drug and alcohol use, then these issues 
could also be the focus of treatment (if the D&A 
professional is suitably skilled) or referral. 
Clients may request a court report from the D&A 
professional to assist with any legal matters arising from 
their involvement in domestic/family violence situations. 
These requests should be clarified as early as possible 
in treatment, and need to be managed with care. The 
D&A professional should clarify their role in this process, 
and ensure that treatment and thus their report remains 
focussed on the problematic drug and alcohol use issues 
of the client. D&A professionals should also clarify their 
role with the client (eg. case co-ordination, treatment, 
advocacy) and be aware of the different legal and ethical 
responsibilities associated with each of these roles in 
situations of violence.
If asked to provide a court report relating to domestic/
family violence situations, D&A professionals need to be 
clear that the report can only be related to their drug 
and alcohol work with the client and not the violent 
situation, if this has been the focus of their work with 
the client. 
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7.3 Child protection services 
The NSW Interagency Guidelines For Child Protection 
Interventions 2006 (http://www.health.nsw.gov.au/
pubs/2006/iag_childprotection.html) outlines NSW Health’s 
and other government agencies’ roles and responsibilities 
in relation to the safety, health and wellbeing of children 
and young people. All D&A professionals working in these 
agencies should be familiar with and follow these guidelines. 
In particular, these guidelines provide information about:
■  How to identify child abuse, neglect, domestic violence, 
sexual abuse, physical abuse and psychological harm
■  When and how to make a report to Department of 
Community Services (DoCS) helpline
■  Important contacts including web addresses.
Information about these issues is likely to benefit D&A 
professionals working in the private sector. However, 
these professionals should also refer to the guidelines 
provided by their own professional bodies.
Effective service delivery to families is dependent on 
the provider of drug and alcohol interventions, DoCS 
and other agencies involved working collaboratively, 
cooperatively and with a clear understanding of each 
other’s roles and responsibilities. 
Reports to DoCS are mandatory if:
■ A child reports that they have witnessed (seen/
heard) abuse/violent behaviour, or if they have been 
the victim of such behaviour
■ A drug and alcohol client reports that their child 
has witnessed or been the victim of abuse/violent 
behaviour. In these cases, the child becomes the 
client by proxy and drug and alcohol professionals 
have a responsibility to that child to notify DoCS.
If a decision to make a report is made, the following 
process will occur: 
■  The D&A professional should contact DoCS in accordance 
with state legislation and mandatory report requirements
■  The information will be passed onto a “professional” 
person who may then speak with the D&A professional 
about more specific details of the case
■  This person will then consult with other members of the 
DoCS team about the case and a decision will be made 
that same day about how to proceed. The options are:
a)  The report will be treated as an “intake only”. This 
means that no information will be recorded against 
the client/child
b)  The report will be filed as an “active case”. This 
means that the information will be recorded on the 
client’s file and on the DoCS database
c)  The report is considered serious enough to warrant 
follow-up by the local DoCS office. In this case, 
DoCS will make contact with the client/child and 
conduct a thorough risk assessment to determine 
the need for further intervention with the child. 
During this assessment, individual interviews will 
be conducted with the child and his/her parents. 
Open-ended questions are asked, and where 
possible specific incidents involving abuse will not 
be mentioned. In addition, no mention will be made 
about who reported the abuse to DoCS.
■  The D&A professional, when talking with DoCS, may 
need to provide a recommendation as to what the 
course of action should be for a particular client.  
Information can also be provided to DoCS about how 
best to manage the client’s problematic drug and 
alcohol use.
It is important that the decision to report suspected 
cases of abuse should not be based on whether or 
not the D&A professional believes that their report 
will be followed-up by DoCS. The consequences of 
not reporting incidences of abuse/violence against or 
witnessed by children are serious. Risk to the child can 
be re-assessed as more information comes to light 
about the family situation. One report to DoCS does not 
absolve the D&A professional of reporting requirements, 
and it is extremely useful for DoCS to have any new 
information about the same client, particularly if it is to 
establish a pattern of behaviour. 
A therapeutic relationship should be maintained with the 
client (carer/parent) throughout this process, however 
duty of care to the child overrides duty of care to the 
client. Where appropriate, there are harm reduction 
suggestions that can be discussed with clients, such 
as not using in front of children, etc. Further, for many 
clients, a large proportion with children will cite their 
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children as primary reasons for reducing/ceasing use. 
An effective D&A professional can use this to motivate 
change, along with techniques to improve the client’s 
parenting skills and capacity to be positively involved 
with their children. This can have a flow-on effect to 
mental health and drug and alcohol use.
If something worthy of notification is raised during a 
session with a client, the D&A professional needs to 
address that issue within that session (eg. client reveals 
he/she is having thoughts of killing self and children): 
“What you are telling me is important information, and 
as a responsible professional I can’t let it pass. I feel 
really bad about this, but I am required by law to inform 
welfare about this to see if you can get some helpIn all 
likelihood, the welfare people will be pleased to know 
we are currently involved in treatment and will see that 
as good enough - they may not need to do anything 
else, but they do need to be told.”
Supervision can assist the D&A professional to make 
decisions about when and how to manage these types 
of difficulties with clients.
7.4 Sexual and gender diverse groups 
Some evidence exists to suggest that a higher incidence 
of problematic drug and alcohol use may occur in gay 
and bisexually active men and lesbian women than for 
women and men in exclusively heterosexual relationships 
(16). This is particularly true for cannabis and tobacco use 
(16). The percentages of same sex attracted young people 
injecting drugs dropped from 11% in 1998 to 4% in 2004. 
Nevertheless drug use still remains substantially higher than 
for heterosexual young people, with double the number of 
same sex attracted young people having injected drugs. 
Despite any improvements that may have occurred 
within society in terms of attitudes towards sexually and 
gender diverse groups, discrimination and stigma still 
exists in many situations, communities and workplaces. 
Clients of sexual and gender diverse backgrounds 
will often have experienced overt forms of violence 
and abuse, and also quite subtle forms of abuse and 
discrimination. This has important consequences 
for clients, given national and international research 
indicating a strong relationship between homophobia, 
heterosexism, social exclusion and the health status 
of individuals. As such, D&A professionals may need 
to provide this client group with additional support 
and intervention related to disrupted peer/family 
relationships, harassment and violence, and anxieties 
about sexual behaviour.
Fundamentally, drug and alcohol treatment for clients 
of sexual and gender diverse backgrounds is the same 
as for any other client group, with the focus remaining 
on the client being treated. Small modifications in 
language will need to be made, particularly for the 
way in which family members and partners are referred 
to. Importantly, the D&A professional should take the 
client’s lead in discussing the importance of issues 
related to their sexuality and treatment. 
Of particular importance to D&A professionals providing 
treatment for clients of sexual and gender diverse 
backgrounds, is the increased proportion of HIV 
experienced by this group. Given the higher incidence of 
drug and alcohol use among drug and alcohol clients of 
these backgrounds, their risk of engaging in risky sexual 
practices is also significantly higher than for other groups 
in the Community. D&A professionals need to be aware 
of these issues, and provide support and information 
about harm reduction strategies to clients of sexual 
and gender diverse backgrounds. Such information and 
support will not be limited to problematic drug and 
alcohol use. This should also include safe sexual practices 
and information or access to appropriate role models 
to provide support and acceptance around same-sex 
relationship issues. Evidence suggests that internet use 
among clients of sexual and gender diverse backgrounds 
is common, particularly given the anonymity associated 
with accessing this media and the access to information 
and on-line support. D&A professionals can also then 
provide this client group with relevant and appropriate 
web addresses for these purposes.
7.5 Ageing population 
As the age of the Australian community increases it is 
necessary to recognise the needs of the elderly. Elderly 
people with problematic drug and alcohol use have 
greater need for support services. Their increased age, 
coupled with the effects of drug or alcohol misuse, make 
them less able to cope in the community. Older people 
are also more vulnerable to the effects of alcohol/other 
drugs and to the deleterious side effects and illness 
associated with problematic drug and alcohol use 
(241). They will be more susceptible to complications 
in withdrawal phases of treatment, and more likely to 
experience falls and associated injuries (28, 241). The 
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relevant clinical guidelines are the NSW Health Drug and 
Alcohol Withdrawal Clinical Practice Guidelines (6). 
In assessing older clients, a lifespan problematic drug 
and alcohol use history is essential, although this can 
be difficult if memory problems are present (241). Very 
few assessment instruments exist to assist this process. 
However, problematic drug and alcohol use is likely in 
older people exhibiting the following signs (pg 350, 241), 
and these issues could be raised by the D&A professional 
in their assessment: 
■  Falls or accidents
■  Poor nutrition
■  Family problems and social isolation
■  Medical problems
■  Inability to perform everyday activities
■  Unfit to drive a car.
Once a psychosocial treatment program has commenced 
with an older client, it is reasonable to expect that a 
significant and sustainable change in problematic drug 
and alcohol use is possible (241). Older people will 
likely have experienced a range of losses that could 
be targets for psychosocial treatment (eg. retirement, 
loss of spouse/friends, loss of health/mobility, etc). For 
clients with memory problems, any treatment strategy 
should be adapted sensitively, with the D&A professional 
offering written information to support key messages, 
and working with the client to develop strategies to 
remember important activities, tasks, etc. Suicidality is 
often high among people over 65, and attempts are 
usually more lethal by virtue of the potential for medical 
complications in older people (241). Regular suicide risk 
assessment should form part of routine practice for D&A 
professionals treating this client group.
7.6 Coerced clients 
The concept of “coerced” clients takes in a wide 
variety of presentations that can include court referrals, 
requirements of employment, requirements of schools and 
educational facilities and finally partner or family pressure 
(2). It is likely that the numbers of coerced clients seen by 
D&A professionals and agencies will increase in coming 
years in part due to changes of government and industry 
policy. This section will look first at therapeutic issues that 
are common to most presentations with coerced clients 
and then focus on some specific issues relating to criminal 
justice coerced clients.
Some of the key general issues relate to special care than 
needs to be taken in establishing and negotiating the 
treatment framework and plan. These include: (242, 243):
■  Confidentiality, which needs to be clarified, negotiated 
and agreed upon by all key stakeholders from the 
outset of treatment
■  Conflicts of interest between the views of the D&A 
professional and the conditions under which the client 
accesses treatment
■  Client resistance to change, given motivation to engage 
in treatment is usually external rather than internal
■  The client goal regarding substance use and how 
that relates to agency, employer, court and family 
requirements or concerns. It is here that goals of 
abstinence or harm minimisation can often prove 
problematic when there are differing views from the 
client and the other stakeholders involved. 
If a coerced client is motivated to engage in a 
psychosocial treatment program, treatment should 
proceed as per any client (see Sections 3 and 4). 
However, if a client is unmotivated and unresponsive, 
then a brief motivational, educational intervention is 
indicated as a first step, prior to any more intensive 
treatment being commenced (50, 54). 
7.6.1  Coerced clients from criminal 
justice settings
D&A professionals may see coerced clients in at least 
three broad categories:
■  When a client is referred without any apparent 
coercion but on assessment or during treatment it 
emerges that legal or court issues are in fact an issue 
for the client. There may or may not be expectations of 
feedback or reports to the courts or legal stakeholders
■  When a court or legal stakeholder refers to a D&A 
professional or agency with a view for an assessment 
or treatment to be provided. There is usually a strong 
expectation that feedback or a report will be provided 
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■  When a court or legal stakeholder refers to a drug 
court or court diversion programme, which is governed 
by formal protocols including the reporting framework.
The key point here is that while the psychosocial 
treatments that are provided will remain broadly 
similar in all three situations, the establishment of the 
therapeutic framework and the process of negotiating 
coordinated care and the agreed reporting process may 
differ. D&A professionals need to ensure they are clear 
what service it is that they are providing and how they 
will communicate this with courts and related agencies.
There is good evidence that drug court and court 
diversion programs, with their associated psychosocial 
elements, can produce beneficial treatment outcomes 
in terms of reduced substance use, better psychological 
functioning and reduced criminal activity. There is 
also evidence that programs that address social and 
environmental factors, in addition to focussing on 
the substance use, will be more successful. Evidence 
also exists that outcomes are better when clients 
complete programs (244). Outcomes from these types 
of programmes indicate that good outcomes can 
occur when a partnership occurs between health, 
legal professionals and the offender client (‘therapeutic 
jurisprudence’, 245). The implication is that similar results 
may also be obtained in more general settings providing 
that a partnership, with client’s consent, is formed by the 
D&A professional and the court related agencies. 
When treating coerced clients and/or those 
involved with the criminal justice system, drug 
and alcohol professionals need to be aware of 
the legal implications of treatment they provide 
to the client including questions of whether 
the court has mandated treatment or a form of 
treatment and what occurs if the client completes 
or does not complete treatment. Obtaining clear 
information about things such as bail conditions, 
court orders, court dates, solicitor contact details 
and prior criminal history are often extremely helpful 
when formulating treatment plans and providing 
treatment. Drug and alcohol professionals also 
need to be mindful that court processes are usually 
stressful for clients and may themselves influence 
current behaviour and self-report.
When treating clients involved with the criminal justice 
system, it may be necessary for the D&A professional 
to provide a formal report to the courts regarding client 
progress. In these cases, the following guidelines can be 
helpful:
■  Keep all reports and clinical records factual rather than 
speculative or reflective
■  Verify the facts of the client’s case and behaviours by 
checking to make sure what the client claims is actually 
correct
■  Avoid offering suggestions for client sentencing
■  Avoid the use of jargon and opinion unsupported 
by facts.
7.7  People from diverse cultural and 
linguistic backgrounds 
There can be diversity in the patterns of use within cultural 
groups, as well as differences in usage patterns between 
difference cultural groups. For example, people from 
a European background are more likely to have used 
alcohol and cannabis than those from an Asian or Arabic 
background (246). Each cultural group will also have its 
own norms and values in relation to drug and alcohol use 
and, whilst it is important for D&A professionals to be 
aware of these norms, it is also important to understand 
that a client’s drug and alcohol use may not necessarily be 
in accordance with these norms.
Very little firm evidence exists to suggest any culturally 
bound variables that are associated with problematic 
drug and alcohol use among people from culturally 
and linguistically diverse communities in Australia (247). 
However, immersion in Australian culture may play a role 
in the initiation and maintenance of problematic drug 
and alcohol use among people from diverse cultural 
backgrounds, as they try to adapt to life in Australia. 
For example, for people immigrating to a new country, 
problematic drug and alcohol use may be used as a stress-
reduction strategy adopted in response to the pressures of 
adapting to a new environment, or as a means to ‘fit-in’ 
with the new community (245). This experience will often 
be compounded for those people who are refugees (i.e. 
Involuntary migrants), who may also struggle with issues 
of family separation, socio-economic disadvantage and 
the impact of traumatic events experienced or witnessed 
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in their home country (248) these issues will increase risk 
of drug and alcohol use. 
It may also be that the strong anti-drug and alcohol 
messages that people in the general community 
in Australia have been receiving via the media for 
decades have been missed or not understood by those 
immigrating to Australia, particularly those from non-
English speaking backgrounds (249). As such, there 
remains a key role for D&A professionals to ensure that 
health promotion messages targeted to the english-
speaking population are applied in an accessible and 
appropriate format for people from culturally and 
linguistically diverse backgrounds (246). Strategies could 
include translation of written materials, and the provision 
of alternatives to written materials such as audio, 
visual, or theatrical resources. A range of multicultural 
information is also available via the internet, including 
the following websites:
■  Druginfo clearinghouse – http://www.druginfo.adf.org.
au/multicultural/
■  NSW Multicultural Health Communication Service - 
http://www.mhcs.health.nsw.gov.au
■  National Drugs Campaign – http://www.drugs.
health.gov.au/internet/drugs/publishing.nsf/content/
languages-other-than-english
■  QUIT (tobacco) – http://www.quit.org.au/browse.
asp?containerid=1643.
It is suggested that psychosocial approaches to 
problematic drug and alcohol use (see Sections 3 and 4) 
can be used with people of different ethnic backgrounds 
(250). However, very little research exists that directly 
tests the application of these approaches to people from 
culturally and linguistically diverse backgrounds. It is 
not immediately clear how the needs and perspectives 
of people from culturally and linguistically diverse 
communities fit within these approaches, nor whether 
doing so will influence problematic drug and alcohol use 
(246). Some experts suggest that traditional treatment 
approaches may not be appropriate for use among people 
from culturally and linguistically diverse backgrounds, 
and that seeking out or engaging with external agencies 
(i.e. those outside the family or community) may not be 
culturally acceptable (251). Additional efforts may need to 
focus on engaging with the community in general, with 
the aim of establishing trust and rapport. 
For the D&A professional working with people from 
culturally and linguistically diverse groups, engagement 
with the community is vital. Messages regarding the 
impact of problematic drug and alcohol use should 
be presented in a language that the target audience 
can understand easily and be reinforced by prominent 
members within the cultural community, instead of 
being imposed from the outside (246). The influence of 
the cultural community of the client might be important 
in strengthening the messages delivered in treatment, 
perhaps in the same way that the community plays an 
important role in the health and well-being of clients of 
Aboriginal and Torres Strait Islander descent. 
Being aware of local migrant health services within 
and external to drug and alcohol services is essential, 
as is access to a professional interpreting service when 
issues of language arise. NSW Health has provided a 
policy directive governing when and how professional 
interpreters should be used (see http://www.health.nsw.
gov.au/policies/pd/2006/pdf/pd2006_053.pdf). Such 
situations include: assessments, explanations of treatments/
medical instructions, obtaining consent for treatments, 
at discharge, counselling (including psychosocial 
interventions), high risk and life threatening situations, 
etc when a professional interpreter cannot be present in 
person, telephone or videoconferencing may be used.
NSW Health Care Interpreter Service is available 
at all NSW public health facilities, free of charge, 
seven days a week, 24 hours a day. See the NSW 
Health Policy Directive PD2006_053. The relevant 
Area Health Service contact numbers are listed in 
Appendix C of this document. 
A general telephone-based translating and 
interpreting service is also available: 131 450
7.8 Rural communities 
People living in rural/remote communities report 
particular difficulties accessing psychosocial treatments 
because of limited available services and geographic 
isolation (242, 252). In addition, attitudinal or cultural 
barriers to treatment for substance misuse may be 
more prominent, affecting a rural client’s likelihood 
of engaging in self-help meetings or treatment more 
generally (16). The utility of self-guided approaches, such 
as bibliotherapy or computerised treatments, in these 
settings cannot be overstated, along with the potential 
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for psychosocial treatments to be offered via alternative 
methods to face-to-face (eg. telephone, email, internet, 
etc, see section 4). Telecommunications and the use of 
technology in service delivery have a special role to play 
in making services accessible to these populations.
As with other communities, D&A professionals 
working in rural/remote areas need to spend time 
networking with local health providers, and fostering 
trust, non-judgemental acceptance and confidentiality 
in their engagement with rural clients. In small rural 
communities, anonymity is very difficult to maintain, 
presenting a range of additional challenges for the D&A 
professional in maintaining professional boundaries with 
the client group.
7.9 Parents with drug and alcohol issues 
The Department of Corrective Services Families First has 
received drug summit funding for innovative prevention 
and early intervention projects to support families, 
communities and individuals with problematic drug and 
alcohol use. In a number of area health services, this 
funding has been used to implement projects to support 
substance-using mothers during pregnancy, and during 
the child’s early infancy.
For clients who already have children, assessment should 
cover family functioning and how the children function 
and develop, even when there are no child protection 
concerns present for the family. D&A professionals 
should be able to provide basic parenting advice to 
clients with families, however should refer to specialist 
services such as family support in cases where more 
intervention is required.
7.9.1 Drug and alcohol use in pregnancy 
The American Psychiatric Association (16) highlights 
the potential for problematic drug and alcohol use to 
impact negatively on the developing foetus. Accordingly, 
D&A professionals should be encouraged to work 
with pregnant women on a plan to manage/reduce/
abstain from substances during pregnancy and while 
breastfeeding, with psychosocial approaches central to 
this process. It is vital that partners/significant others of 
pregnant women be engaged in the drug and alcohol 
treatment process to assist in reinforcing messages 
provided during treatment and in encouraging treatment 
adherence and attendance. Treatment may also be offered 
to partners/significant others for problematic drug and 
alcohol use (if present) as this will impact significantly on 
the pregnant woman’s drug and alcohol use (253).
Tobacco has long been considered harmful to the 
developing child, and is associated with increased risk 
of miscarriage, premature birth, low birth weight and 
longer-term health effects (253). Pregnant women who 
smoke should be encouraged to engage with a smoking 
cessation program to mitigate these risk factors. The 
national clinical guidelines for the management of drug 
use during pregnancy, birth and the early development 
years of the newborn (253) recommend that five steps be 
taken to assess and manage smoking in pregnancy clients.
The ‘5 As’ (brief intervention for smoking 
cessation in pregnant women, 253)
■  ASK all women if they smoke tobacco and record 
smoking status (including recent quitters).
■  Provide ADVICE regarding smoking cessation to 
continuing smokers.
■  ASSESS stage of change for continuing smokers.
■  ASSIST continuing smokers to modify use (eg via 
motivational interviewing, CBT), with abstinence 
recommended in all cases.
■  ARRANGE follow-up after a quit attempt.
It is unclear whether Nicotine Replacement Therapy is 
safe in pregnancy, and psychosocial options should be 
tried as a first line treatment option (253).
Alcohol consumed by mothers during pregnancy can 
seriously affect the health and development of their 
unborn child. For example, some babies will be born with 
foetal-alcohol syndrome, which can include weighing less 
than expected at birth and having unusual facial features. 
Foetal-alcohol syndrome is more prevalent in indigenous 
than non-indigenous infants. Secondary effects of this 
disorder, such as behavioural, learning and mental health 
problems may not manifest in babies until well after birth. 
The World Health Organisation has stated that foetal-
alcohol effects are the commonest cause of congenital 
developmental delay.
The World Health Organisation suggests that 
there is no safe level of drinking alcohol during 
pregnancy and that abstinence from alcohol is the 
safest approach (254).
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Pregnant drug and alcohol clients should be encouraged 
to reduce alcohol consumption as much as possible, 
if not eliminate it completely. Psychosocial treatment 
approaches are potentially of most benefit in reducing 
alcohol consumption, however pregnant women should 
also be offered priority access to the range of treatment 
options where indicated (253). At the very least, only 
small amounts (eg. One drink less than once a week) 
should be consumed (254). These levels should be 
maintained while the mother is breastfeeding, as the 
infant’s brain continues to develop over the first 12 
months and can be affected by alcohol crossing into the 
mother’s milk (254).
Mothers using heroin during pregnancy and whilst 
breastfeeding are also placing their babies at increased 
risk of a range of abnormalities and developmental 
problems, including HIV, HCV, HBV and other infections 
associated with injecting drug use. Heroin dependent 
pregnant women are strongly advised to enrol in 
methadone maintenance program for their pregnancy 
and following birth to reduce these risks, particularly 
given the improvements in health, diet and other 
lifestyle factors that often coincide with engagement in 
Methadone Maintenance Programs (253, 254). However, 
methadone does cross the placenta, so neonates will still 
have a risk of developing a neonatal opiate withdrawal 
syndrome. Importantly, pregnant mothers using 
heroin are advised against an unsupported attempt at 
withdrawal as the effects on the mother and unborn 
child include miscarriage and premature labour(254). 
Managing/reducing heroin use and/or methadone 
treatment should be closely monitored by a range of 
medical and D&A professionals. The first-line treatment 
for opioid-dependent pregnant women is methadone 
maintenance treatment (253). However, if a woman is 
already established on a buprenorphine maintenance 
program, then this can be continued during pregnancy 
and while breastfeeding. 
Much less research has been conducted on the effects 
of cannabis, amphetamines and other illicit drugs on 
the developing foetus. However, drugs will cross the 
placenta and be excreted in breast milk, resulting 
in a range of infections, breathing problems, and 
developmental issues in babies (254). Pregnant and 
breastfeeding mothers are advised to reduce their use 
of cannabis, amphetamines, etc. To reduce these effects 
on the baby, with abstinence being the ideal goal during 
this time (253). Psychosocial treatment approaches are 
central to this reduction process.
In general, breastfeeding mothers who are using drug 
and alcohol should be advised to express breast milk 
prior to using to minimise the amount available to the 
baby through breast milk (254). 
It is a given that problematic drug and alcohol use in 
pregnancy is associated with a range of risks for the 
mother and developing child. However, such behaviour 
also highlights the potential need for education and 
training in parenting skills, and a range of socioeconomic 
issues that may need to be addressed (16, pg 43). 
The goals of treatment for pregnant women 
should be to (16):
1. Provide treatment for the substance use problem
2.  Provide treatment for any co-occurring psychiatric 
or medical conditions
3.  Monitor the pregnant mother’s behaviour and 
risk taking activities during and following the 
pregnancy
4.  Encourage the development of effective parenting 
skills
5.  Encourage the mother to keep to drug and 
alcohol goals following childbirth.
More information about pregnancy, breastfeeding and 
drug and alcohol use is available from the Australian Drug 
Foundation (http://www.adf.org.au) and the Drug Info 
Clearinghouse (http://www.druginfo.adf.org.au). NSW 
Health has published national clinical guidelines for the 
management of drug use during pregnancy, birth and 
the early development years of the newborn, which are 
available at http://www.health.nsw.gov.au/pubs/2006/
ncg_druguse.html. In addition, D&A professionals are 
encouraged to make use of the range of strategies and 
treatment programs available within NSW Health to assist 
pregnant women address these issues.
7.10  Young people with emerging 
problems 
D&A professionals and services need to tailor their 
treatments differently to young clients with emerging 
problems (2). This will not be necessarily in terms of 
the content of psychosocial interventions offered to 
young people (eg. brief interventions, CBT, motivational 
enhancement, systemic/family therapy, psychodynamic 
PAGE 66 NSW HEALTH Drug and Alcohol Psychosocial Interventions Professional Practice Guidelines 
therapy, see Section 4), rather the process of engagement 
and providing treatment will need to consider the young 
client differently from an adult client (16).
Firstly, experimentation, including with drugs 
and alcohol, forms a relatively normal part of 
adolescence (255). Indeed, for some adolescents, this 
experimentation and experience with trial and error 
processes may be their way of developing a fully formed, 
healthy personality. While many young people do not 
use drugs and alcohol at dangerously high levels, there 
are known harms associated with all levels of misuse. It 
is also recognised that some young people will develop 
chronic patterns of drug use and engage in frequent 
harmful binging. As with adult clients, when drug and 
alcohol use becomes habitual and/or normal functioning 
is affected, it is cause for concern. 
The assessment and diagnosis of problems among 
young people is difficult, given adolescence is a time 
of potentially tumultuous growth and change (255). 
However, the first presentations of psychosis will be 
emerging for vulnerable clients at this time, and this 
is often associated with cannabis and amphetamine 
use. Depression and anxiety disorders also first emerge 
during adolescence, which can also be exacerbated 
or ‘self-medicated’ with problematic drug and alcohol 
use. Characteristic of these emerging conditions will be 
obvious changes from previous levels of functioning, 
and treatment will also need to target these changes 
and symptoms in addition to problematic drug and 
alcohol use.
It is important that the D&A professional understands 
that the adolescent drug and alcohol user is not just a 
younger version of an adult drug and alcohol user (255). 
Adolescence is a time of establishing independence 
(especially from parents and adult authority figures), 
where relationships with peers are exceptionally important 
(255). D&A professionals working with young people 
need to recognise this, and use strategies such as humour 
to assist in the rapport and engagement process (255). 
Encouraging the development of ‘normal’ peer-related 
activities outside of therapy, such as playing sports, joining 
various social groups, playing music, drawing/artistic 
expression, should also be the focus of treatment sessions 
with adolescence. Or, at least these activities, when they 
are already occurring for some young people, should be 
strongly reinforced during therapy.
Young people also typically have higher energy 
levels than older adults, and as a therapist, the D&A 
professional must also be prepared to take on a more 
active, energetic role in treatment, rather than relying 
on some of the more passive, reflective skills to promote 
engagement and build rapport. In addition, having a 
‘youth-friendly’ environment in which to see young 
people is important. Simple strategies such as setting 
up a waiting room to indicate that young people are 
welcome can be useful in promoting engagement with 
a young client population. This might include photos 
of young people, images of activities relevant to young 
people displayed, etc.
Marsh and Dale outline several key strategies to 
consider when working with young people (pgs 
290-294, 2):
■  Limit use of scare tactics
■  Take longer to establish rapport and trust 
within therapy
■  Ensure confidentiality is maintained
■  Provide structure, and set and reinforce clear limits
■  Allow the young client some freedom to choose 
their own goals for behaviour
■  Young people learn best when they try out 
experiences for themselves
■  Take a harm reduction approach
■  Use concrete, behavioural strategies
■  Remember that the young client operates within 
the context of a family, so they should also be 
involved where possible.
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The NSW Health clinician’s toolkit defines clinical 
governance as: 
“The framework through which health organisations 
are accountable for continuously improving the quality 
of their services and safeguarding high standards of 
care by creating an environment in which excellence in 
clinical care will flourish” (pg 2, 256).
Excellence in clinical care will therefore involve 
integration between individual D&A professionals, 
the team within which they are operating, and the 
wider service in which their team sits. Individuals 
working at each of these levels will have differing 
roles and responsibilities in ensuring that high quality 
clinical care is being consistently delivered to clients 
engaged with drug and alcohol services. 
This section focuses on clinical governance at the 
managerial, team and clinician level. Note however 
that clients, and sometimes significant others, are 
also important partners in the clinical governance 
process, most often as active participants in 
individual clinical reviews. More detailed discussion 
of client collaboration, the engagement of significant 
others, communities and other support people are 
outlined in Sections 3, 4 and 7.
8.1  Suggested responsibilities of 
D&A professionals
Individual D&A professionals are responsible for their 
individual clients, and need to have sufficient skills, 
training and competence regarding the treatment 
of presenting complaints of clients accessing their 
service. However, no single D&A professional is 
expected to be an expert in the treatment of every 
issue or problem a client presents with, nor is any 
one team or service. Knowing one’s limitations, 
or those of the team or service, is important in 
providing effective, quality and helpful clinical 
interventions (4).
Before proceeding, it is important to acknowledge that 
private practitioners usually develop their own clinical 
governance system, be it in individual or group practice. 
This can usually be tailored to the individual needs of 
the professional involved. Private practitioners are able 
to consult with local drug and alcohol agencies and 
the specialist advisory service over individual cases. For 
other forms of skills development or training, private 
practitioners may need to talk to the local drug and 
alcohol agencies, local or regional professional groups, 
or attend courses offered by training organisations and 
universities in order to see what is available that might 
meet their needs.
As described in previous sections, one component of 
good clinical care involves the implementation of a 
range of assessments and evidence-based treatment 
strategies by the D&A professional to assist clients work 
towards their identified goals. At a broader service level, 
formalised clinical reviews of client progress through 
treatment, including the core activities of regular 
consultation, supervision and clinical review/measurement 
of outcome will also be central to the provision of good 
clinical care (4, 256). The ways in which these activities 
are routinely incorporated into a team or service context 
should be determined at a local level, in line with policies 
and the needs of the clinical team. 
Once a client has been accepted into a service, 
completed the assessment and treatment planning 
processes and has engaged in a treatment program, 
review and monitoring processes become important 
in determining how well the client has responded. 
From the perspective of the individual D&A 
professional, accurate clinical record keeping is an 
essential component of good clinical practice in these 
circumstances. Clinical/medical records also serve the 
broader purposes of teaching, as clinical audits, and 
providing evidence in the event of medico-legal issues. 
They are also a vital source of statistical and managerial 
information for the day to day running of the service. 
Core components of clinical/medical notes for drug and 
alcohol clients are suggested below.
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Content of clinical/medical notes (257)
■  Contain clinically relevant information only
■  Judgements of a personal nature should not 
be used. Comments about a client should be 
objective, factual and be relevant to their clinical 
assessment and treatment
■  Record presenting symptoms, diagnosis, and 
treatment (document each episode of care 
including telephone calls, consultation with other 
professionals etc.)
■  Summarise the following issues: what are your 
goals in treatment, why did you choose that 
treatment, have you provided informed consent 
by talking with the client about risks involved and 
alternatives to that treatment, and what are your 
rationales for referrals you’ve provided?
■  Any release of information obtained
■  Details of any risk assessments conducted 
(eg assessment of suicide risk, justification of level 
of risk assigned to client, etc).
Common problems with clinical notes include the 
following issues (257):
■  Absence of clarity eg the meaning of ‘had a good day’ 
and ‘slept well’ is not clear
■  Failure to record action taken when a problem is 
identified, eg ‘is suffering increasing pain’ then no 
record of action taken
■  Failure to document conversations
■  Failure to document care given
■  Failure to document special needs
■  Failure to record telephone calls, eg, on risk of suicide.
8.2  Suggested responsibilities of 
clinical teams and services
Where possible, D&A professionals should not work in 
isolation, and so responsibility for client welfare will also 
rest with the service team and the larger drug and alcohol 
agency, where there is more than one team. In practice, all 
these levels provide input into the consultation, supervision 
and management process. This can be complex, as staff 
involved at each level need to communicate well, and have 
an understanding and respect for the tasks required by 
each member of the team/service. 
Within a clinical team, a range of disciplines will be 
represented, and each professional will have a defined 
role in addressing a client’s problematic drug and alcohol 
use. D&A professionals working in a team environment 
need to acknowledge these different roles, particularly 
of those with different professional backgrounds and 
training from the D&A professional. In communicating 
with other D&A professionals, good clinical practice 
continues to apply. For example, a D&A professional 
should be aware of psychological questions that may be 
asked by a psychologist, and aware of medical questions 
that may be asked by a medical professional, etc, in 
consulting with medical professionals, non-medical D&A 
professionals should also appreciate the need to present 
them with facts, figures and particulars of a client, make 
a hypothesis about the problem situation, and be direct 
and specific about the questions requiring input.
8.2.1 Clinical supervision 
Regular clinical supervision and review is important to 
good clinical practice, and is not a process meant to 
undermine practice or confidence, but rather to support 
the D&A professional and the client. The NSW Drug 
and Alcohol Clinical Supervision Guidelines (10) and the 
Clinical Supervision Resource Kit for the alcohol and other 
drugs field published by the National Centre for Education 
and Training on Addiction (NCETA, 258) provide detailed 
information about the process of clinical supervision 
and the roles of key players in the supervision process. 
In particular, clinical supervision is considered to be a 
tool for workforce development, can be used to review 
and maintain quality and clinical safety, and is a method 
by which D&A professionals can provide and receive 
support and debriefing for what is often a difficult and 
complex client group (10). These guidelines define clinical 
supervision in the following terms (pg 6-7, 10): 
“A formal and ongoing arrangement between one 
worker and a (generally) more experienced practitioner 
whereby the clinical practice of the worker is reviewed 
and discussed in confidence for the purposes of:
■  Further developing the worker’s professional identity 
and practice
■  Ensuring workers are operating within relevant clinical, 
organisational, ethical, professional boundaries
■  Monitoring and supporting the worker’s wellbeing and 
coping capacity in relation to their work.”
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Broadly, clinical supervision could cover the following 
issues (pg 9, 10): 
■  Methods and modalities of clinical practice
■  Concerns the drug and alcohol professional has 
about client progress, establishing or maintaining 
boundaries, etc
■  Any negative impact a client is having on the drug 
and alcohol professional
■  Skill and knowledge development
■  Ethical and professional practice
■  Workload issues.
Clinical supervision can be conducted individually or 
in groups, and is usually conducted by experienced 
clinicians. Supervision with peers is more frequent 
with senior staff. There is agreement that, except in 
special circumstances, clinical supervision should not 
be provided by the D&A professional’s clinical line 
manager, as this may affect the supervision process.(10). 
Clinical line managers still have an indirect role in the 
clinical supervision process, by allowing the supervisor 
and supervisee time within the work day to conduct 
supervision sessions (10). 
Clinical supervision is often characterised by a high but 
not absolute degree of privacy for the supervisee(s), 
which distinguishes it from most clinical review and 
clinical line management processes. Another feature 
of clinical supervision is that it should be adaptable to 
the needs of the professional. For example, a highly 
structured approach that may be necessary with a novice 
professional may be inappropriate for a professional of 
20 years’ standing.
8.2.2 Clinical review
The concept of clinical review can relate to a range of 
clinical governance activities. For this section, “client” 
and “clinical” review will be combined. While there 
are many variations on clinical review, the following 
strategies highlight the key ways in which this process 
may be carried out:
■  A form of clinical supervision whereby clinical 
line management is excluded and the focus is on 
professional development for each participant (10)
■  A team activity that forms part of the clinical 
governance procedures for a team (4). Usually this 
activity ensures that most, if not all, clients of a service 
team have some discussion regarding their entry, 
progress and discharge. Clinical line managers and 
sometimes staff from other teams or disciplines may be 
involved in this type of clinical review. Documentation 
from this type of review will be apparent in the 
individual medical records, client review pro-forma and 
team summaries capable of audit
■  A review of an individual client between the treating 
D&A professional and the clinical line manager or a 
senior clinician. The features of this type of review is 
that it often leads to re-formulated treatment plans 
that can be documented and is usually used when 
complex issues are identified with a particular client (4)
■  A review to look at a particular client, sentinel event or 
a clinical issue impacting on a class of clients (256).
D&A professionals need to be knowledgeable about the 
differing types of clinical review in addition to clinical 
supervision. Good clinical practice is indicated by a well 
thought out mix of clinical review and clinical supervision 
practices.
The clinician’s toolkit (256) makes many valuable 
suggestions about the differing approaches a review 
meeting can take, although some adaptation may be 
required as some of the suggestions are more relevant 
to hospital rather than community health based settings. 
The toolkit provides some detail on how to review 
and discuss one’s own and others’ clinical practices; 
adverse events and the team’s performance; morbidity 
and mortality meetings to review deaths and other 
adverse outcomes in clients; or ad hoc reviews/audits 
of specific practices, case notes to identify any general 
problems with the team/service in providing care (256). 
Importantly, clinical indicator data such as local activity 
data, minimum data set and IIMS data can be used 
to highlight possible problems or opportunities for 
improvements in client management of individual clients 
and client groups. 
For client reviews to function well, there needs to be 
a culture where D&A professionals can talk about 
successes, near misses and mistakes within the context 
of trying to improve individual client care, and fix 
problems that might be occurring at a service level. An 
often-delicate balance needs to be struck between the 
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need for individual accountability within a team dynamic 
that encourages both transparency, support, and 
learning, so that client care is improved. 
Suggestions for clinical review sessions 
(pgs 3-16, 256):
■  Client reviews on presenting, complex and 
discharged clients
■  Facilitated incident monitoring (in response to event)
■  Sentinel event monitoring (prospectively or in 
response to event)
■  Effective use of clinical indicators (as required)
■  Peer review meetings; 
■  Morbidity and mortality meetings
■  Ad hoc audits/reviews.
8.2.3 Clinical line management 
All D&A professionals will report to a senior person or 
clinical line manager. Just as the knowledge base and 
competencies for a D&A professional is varied and takes 
many years to learn, so it is that the management of 
psychosocial services requires learning. At a minimum, 
the management of psychosocial work/teams 
needs to be done by managers who are themselves 
knowledgeable about the range of psychosocial 
treatments and the often-complex issues that are 
involved in delivery of these treatments. In contrast 
to clinical supervisors (who are only responsible for 
addressing matters raised within clinical supervision 
sessions), clinical line managers carry the overall clinical 
accountability on behalf of the agency (10). Clinical line 
managers usually have the following tasks:
■  Provide consultancy and at times direction to 
D&A professionals. This can include sharing medico-
legal risk 
■  Ensure that procedures are happening in line with 
service- and state-wide policies
■  Ensuring the workforce development issues for D&A 
professionals and service teams are being met, such 
as in facilitating attendance at professional training, 
clinical supervision, quality improvement activities and 
research
■  Ensure D&A professionals and service teams have the 
opportunity to work in a harmonious and supportive 
environment, where the employer demonstrates care 
for the staff and encourages self-care from the staff. 
Good clinical outcomes with clients will be impaired 
when D&A professionals and teams suffer from 
low morale, poor workforce development, lack of 
consultation and a culture of aggression or neglect. 
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The following clinical experts provided advice regarding 
the content of the guidelines:
■  Professor Bob Batey, AM 
Clinical Advisor, Mental Health and Drug & Alcohol, 
Co-chair, Quality in Treatment Committee
■  Dr John Howard 
Quality in Treatment Committee. Director of Clinical 
Services, Training and Research, Ted Noffs Foundation 
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Below are the Area Health Service contact telephone 
numbers for the NSW Health Care Interpreter Service. 
The numbers below are valid as at 5th March 2008.
Sydney South West (Western zone) 
02 9828 6801
 
Sydney South West (Eastern zone) 
02 9515 9516
 
SESIAHS - Northern Sector 
02 9515 9516
 
SESIAHS - Southern Sector
02 4274 4211
 
Greater Southern Area Health Service
02 4274 4211
NSCC - Northern Sydney sector 
02 9926 7690
 
NSCC - Central Coast sector 
02 4924 6286
 
Hunter New England 
02 4924 6286
 
Sydney West 
02 9840 3697
 
To contact the Translating and 
Interpreting Service (TIS):  
131 450
 
See also NSW Health Policy Directive PD 2006_053 
dated 11 July 2006
APPENDIX C
NSW Health Care Interpreter Service 

SHPN (MHDAO) 070224
